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ABSTRACT 
Two superfamilies were used to explore the structure/function relationship as it 
pertains to enzyme specificity.  The structures and mechanisms of phosphatases belonging 
to the Haloalkanoate Dehalogenase Superfamily (HADSF) and thioesterases of the Hotdog 
Fold Superfamily (HDFSF) were determined using X-ray crystallography and other 
biophysical tools in combination with steady-state kinetics and site-directed mutagenesis. 
Together, the specific structural components of enzymes crucial for substrate recognition, 
substrate promiscuity, and catalysis were uncovered. In the HADSF, the 
phosphomannomutases (PMMs) catalyze the interconversion of mannose 6-phosphate and 
mannose 1-phosphate, an essential step in the protein glycosylation pathway.  In humans, 
two isoforms PMM1 and PMM2 catalyze this reaction.  Deficiency in PMM2 activity is 
the major cause of congenital disorders of glycosylation (CDG-1a).  However, PMM1 
activity is not sufficient to replace PMM2 in protein glycosylation.  Instead, PMM1 
viii 
functions as a glucose-1,6-bisphosphate phosphatase in the presence of IMP and enables 
the temporary rescue of glycolysis during brain ischemia.  Herein, the structure of IMP 
bound to PMM1 in combination with kinetics revealed a mechanism for the differential 
substrate preference and the mechanistic switch from a mutase to phosphatase activity.  In 
the HDFSF, the majority of which function as thioesterases of aliphatic or aromatic 
compounds bound to coenzyme A or acyl carrier protein (ACP), the structural determinants 
for substrate preference were identified in PA1618, an enzyme with high substrate 
promiscuity.  The structural determinants of the specific thiosterases MA0038 and 
BVU1957 were also identified.  The variation in substrate range observed among these 
enzymes, from specific to promiscuous, led to the design of a comprehensive thioester 
screen to identify HDFSF thioesterase substrates.  The profiles of substrate specificities 
from 42 previously uncharacterized thioesterases were determined allowing comparison of 
the sequence/substrate relationships across a representative selection of thioesterases. 
Examples drawn from both HADSF and HDFSF enzymes suggested a model relating 
substrate promiscuity and specificity to regions of protein flexibility.  The motion of a 
domain within a multidomain protein or a flexible loop near the active site was correlated 
with the occurrence of substrate promiscuity/specificity. 
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Chapter 1:   Introduction 
1.1  Enzyme superfamilies: Structure and function relationship 
Enzymes are protein macromolecules that act as the catalysts to the majority of 
biological processes essential to sustain all forms of life.  They catalyze chemical reactions 
at a rate that is millions of times faster than uncatalyzed reactions (107 to 1019-fold) by 
promoting a reactive transition-state conformation thereby lowering the activation energy 
of the reaction (Wolfenden & Snider 2001).  It follows that enzymes are remarkably 
proficient and it is generally beleived that they must also be specific for their substrates in 
order to allow the precision necessary for biology to function and flourish.  Regulation of 
enzymes is tightly controlled by factors including, but not limited to, association and 
dissociation of regulatory proteins, binding allosteric effectors, and post-translational 
covalent modifications.  Alternatively, however, recent research has demonstrated that 
many enzymes are highly promiscuous and capable of catalyzing a reaction on multiple 
substrates with equal proficiency (Khersonsky et al. 2006; Khersonsky & Tawfik 2010). 
Specificity and thus, function of enzymes is dictated by the overall protein 
architecture.  The features of an active-site pocket, for example the volume and shape 
complementarity between the pocket and substrate and the molecular interactions between 
protein side chains and substrate, dictate the substrate specificity and the binding affinity 
of the enzyme to its substrates.  Thus, atomic-resolution crystal structures are crucial for 
understanding the complexities of enzymatic reactions. 
2 
 
 
 
 As a result of selective pressure, nature has evolved efficiently to reuse many 
structural motifs or domains and active-site configurations to catalyze similar reaction 
mechanisms on different substrates.  These commonly conserved domains, such as the αβ 
Rossmann fold, TIM barrel, and αβ hydrolase fold, are found in superfamilies of enzymes 
which share a common ancestry and thus, often have related chemistries.  Superfamilies 
are further divided into families that share a higher level of sequence identity.  Protein 
structure-to-function studies aim to understand the relationship of an enzyme fold to the 
chemical reactions catalyzed in the cell.   
 Enzyme structure-to-function studies exploit the idea that proteins are classified 
within ancestrally related superfamilies; thus information on a subset of enzymes can give 
insight to many related enzymes.  With the recent explosion in whole genome sequencing 
information and increase in structural PDB depositions, many databases are available to 
analyze related proteins such as Pfam (Finn et al. 2014) and UniProt (The UniProt 
Consortium 2014) using protein sequence alignments and protein structure classification 
databases, CATH (Sillitoe et al. 2013) and SCOP (Conte 2002).  With these tools in hand, 
we can study enzyme families to understand specific in vivo functions. 
 In the functional study of enzymes, kinetics often go hand in hand with X-ray 
crystal structures to understand how enzymes work as catalysts by measuring the rate of 
reaction and how it changes based on the active-site architecture.  Atomic resolution 
structural elucidation in combination with enzyme kinetics determination is a powerful 
combination for assessing the interactions between enzymes and substrates (or substrate 
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analogs).  The interactions that confer enzyme specificity and side chains involved in 
substrate stabilization or polarization, for example, can be resolved by ligand bound 
structures and confirmed by enzyme kinetics with either alternate substrates or site-directed 
protein variants. 
 In my thesis project, I have selected representative enzymes from two enzyme 
superfamilies—the haloalkanoic acid dehalogenase (HAD) superfamily and the hotdog-
fold (HD) superfamily.  In these projects, the aim was to gain structural insight for the 
reaction mechanism, substrate recognition, and structural components that determine 
substrate specificity and promiscuity.  Within the HAD superfamily, my thesis includes the 
study of two human phosphomannomutases, PMM1 and PMM2 (chapter 2), to characterize 
the difference between these two highly similar isoforms in vitro in order to explain their 
biological function in vivo.  In the Hotdog thioesterase superfamily, I have contributed 
toward the understanding of promiscuity and specificity within the superfamily by 
examining examples of substrate promiscuous (PA1618) enzymes (chapter 3) and specific 
(fluoroacetyl-CoA thioesterase) orthologs (chapter 4).  Moreover, on a more global scale, 
I have designed a high-throughput method for the detection of enzyme-catalyzed 
hydrolysis of thioester substrates (chapter 5) to further analyze the substrate range of the 
hotdog-fold.  In chapter 6, I proposed a model which relates enzyme flexibility to substrate 
promiscuity based on the results from my work at Boston University.  
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1.2  Haloalkanoate Dehalogenase Superfamily (HADSF) 
1.2.1 Role of Phosphoryl Transfer Enzymes 
 The addition and removal of phosphoryl groups to small metabolites or protein 
macromolecules is a central biochemical process in all cellular organisms; thus there is a 
large demand for phosphate-transfer enzymes.  To demonstrate, roughly 30-40% of 
bacterial metabolites are phosphorylated metabolites (Kuznetsova et al. 2006).  The process 
of addition of a phosphoryl group to a substrate is achieved by phosphorylases and kinases, 
while the removal is carried out by phosphatases.  Transfer of phosphoryl groups from 
substrates is a common mechanism that nature uses in such processes as the repair of 
damaged DNA and maintenance of a balanced pool of nucleic acids, metabolism of lipids, 
biosynthesis of polysaccharides and as an on/off switch in signal transductions (Figure 
1.1).  The diverse substrates that HAD enzymes act on allows their participation in an 
extensive number of reactions making it the dominant superfamily responsible for 
phosphatase reactions in many organisms. 
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Figure 1.1  Importance of phosphatase activity in all organisms exemplified by the 
processes phosphatases in which it is involved. 
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1.2.2 Haloalkanoic acid dehalogenase superfamily (HADSF) 
The haloalkanoic acid dehalogenase (HAD) superfamily is a ubiquitous enzyme 
family that is represented in all domains of life—prokaryotes, eukaryotes, and archaea.  To 
date, there are >120,000 gene sequences that encode for proteins belonging to this 
superfamily—with 28 in Escherichia coli, 30 in Mycobacterium tuberculosis, 84 in 
Caenorhabditis elegans, 169 in Arabidopsis thaliana, 183 in Homo sapiens (Allen & 
Dunaway-Mariano 2009).  To further exemplify the evolutary success of the HAD 
superfamily, it is one of the largest enzymes families and accounts for most of the 
phosphatase reactions that occur in the cell.  For example, the E. coli genome encodes 28 
HAD members which surpasses any other phosphatase family in E. coli as depicted in 
Figure 1.2.   
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Figure 1.2 All phosphatases in E. coli segregated by superfamily.  E. coli contains 28 
HADSF members which accounts for about 50% of all phosphatase activity in E. coli. This 
demonstrates the success of this superfamily in acquiring roles in phosphoryl transfer.  
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1.2.3 Reactions catalyzed by HAD enzymes 
The first reported crystal structure of a HAD member was that of 2-haloalkanoate 
dehalogenase from Psudeomonas sp. YL which catalyzes reaction at carbon, thus leading 
to the misleading family name in terms of major activity (Hisano et al. 1996a).  This class 
of bacterial haloalkanoic dehalogenases catalyzes the hydrolysis of the carbon-chloride 
bond of halogenated aliphatic hydrocarbons for detoxification of chlorinated compounds 
(Koonin & Tatusov 1994; Weightman et al. 1982).  However, the majority of HAD 
enzymes function as phosphoryl transferases.  
The evolutionary success of this large superfamily is not only displayed by the sheer 
size of the superfamily but also by its substrate diversity.  In contrast, the diversity of 
chemistries catalyzed is not extrememly broad. HAD enzymes have been shown to exhibit 
phosphatase (Rangarajan et al. 2006; Collet et al. 1997), phosphonate hydrolase (Morais et 
al. 2000a), ATPase (Aravind et al. 1998; Iyer et al. 2004), and phosphomutase activity 
(Nogly et al. 2013; Silvaggi et al. 2006), as well as reactions at carbon (Hisano et al. 1996b; 
Gross et al. 2008) (Figure 1.3).  However, the majority of the family are phosphatases that 
hydrolyze phosphate monoesters and ATPases that hydrolyze phosphoanhydride bonds 
which account for 79% and 20% of HAD members, respectively (Allen & Dunaway-
Mariano 2009).  These reactions are extended to a wide range of substrates from 
macromolecules including phosphoproteins, nucleic acids, phospholipids, or 
polysaccharides to simple metabolites such as small sugars and phosphoglycolates (Allen 
& Dunaway-Mariano 2004).   
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Figure 1.3 Diversity in HADSF catalytic reactions.  The HADSF active site supports a 
number of different phosphoryl transfer reactions and dehalogenase activities.  The 
majority, 79% are phosphatases with phosphate monoester hydrolase activity, 20% are 
ATPase that have phosphoanhydride hydrolase activity, and the remaining 1% are 
phosphonastases, phosphohexose mutases, and dehalogenases. 
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1.2.4 Structure 
HAD enzymes are structurally comprised of two domains referred to as the cap and 
core domain.  The core domain houses an active site that is tuned to perform phosphate 
hydrolyzing reactions and share a common core Rossmann-fold domain.  The cap domains 
have greater structural diversity that can be used to categorize the family into 4 subfamilies.  
But despite the tertiary structural similarity, the family shares very low sequence identity 
between members, ~10-15%, which will be further discussed below.  
 
1.2.5 Core Structure  
The core catalytic domain consists of a conserved Rossmann-like fold with a 
magnesium atom bound at the active site that is required for coordination of substrate to 
form the Michaelis-complex.  The folds secondary structure comprises at least 5 repeating 
units of β-sheet/α-helix (αβ-strands) organized in the topological order 54123 (Figure 1.4).  
The β-strands align to form a parallel β-sheet arranged at the center of the core domain 
with α-helices at the surface of the domain (Figure 1.5a).  In addition to the conserved 
Rossmann-like fold, the HAD core domain is also identified by 4 conserved sequence 
motifs (Figure 1.5b) located at loops of the cap-core interface which together form the 
enzyme active site in the three-dimensional structure (Aravind et al. 1998).   
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Figure 1.4 Topology of HADSF core domain.  The core domain resembles a Rossmann-
like fold.  It consists of at least 5 repeating units of β-sheet/α-helix (αβ-strands) organized 
in the topological order 54123.  There are 2 sites of cap insertions-the C0C1 cap insertion 
site and C2 cap insertion site. 
 
Motif 1 contains a conserved Aspn-X-Aspn+1 (DnXDn+1) sequence located at the C-
terminus of strand 1.  The carboxylate group of Aspn and the oxygen of the peptide 
backbone of Aspn+2 coordinate the Mg
2+ cofactor.  Additionally, this conserved sequence 
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motif contains the catalytic residues where Dn acts as the catalytic nucleophile and Dn+2 
acts as the general acid-base.  The first Asp, Dn, forms an aspartyl-intermediate during 
catalysis (Morais et al. 2000b).  The second Asp, Dn+1, in the case of phosphatase and 
phosphomutase members, is often used to protonate the substrate leaving group in the first 
step and deprotonates the nucleophile, Dn, in the second step (Lahiri et al. 2002).  Motif 2, 
located at the C-term of strand 2, contains a highly conserved Thr or Ser and motif 3 
contains a Lys at its N-terminus which together contributes to the stability of the reaction 
intermediate.  Motif 4 retains 1-3 conserved acid residues necessary to coordinate Mg2+ 
cofactor near the active site (Burroughs et al. 2006).  These 4 conserved sequence motifs 
and the bound Mg2+ allow for the ideal binding and stabilization of the phosphate leaving 
group in the high energy transition state for catalysis (Figure 1.5a right).  Figure 1.5a 
illustrates the trigonal-bipryamidal transition state that forms during phosphoryl transfer 
captured in the X-ray structure of hexose phosphate phosphatase, BT4131 bound to a 
transition-state analogue (Lu et al. 2008).  The active site is tuned to accept a phosphate to 
catalyze the removal of a phosphoryl group from the substrate.  While the core domain 
does the actual work on the substrate, it does not discriminate against varying 
phosphorylated substrates.  Instead, substrate selectivity is a result of cap domain evolution 
and the dynamics between the cap and core domain can also contribute to substrate range.  
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Figure 1.5  HADSF active site.  a. Core Rossmann fold with 4 loops that comprises of the 
active site circled in orange (left).  Coordination of active-site side chains with phosphate 
leaving group and Mg2+ cation (right).  b. The 4 conserved motifs located at the 4 loops 
that make up the active site.  Conserved residues within each motif are colored in black. 
 
        
Motif II Motif III Motif IV Motif I 
a
. 
b
. 
  
  
 
 
 
14 
 
 
 
1.2.6 Active site conformation and mechanism of phosphoryl transfer 
 The HADSF Rossmann core structure houses an ideal active site for evolution and 
superfamily expansion because the position of the coordinated substrate leaving group at 
the cap-core interface allows surrounding side chain residues to mutate and evolve new 
substrate specificities without affecting the core phosphoryl transfer chemistry.  The 
catalytic Asp positioned at motif 1 serves as a nucleophile to catalyze the reaction of 
dehalogenases, phosphatases and ATPases, phosphonatases, and phosphohexomutases 
(Figure 1.6) (Burroughs et al. 2006).  HAD enzymes involved in phosphoryl transfer 
require a Mg2+ cofactor for catalysis.  However, the carbon group transfer catalyzed by 
haloalkanoate dehalogenases does not utilize a cation.  In each of the reactions, except 
phosphohexomutases, the catalytic Asp of the enzyme attacks the electrophilic center of 
the substrate (ie. phosphorus of phosphoryl leaving groups or the carbon of C-halogen 
bonds).  These reactions consist of two-steps in which a covalent intermediate is formed 
and hydrolyzed by a water molecule.  In the case of a phosphohexomutase, such as β-
phosphoglucomutase and α-phosphomannomutase, the active form of the enzyme bears a 
phospho-aspartate.  The activation step of a phosphohexomutase requires a bis-
phosphorylated sugar molecule that transfers a phosphorul group to the catalytic Asp in a 
similar mechanism to the first step of a phosphatase reaction.  Rather than being hydrolyzed 
by a water molecule, the phosphoryl group is donated to a phosphorylated sugar (ie. 
glucose or mannose) to form a bisphosphorylated sugar intermediate.  The 
bisphosphorylated intermediate is reoriented to position the leaving phosphoryl group to 
the catalytic Asp and transferred to the Asp thus restoring the “active” form of the 
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phosphomutase.  The phosphohexomutase activity is discussed in further detail in Chapter 
2. 
 
 
Figure 1.6  The catalytic mechanisms of the Haloalkanoate dehalogenase superfamily.  
The superfamily is known to catalyze up to four different reactions.  The majority of these 
reactions involved the transfer of a phosphate group (ie. phosphatases, ATPases, 
phosphonatases, and phosphohexomutases) but can also catalyze the hydrolysis reaction at 
a carbon center (ie. the haloalkanoate dehalogenase). Figure taken from Burroughs, M. A., 
et al. 2006, J. Mol. Biol. 
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1.2.7 Cap Structure 
 While the core Rossmann domain is responsible for substrate catalysis, it owes its 
ability to distinguish between substrates to the cap domain.  The cap domain is responsible 
for recruitment of proper substrates and the dynamic motion between the cap and core 
domains guide the phosphoryl leaving group of the substrate to the active site.  Generally, 
a loop that faces the cap-core domain interface contributes to substrate binding-termed the 
“substrate binding loop” or the “distal phosphate binding site” in the case of 
phosphomutase enzymes.  The HAD superfamily is subdivided into 4 subfamilies 
classified by the topology of the cap type-C0, C1, C2a and C2b, and members that have 
both C1 and C2 domains (Figure 1.7).  In the HAD superfamily the cap domain is inserted 
within the core Rossmann fold sequence instead of a domain fusion in which a domain 
sequence is joined at the terminus of another domain evolved through gene fusion.  It is 
predicted from phylogenetic analysis and analysis of occurance of the cap types in extant 
organisms that the last universal common ancestor (LUCA) included 5 HAD members 
from each of the cap subtypes (Burroughs et al. 2006; Pandya et al. 2013).  
 There are two sites of cap insertion.  Cap domains can be inserted either 
downstream of β-strand 1 (between motifs 1 and 2) or after β-strand 3 (between motifs 2 
and 3) (Figure 1.7). Type C0 members consists of small and simple cap insertion with a 
β-hairpin found in the first insertion site and/or varying loop extensions found in either of 
the two insertion sites. Examples of C0 type enzymes include deoxy-D-mannose-
octulosonate 8-phosphate (KDO 8-P) phosphatase (1K1E) (Parsons et al. 2002) consisting 
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of the most minimal cap insertion and polynucleotide phosphatases (CTD phosphatases) 
(1TA0) (Kamenski et al. 2004) and MDP-1 like phosphatases (1U7O) (Peisach et al. 2004)) 
which is comprised of a longer loop with two β-strands (Burroughs et al. 2006).   
 Type C1 enzymes are the most ubiquitous HAD subtypes, representing 65% of all 
HAD members.  These enzymes consist of α-helices inserted between motif 1 and 2 with 
sizes ranging from bi-helical α-hairpin to 4-helical bundles.  Small bi-helical HADs are 
seen in acid phosphatase (1N9K) (Calderone et al. 2004) and cN-II nucleotidase (2J2C) 
(Walldén et al. 2007).  The majority of C1 caps consist of the 4-helical bundles, as seen in 
deoxyribonucleotidases (1MH9) (Rinaldo-Matthis et al. 2002), phosphoserine phosphatase 
(1F5S) (Wang et al. 2001) and the quintessential C1 HAD member, β-phosphoglucomutase 
(β-PGM) (1LVH) (Lahiri et al. 2002; Nogly et al. 2013). 
 Type C2 caps are large, complex domains consisting of α-helices and β-sheets 
inserted between motifs 2 and 3.  C2 caps are further subdivided into type C2a and C2b 
because of their structurally distinct topology within C2 cap HAD proteins.  The major 
difference between the two subtypes is that in the case of C2a cap domains, the β-strands 
form parallel sheets, whereas C2b domains align in an anti-parallel manner.  Examples of 
C2a enzymes include the NagD clade, TM1742 (1VJR) consisting of a 5-stranded sheet 
and 4 helices.  The more commonly found C2b types are seen in the Cof family (ie. Tm0651 
(1NF2) (Shin et al. 2003), Apc0014 (1L6R) (Kim et al. 2004) consisting of 6-strand and 6-
helices, and 3-strand and 3-helices, respectively). 
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Figure 1.7 HAD protein subclasses are organized by cap type and point of insertion.  Cap 
domain shown in yellow and core Rossmann domain in blue.  Cap types C0 and C1 are 
inserted between motifs I and II and type C2 are inserted between motifs II and III.  Figure 
courtesy of Nicholas Silvaggi, PhD.  
 
1.3  Hotdog Fold Thioesterase Superfamily (HD thioesterase) 
1.3.1 Biological significance of thioesters and thioesterases 
 Biologically relevant thioesters include acylated glutathione, acylated protein 
cysteine, acylated or aroylated coenzyme A (CoA) and acylated or aroylated holo acyl 
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carrier protein (ACP) (Figure 1.8).  Thioesters are produced by the esterification reaction 
of a thiol group and a carboxylic acid.  The carboxylic acid group may vary in size, shape, 
and polarity whereas the free thiol is supplied by either a glutathione molecule, the cysteine 
side chain of a protein, and the pantotheine arm of CoA or holo-ACP.  The thioesters that 
are discussed in this thesis will be those formed as the intermediates of biochemical 
pathways for metabolism by the derivatization of an organic acid with a CoA or holo-ACP 
molecule (the thiol group).  These compounds play a central role in energy production, cell 
cycling, signal transduction, and gene regulation (Hunt & Alexson 2002).  More 
specifically, conversion of carboxylic acids to thioesters by ligation of CoA or holo-ACP 
marks the activation process of biosynthesis of polyketide synthesis and fatty acids (Katz 
& Donadio 1993), biodegradation of aromatic compounds (Fuchs et al. 2011) or β-
oxidation of fatty acids (Hunt & Alexson 2002), or oxidation of pyruvate in the citric acid 
cycle (Seymour Korkes 1952). 
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Figure 1.8  Biological thioesters. Top to bottom: Coenzyme A, holo-acyl carrier protein 
(ACP), modified protein cysteines, and glutathione.  R groups represented varying acylated 
or aromatic compounds.  
 
 Polyketides are a class of structurally diverse secondary metabolites formed 
through successive condensation of small carboxylic acids.  Polyketide structures range 
from small 6-carbon chain (6-methylsalicyclic acid) to as large as 50-carbon molecules, 
allowing a diverse range of biological properties and potential pharmacological effects.  
These compounds often exhibit antibacterial, antifungal, antitumor, and anthelmintic 
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properties (Katz & Donadio 1993).  Fatty-acid acyl chains play a crucial role in a multitude 
of biological processes and cellular structures.  To name a few, long-chain fatty acids make 
up the hydrophobic layer of cell membranes, are converted to intracellular storage 
compounds and used to modify protein properties and function as protein membrane 
anchors (Seymour Korkes 1952).  The activation step for the biosynthesis of both 
polyketides and fatty acids follows a similar pathway by ligation of a carboxylic acid to 
ACP modified at a conserved serine with a pantetheine phosphate unit (holo-ACP), and in 
the case of type III polyketide synthesis, the starting material is activated by a molecule of 
CoA (Cronan & Thomas 2009).   
 Aromatic compounds are highly abundant in nature and are efficiently used as 
growth substrates by microorganisms (Gescher et al. 2005) and are also environmental 
pollutants.  In fact, next to carbohydrates or glucosyl compounds, aromatic benzoyl groups 
are the second most widely distributed chemical structure in nature (Parales 1996).  They 
are found in all organisms in the form of amino acids (phenyalanine, tyrosine and 
tryptophan) but plants are the main producers of aromatic compounds which can account 
for one-quarter of the biomass of land plants (Fuchs et al. 2011).  Other sources of aromatic 
compounds come from common environmental pollutants, BTEX (benzene, toluene, 
ethylbenzene and xylene), which are derived from petroleum derivatives such as gasoline.  
While plants biosynthesize these compounds, they have no way of degrading or recycling 
them.  Instead, aerobic and anaerobic bacteria and aerobic fungi have evolved to become 
the dominant organisms for the degradation of aromatic compounds.  The classical pathway 
for degradation of aromatic compounds entails the hydroxylation of the aromatic ring by 
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as oxygenase resulting in ring cleavage facilitated by activated molecular oxygen (Fuchs 
et al. 2011).  In recent years, studies have shown alternative strategies for aromatic 
degradation involving the ligation of the aromatic species to a molecule of CoA by 
formation of a thioester bond.  The reason for the various bacterial methods of degradation 
is unclear.  However, it is hypothesized that because CoA is membrane impermeable, the 
CoA linkage could be advantageous by retaining the intermediates in the cell.  Another 
possibility is the CoA bound intermediates can be readily recognized by subsequent 
enzymes within the pathway for tight control of metabolism (Rather et al. 2011). 
 Similarly, β-oxidation is activated by ligation to CoA.  The process occurs in the 
mitochondria and peroxisome of mammalian cells and mainly the peroxisome of fungi and 
plants.  In both locations, β-oxidation is the shortening of acyl-CoA chains to acetyl-CoA 
or propionyl-CoA products. Products of β-oxidation leave the organelles, mitochondria, or 
peroxisome, after the hydrolysis of CoA from the fatty acid by acyl-CoA thioesterases or 
after transesterification (Poirier et al. 2006).  Thus, these enzymes play an essential role in 
maintaining a properly balanced pool of free CoA and CoA-esterified fatty acids. At least 
12 mammalian acyl-CoA thioesterases (ACOTs) exist to sustain this constant pool of 
available free CoA for further esterification of fatty acids (Cantu et al. 2010).  
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1.3.2 Specialized CoA and holo-ACP thioesterases 
 Thioesterase play an essential role in many cellular processes described above by 
catalyzing the hydrolysis of a thioester bond between a carbonyl group and a sulfur atom 
to produce a thiol group and an acid group.  Two enzyme families have evolved to catalyze 
the hydrolysis of thioesters-the α/β-fold hydrolase superfamily and the Hotdog-fold 
thioesterase superfamily (Nardini & Dijkstra 1999; Dillon & Bateman 2004; Cantu et al. 
2010). 
 While this project focuses on thioesterases of the Hotdog-fold superfamily, it is 
worth noting some of the key features of the α/β-fold hydrolase superfamily.  The α/β-fold 
hydrolase family of thioesterases is highly variable in structure and contains no obvious 
sequence similarity (Nardini & Dijkstra 1999).  Nature’s most commonly found domain is 
characterized by repeating α/β secondary structures in which the β-strands form the central 
sheet of the domain (Nardini & Dijkstra 1999).  This fold supports hydrolases including 
proteases, lipases, esterases, dehalogenases, peroxidases, and epoxide hydrolases-making 
it one of the most functionally diverse protein folds.  A typical α/β-fold hydrolase contains 
eight-stranded parallel β-sheet sandwiched by α-helices on both sides (Figure 1.9).  Many 
α/β-fold hydrolase structures have been solved by X-ray crystallography showing that the 
active site contains a well conserved Ser-His-Asp catalytic triad.  While the fold is 
ubiquitous, there is only one α/β-fold with thioesterase activity in E. coli and 18 in humans 
(Cantu et al. 2010). 
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Figure 1.9  Structure of α/β hydrolase fold.  a. Topology diagram of the typical α/β 
hydrolase fold.  The location of the catalytic residues is depicted with black dots. Dashed 
lines indicate locations of possible insertions.  Figure from Nardini, M., et al. (1999) Curr. 
a. 
b. 
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Opin. Struct. Biol. 9, 732–737. b. Three-dimensional crystal structure of the human acyl 
protein thioesterase 1 (1FJ2) containing the α/β hydrolase fold. 
 
1.3.3 Thioesterases of the Hotdog-fold superfamily 
 The Hotdog-fold is a protein domain ubiquitously expressed in eukaryotes, 
bacteria, and archeaea.  Genome sequencing has identified ~85,000 genes encoding the 
Hotdog-fold domain.  While the superfamily has low sequence identify (10-20%), it shares 
a distinct common fold and catalyzes several distinct chemical reactions (Pidugu et al. 
2009).  The first structurally characterized Hotdog enzyme was E. coli β-hydroxydecanoyl 
thiol ester dehydratase (FabA) (1MKA) solved by X-ray crystallography in 1996 by 
Leesong et al. (Leesong et al. 1996).  FabA is involved in type II fatty acid biosynthesis, 
specifically catalyzing the dehydration and double-bond isomerization of 10-carbon thiol 
esters of ACP (decanoyl-ACP) resulting in the product cis-3-decanoyl-ACP.  Its tertiary 
structure consists of a seven-strand anti-parallel β-sheet wrapped around a long α-helix, 
where the sheets resembled a hotdog bun and the helix resembled a sausage; thus the name 
“Hotdog-fold” was coined (Figure 1.10a).  Subsequent Hotdog-fold structures were solved 
including 4-hydroxybenzoyl-CoA thioesterase (4HBT) from Pseudomonas sp. strain CBS-
3 (Benning 1998) and Arthrobacter sp. strain SU (Thoden et al. 2003), a novel gentisyl-
CoA thioesterase from Bacillus halodurans (Zhuang et al. 2003) and in Escherichia coli 
thioesterase II (Li et al. 2000) demonstrated that the monomeric subunit is highly conserved 
comprising of a 5-7 stranded β-sheet and a long α-helix.   
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 The minimal quaternary structure forms a dimer, but the subunits are often found 
as a tetramer or hexamer arranged in several different orientations (Figure 1.10c).  The 
minimal catalytic unit is comprised of two subunits oriented with the α-helix of each 
subunit facing one another and the β-sheets of each monomer associate to form an 
elongated β-sheet (Figure 1.10b).  Two active sites sit at opposing ends of each dimer 
interface.  The catalytic residues are located at the N-terminus loop of the α-helix and the 
center of the opposing α-helix, described in detail below.  While the majority of this 
superfamily function as thioesterases, the fold can support several other chemical reactions 
including desaturase/isomerase (Leesong et al. 1996), (R)-Enoyl-CoA hydratase (Hisano 
et al. 2003), cyclase/aromatase (Crawford et al. 2009), and most recently discovered, lyase 
activity (Heine et al. 2014) (Figure 1.11).  Although the same fold can catalyze several 
different chemical reactions by housing different active-site architectures, the substrate 
recognition components are similar with substrates containing either CoA or ACP.  Sixty-
five percent of Hotdog-fold enzymes, however, are thioestereases that cleave the thioester 
bond of an aliphatic or aromatic compound bound to coenzyme A or acyl carrier protein 
(ACP).  The Hotdog enzymes discussed in this dissertation are thioesterases. 
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Figure 1.10 Structures of the Hotdog-fold.  a. Monomeric unit of a typical Hotdog-fold 
represented by FabA (1MKA).  b. Dimer formation of 2 subunits that make up the minimal 
catalytic unit with active sites region located at two opposite ends of the dimer interface 
(circled in yellow).  c. Arrangements of quaternary structure.  On left are dimer of dimers 
assembled in a “front-to-front” manner (top) and “back-to-back” manner (bottom).  On the 
right are hexameric subunits assembled in different orientations.  Figure 10c taken from 
Lakshmi et al 2009, BMC Structural Biology 
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Figure 1.11  Reactions supported by the Hotdog-fold.  Structurally characterized Hotdog-
fold enzymes have been shown to catalyze the depicted generalized chemical reactions.  
The majority, 65%, of this fold function as hydrolases to remove the CoA or ACP moiety 
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and releasing an organic acid.  Other reactions supported by this fold share a common 
substrate structure which contains either CoA or ACP. 
 
1.3.4 The substrate recognition site and active site  
 The Hotdog-fold recognizes substrates containing acyl-CoA or acyl-holo-ACP.  
Substrate recognition can be broken down to three components based on its binding 
position to the enzyme (Figure 1.12).  Both acyl-CoA and acyl-holo-ACP substrates 
structurally contain a long flexible pantetheine groups that fits through a hydrophobic 
tunnel between the dimer interfaces and directs the leaving group to the active site.  The 
CoA nucleotide or ACP is docked at the surface of the protein and has little contributing 
interactions to the protein, but may serve as an anchor to properly align the thioester at the 
catalytic scaffold.  Finally, the leaving group pocket of the enzyme is most structurally 
diverse and defines the substrate specificity-that is its preference for short or long aliphatic 
chains or aromatic rings, varying number of hydroxylation states or branched modifications 
to name a few.  
 The active sites of Hotdog-fold thioesterase enzymes are positioned at opposing 
ends of the dimer interface thereby having two active sites per dimer called the “catalytic 
scaffold”.  The catalytic scaffold consists of the N-terminus of the elongated α-helix and 
the connecting loop of one subunit (subunit A) and the middle segment of the elongated α-
helix of the opposing subunit (subunit B) (Figure 1.12).  A bound substrate thioester C=O 
forms a hydrogen bond with a backbone amide NH of an α-helix N-terminus residue to 
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orient and polarize the C=O for nucleophilic attack.  A carboxylate residue (usually a 
conserved Asp or Glu) participates in catalysis by acting as either a nucleophile or a general 
base.  In the general base mechanism (Figure 1.13a) the catalytic carboxylate is used to 
activate water which in turn hydrolyzes the thioester to form the organic acid and CoA.  In 
nucleophilic catalysis (Figure 1.13b) the carboxylate is used to form an acyl-enzyme 
mixed anhydride, releasing the CoA in the first half reaction.  Water attack at either 
carbonyl restores the active site carboxylate and forms the organic acid. This catalytic 
carboxylate residue has been found to be positioned at either subunit A or subunit B, which 
is a characteristic that divides the family into two motifs referred to as the catalytic scaffold 
type AA and type AB (Willis et al. 2005).  Two structurally divergent enzymes of 4-
hydroxybenzoyl-CoA thioesterase (4-HBT) from Arthrobacter and Pseudomonas 
represent the two catalytic scaffolds. 
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Figure 1.12 Substrate recognition site.  a. Substrate analog, 4-hydroxyphenacyl-CoA 
bound to 4-HBT of Arthrobacter sp. strain SU (1Q4U) shows site of ligand binding at the 
dimer interface between the loop of subunit A and the middle region of the α-helix in 
subunit B. b.  Substrate binding sites can be broken down to three components (nucleotide 
(or ACP), pantetheine moiety, and the acyl leaving group. 
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Figure 1.13  Known mechanisms of catalysis in Hotdog thioesterases.  a. General base 
method utilizes a conserved water molecule to hydrolyze the substrate in a one-step 
mechanism.  b. Nucleophilic catalysis is a two-step reaction with an acyl-enzyme mixed 
anhydride intermediate. 
a. General Base
Catalysis
b. Nucleophilic Catalysis
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1.3.5 Structural divergence of Arthrobacter and Pseudomonas 4-HBT catalytic 
scaffolds 
 The first structure of a thioesterase Hotdog enzyme to be determined was 4-
hydroxybenzoyl-CoA (4-BHA-CoA) thioesterase from Pseudomonas sp. CBS3 in 1998 
(Benning 1998).  Subsequently, in 2003, the structure of 4-BHA-CoA thioesterase from 
Arthrobacter sp. strain SU was determined (Thoden et al. 2003).  Both enzymes catalyze 
the reaction of hydrolyzing 4-HBA-CoA to 4-hydroxybenzoic acid and CoASH.  This 
reaction takes place in the final step of the 4-chlorobenzoyl-CoA dehalogenation pathway 
involving a ligase, dehalogenase and thioesterase for many Pseudomonas and Arthrobacter 
species.  Additionally, in vitro kinetic assays reveal similar substrate preference profiles.  
Surprisingly however, despite their similarity in cellular role and function, the two enzymes 
are apparently evolutionarily distinct Hotdog thioesterases.  Structural analysis of the two 
enzymes identified structurally distinct actives-site configurations and overall low 
sequence similarity (14%).   
 Both Pseudomonas and Arthrobacter thioesterase 4HBT contain a typical Hotdog 
domain with similar secondary and tertiary structures.  The structure of Pseudomonase 4-
HBT (1LO7) is comprised of 5-stranded anti-parallel β-sheet with an elongated α-helix in 
the topological order β1-α1-β2-β3-β4-β5.  The structure of Arthrobacter 4-HBT (1Q4T) 
contains a 6-stranded sheet in the topological order β1-β2-α1-β3-β4-β5-β6(Thoden et al. 
2003; Benning 1998) (Figure 1.14a).  Purified protein of both 4-HBT-1 and 4-HBT-2 form 
a stable tetramer in solution, however the crystal structures show different assembly 
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orientations.  The 4HBT from Pseudomonas assembles in a “front-to-front” manner in 
which the central α-helices of one dimer face the α-helices of another dimer (Figure 1.14b 
left), whereas the 4HBT from Arthrobacter assembles in a “back-to-back” manner where 
two homodimers assemble through a series of hydrogen bonds between the β-sheets of 
each dimer (Figure 1.14b right).  As a result of the difference in quaternary structure, 
binding of substrates differ in the nucleotide component of CoA substrates. Substrate 
bound at each of the four active sites in the “back-to-back” tetramer formation seen in the 
Arthrobacter 4-BHT is stabilized by 3 subunits, as opposed to be “front-to-front” formation 
of the Pseudomonas that employs 2 subunits to stabilize each substrate at the active site. 
 Structures of Pseudomonas and Arthrobacter 4-HBT bound to a substrate analog 
inhibitor, 4-hydroxyphenacyl-CoA, reveals similarities and differences in molecular detail.  
Distinctions observed in the active site between the two enzymes have divided Hotdog 
thioesterases into two structurally distinct subfamilies.  The 4-HBT from Psuedomonas 
represents the catalytic scaffold type AA and will here forth be called the 4-HBT-1 
subfamily (Song et al. 2006).  The catalytic carboxylate residue, Asp17, is located on the 
loop of the N-terminus α-helix of the same subunit as the polarizing backbone amide, Tyr24, 
in the case of Psuedomonas 4-HBT (Figure 1.14c left).  The 4-HBT from Arthrobacter 
represents the type AB scaffold and is the prototype for the 4-HBT-2 subfamily (Willis et 
al. 2005).  This AB catalytic scaffold, , is characterized by the catalytic carboxylate, Glu73, 
located at the opposing subunit from that of the polarizing N-terminus α-helix backbone 
amide, His64 (Figure 1.14c right).  The substrate benzoyl thioesters bind at the active site 
in slightly different orientations in the two enzymes to position the leaving group toward 
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the catalytic carboxylate while conserving the H-bond interaction between the substrate 
thioester C=O and the polarizing backbone amide of subunit A.  The purpose of the 
difference in the active-site composition and whether it is a result of evolutionary 
divergence or convergence is not known.  However, based on structural evidence from 
many Hotdog enzymes, a carboxylate residue, Asp or Glu (and sometimes Asn or Gln), is 
positioned at both subunits as shown in Figure 14c.  Thus, it is important to note here that 
sequence and structural information is insufficient to determine the type of scaffold it 
possesses.  Rather a combination of ligand bound structures and site-directed mutagenesis 
is required to decipher the scaffold type and mechanism.  
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Figure 1.14 Structural comparison between 4-HBT from Pseudomonas (1LO7) (left) and 
Arthrobacter (1Q4T) (right).  a. Dimer form comprising two active sites for both enzymes 
 
a. 
b. 
c. 
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bound to 4-hydroxyphenacyl-CoA.  b. Biological assembly of the two enzymes show 
different quaternary structure.  Pseudomonas 4-HBT assembles in a “front-to-front” 
manner, Arthrobacter assembles in a “back-to-back” manner.  c. Active site of 
Pseudomonas 4-HBT contains a type AA catalytic scaffold with Asp17 as the general-base 
residue located on the same subunit as the substrate C=O polarizing Tyr24 residue.  Active 
site of Arthrobacter 4-HBT contains a type AB scaffold with the Glu73 nucleophile located 
on the opposing subunit of the polarizing H64 residue.  (* indicates residues on subunit B, 
opposite of the polarizing residue). 
 
 In the next chapter, I will discuss the structure of human HADSF enzymes, 
Phosphomannomutase (PMM) 1 and 2.  A structural comparison between PMM1 and 
PMM2 will be analyzed for its differential cellular functions.  Next, chapters 3 and 4, 
analyzes the structural features that define substrate specificity and promiscuity in Hotdog 
thioesterases.  In chapter 5, we seek to determine the range of substrate specificity and 
promiscuity among the entire Hotdog thioesterase superfamily by developing a high 
throughput substrate screen.  Lastly, chapter 6 includes the major conclusions and findings 
from both the studies of HADSF and Hotdog enzymes, namely with regard to structural 
mobility and its relationship to substrate promiscuity and specificity. 
 
38 
 
Chapter 2: 
Structural analysis of the human phosphomannomutase 1 (PMM1) phosphatase 
activity induced by the presence of inosine monophosphate 
2.1 Introduction   
2.1.1 Congenital Disorders of Glycosylation   
Protein glycosylation is perhaps the most important protein modification in archaea 
and eukaryotes as it the most chemically complex and offers the greatest diversity to 
protein structure.  Most cell surface and secreted proteins undergo glycosylation and it is 
fundamental to biological processes including fertilization, immune defense, cell growth, 
cell-cell adhesion, and inflammation (Dwek 1996).  Inborn defects in protein glycosylation 
are collectively known as congenital disorders of glycosylation (CDG) which cause 
multisystem consequences of varying severity in the nervous system characterized by 
cognitive impairment, speech difficulties, psychomotor retardation, developmental delay, 
vision problems, seizures, and stroke-like episodes (de Lonlay et al. 2001; Grünewald 
2009; Marquardt and Denecke 2003). To date, roughly 700 patients worldwide have been 
diagnosed with CDG, however it is severely underdiagnosed and often misdiagnosed 
because symptoms resemble other genetic disorders and is associated with varying degrees 
of multiple symptoms.   
CDG disorders are classified into two groups—type I and type II.  CDG-type I 
disorders are mutations in genes that are involved in the synthesis of the lipid-linked 
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oligosaccharide or the transferring of oligosaccharides onto proteins.  This includes 
enzymes involved in both the N-linked and O-linked glycosylation pathways.  Type II 
disorders are defects involved in the trimming or processing of the oligosaccharide chain 
of glycoproteins (Barone, Fiumara, and Jaeken 2014)(Cylwik et al. 2013).   
Most diseases are found in the N-linked glycosylation pathway with defects in the 
assembly of the dolichol linked Glc3Man9GlcNAc2 glycan (Figure 2.1).  The pathway 
begins with glucose-6-phosphate (G6P) in the cytoplasm and achieves the activated sugar 
precursor GDP-mannose via four enzymatic steps.  The key enzymes involved are 
phosphoglucose isomerase (1); MPI (mannose-phosphate isomerase) (2); 
phosphomannomutase (PMM) (3); and GDP-mannose synthase (4). Dolichol phosphate 
mannose and dolichol phosphate glucose are synthesized from GDP-Man and UDP-Glc 
(reactions 5 and 15, respectively).  The dolichol phosphate sugar precursors anchored at 
the endoplasmic reticulum (ER) are flipped from the cytoplasmic side to the ER luminal 
side. Cytoplasmic facing dolichol phosphate form dolichol pyrophosphate N-
Acetylglucosamine (GlcNAc) by a GlcNAc-1-phosphate is transferring enzyme (reaction 
6) followed by addition of 5 mannose residues to form 
dolicholpyrophosphate(GlcNAc)2(Man)5 (reaction 7).  This molecule is then flipped into 
the ER luminal side (reaction 8) where addition of four more mannose moieties from the 
dolichol phosphate mannose occurs (reaction 9).  Three molecules of glucose are 
subsequently added from dolichol phosphate glucose (reactions 10, 11, and 12).  The 
complete Glc3Man9GlcNAc2 oligosaccharide is transferred from dolichol pyrophosphate 
to an asparagine residue of a nascent glycoprotein by an oligosaccharyltransferase (reaction 
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13).  The glycoprotein proceeds to the Golgi apparatus for further processing.  CDG-type 
Ia, Ib, Ic, Id, and Ie are caused by defective enzymatic reactions in steps 3, 2, 10, 9, and 5, 
respectively (Grunewald 2002). 
 
 
Figure 2.1 Pathway of N-linked oligosaccharide synthesis for protein glycosylation.  The 
steps of the pathway are assigned in black and in blue the types of congenital disorders in 
glycosylation resulting from defects in the respective steps are labelled.  Figure taken from 
Grunewald, S. Pediatric Research (2000) (Grunewald 2002). 
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2.1.2 CDG-1a and discovery of two PMM isoforms 
The first and most prevalent CDG diagnosed is caused by single base mutation in 
the phosphomannomutase 2 gene (chromosome 16p13), classified as CDG-type Ia or 
PMM2-CDG (Jaeken J. 1993).  CDG-1a patients exhibit symptoms of developmental 
delay, hypotonia, esotropia, lipodystrophy, cerebellar hypoplasia, stroke-like episodes, and 
seizures.There are no treatments for CDG-1a to date (Grunewald 2002).  The first 
documented CDG patients, two young twin sisters displaying psychomotor retardation, 
were diagnosed in 1978 but it was not until 1994 that the disease was assigned to a mutation 
in a gene involved in an early glycosylation step (Wada and Sakamoto 1997).  The gene 
initially identified (PMM1, located on ch22q13), although catalyzing 
phosphomannomutase activity, was found to be unrelated to CDG-Ia (Wada and Sakamoto 
1997).  The major clue suggesting that this gene is not related to CDG is the discrepancy 
in expression pattern.  Expression of the isolated PMM1 is restricted to primarily the brain 
and lungs, whereas the CDG-1a related PMM is ubiquitously expressed in all tissues in rats 
(Figure 2.2) (Pirard et al. 1999). In 1997, the CDG causing phosphomannomutase was 
identified on chromosome 16p13 (PMM2) (Matthijs et al. 1997).  Human PMM2 was 
confirmed to be the enzyme that supplies the cell with the essential N-linked 
polysaccharide synthesis pathway intermediate, α -mannose 1-phosphate (Matthijs et al. 
1997).  This serves as the precursor to GDP-mannose from which the mannose moiety is 
added to growing oligosaccharides in the endoplasmic reticulum during post-translational 
protein glycosylation (Kornfeld and Kornfeld 1985) (Figure 2.1 reaction 3). While PMM1 
displayed similar kinetic characteristics to PMM2 as a phosphomannose transferase, its 
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primary function remained unknown until 2008 when Van Schaftingen’s group found 
PMM1 to be the glucose-1,6-bisphosphate phosphatase originally described by Rose and 
Guha in 1982 (Veiga-da-Cunha et al. 2008).   
 
 
Figure 2.2 Western blot using anti-PMM1 (top) and anti-PMM2 (bottom) shows tissue 
distribution of PMM1 and PMM2 in rats that led to the identification of 2 PMM isoforms.  
Both proteins have similar molecular weights and kinetic parameters but very different 
expression patterns.  Figure from Pirard et al. The Biochemical Journal 1999 (Pirard et al. 
1999). 
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2.1.3 Physiological role of PMM1 
In 2008, the group of Van Schaftingen showed that PMM1 may play a role in 
glycolytic rescue during a temporary shortage of blood to the brain (Veiga-da-Cunha et al. 
2008).  They identified PMM1 as the inosine monophosphate (IMP) activated Glc-1,6-P2 
phosphatase in the brain that was first described by Guha and Rose (Guha and Rose 1983; 
Veiga-da-Cunha et al. 2008; Sites 1982).  This reaction is seen to occur under ischemic 
conditions in the brain where ATP depletion leads to an increase in its metabolic product, 
IMP, through the action of adenosine deaminase on ADP.  Notably, even under saturating 
IMP conditions PMM2 does not show phosphohydrolase activity(Veiga-da-Cunha et al. 
2008).  
Glc-1,6-P2 is biosynthesized from glycerate-1,3-P2 as the phosphoryl donor and 
Glc-1-P or Glc-6-P as acceptor (Rose, Warms, and Kaklij 1975; Rose, Warms, and Wong 
1977) . The brain and red blood cells contain the highest concentration of Glc-1,6-P2 at 
about 70-80 µM and it is rapidly broken down during ischemic conditions (Passonneau et 
al. 1969).  Additionally, during brain ischemia, a shortage of oxygen and glucose to the 
brain causes depletion of ATP thus elevating concentration of ATP metabolites, including 
IMP.  Basal level concentrations of cellular IMP range from 0.02-0.3 mM, and 3-10 mM 
for ATP.  Under hypoxic or ischemic conditions, IMP concentrates are elevated to 0.2-0.6 
mM in concentration and ATP decreases to 1-5 mM in rat/pigeon heart (Bretonnet et al. 
2005; Newby 1988; Truong, Collinson, and Lowenstein 1988).  Because the brain does not 
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have stored energy, excess Glc-1,6-P2 serves as a reserve to temporarily maintain 
glycolysis via PMM1 phosphatase activity.  As the IMP concentration increases, it 
activates PMM1-catalyzed phosphatase activity to accept Glc-1,6-P2 as a substrate 
producing inorganic phosphate and glucose 6-phosphate (Glc-6-P).  This product then 
enters into the second glycolytic step, conversion of Glc-6-P to fructose 6-phosphate (Fru-
6-P) by phosphoglucose isomerase (Figure 2.3).   
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Figure 2.3 Schematic of the alternate entry into glycolysis via Glc-1,6-P2.  PMM1 
catalyzes hydrolysis of Glc-1,6-P2 to Glc-6-P as cellular IMP concentration increases due 
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to ATP depletion and conversion.  This allows a temporary rescue of glycolysis by 
bypassing the entry step under low glucose conditions. 
 
2.1.4 Structural comparison between human PMM1 and PMM2 
PMM1 and PMM2 share very high sequence identity of 66% and 85% similarity 
(Figure 2.4a).  PMM1 is a 262 amino acid (aa) protein (29.7-kDa) and PMM2 is 246 aa 
(28.0-kDa).   PMM1 and PMM2 belong to the haloalkanoate dehalogenase superfamily 
(HADSF).  HADSF members are structurally composed of a core Rossmann fold housing 
four conserved sequence motifs that confer phosphoryl binding and catalytic activity 
(detailed in Chapter 1).    
Unliganded structures of human PMM1 (2FUC) and human PMM2 (2AMY) have 
been determined and shown to have nearly identical architecture-with root mean square 
deviation (r.m.s.d.) of 0.646 Å for the cap and 1.56 Å for the core domains (Figure 2.5).  
Human PMMs belong to the C2b subclass of the HADSF proteins, where the cap is about 
100 aa in length (residues 95-194 of PMM1, 86-185 of PMM2) both including α-helices 
and β-sheets in a ααββααββ orientation inserted between β5 and α7 or motifs 2 and 3 of 
the Rossmann core domain.  The core domain (residues 1-90 and 198-262) consists of 6 
parallel β-sheets (β1-β5 and β10-β11) with a helix enclosed by 5 α-helices (α1-α2 and α7-
α9).  The cap and core are connected by a hinge region composed of residues 91-94 and 
195-197 (Figure 2.4b and 2.5a).  The active sites of both PMM1 and PMM2 are typical of 
HADSF members consisting of conserved DnXDn+2, where Aspn is the catalytic 
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nucleophile and coordinates the essential Mg2+ cofactor and conserved Aspn+2 facilitates in 
stabilizing the substrate during catalysis.  The nucleophilic Asp residue of PMM1 is at 
position Asp19 and for PMM2 is Asp12.  The X-ray crystal structure of liganded human 
PMM1 with substrate mannose 1-phosphate has been published and deposited in the PDB 
(2FUE) (Silvaggi et al. 2006).  This structure revealed the substrate bound at the cap 
domain in the loop region connecting β8 and β9 at the cap-core interface.  This region will 
here forth be called the “distal phosphate binding site”.  The r.m.s.d. of the unliganded 
structure and the structure in complex with M1P is 0.53 Å which show that both structures 
were crystallized in the cap “open” conformation (Figure 2.5b). Both PMM1 and PMM2 
exist in nature as a dimer with the dimer interface located exclusively in the cap region, 
and more specifically the α3 and α6 helix (Silvaggi et al. 2006). 
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Figure 2.4  a. Sequence alignment of human PMM1 and PMM2, residues highlighted in 
red are identical and in yellow are similar.  b. Secondary structure topology map of PMM, 
in purple represents the cap domain, in blue is the core domain.  Figures taken from 
Silvaggi, N. Journal of Biological Chemistry 2006 (Silvaggi et al. 2006). 
 
a. 
b. 
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Figure 2.5  Ribbon diagrams of human phosphomannomutase isozymes.  A. Structure of 
human PMM2 (2AMY, pale green) superimposed with human PMM1 (2FUC, purple).  
The r.m.s.d. between PMM2 and unliganded PMM1 is 0.646 Å for the cap and 1.56 Å for 
the core domain. B.  Superimposition of unliganded PMM1 (2FUC, purple) and PMM1 
bound to Man-1-P (orange sticks) (2FUE, cyan).    The two structures have a rsmd of 0.53 
Å.   
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2.1.4 PMM mutase mechanism 
The mechanism of catalysis by PMM has been proposed by Silvaggi et. al. 2006 
(Silvaggi et al. 2006).  The PMM phosphoryl transfer mechanism is a two-step reaction 
with a bisphosphorylated sugar intermediate (Allen and Dunaway-Mariano 2004).  
Activation of the enzyme requires a bisphosphorylated sugar, Glc-1,6-P2, to transfer its 
phosphate to the catalytic aspartyl nucleophile (Asp19 in PMM1 and Asp12 in PMM2) 
forming an aspartylphosphate intermediate, (Figure 2.6a) as observed in the functionally 
related enzyme β-PGM crystal structure (Lahiri et al. 2002).  Subsequently, the substrate 
mannose 6-phosphate (Man-6-P) is recruited by binding to the cap domain and is guided 
to the active site by the closing of the cap relative to the core.  In this solvent excluded, 
closed conformation, Man-6-P is positioned such that the C1 hydroxyl group is adjacent to 
the aspartylphosphate group and performs a nucleophilic attack on phosphorus of 
aspartylphosphate. The phosphate is thus transferred to the substrate and 
bisphosphorylated-sugar is then released from the enzyme and reoriented/flipped such that 
the C6 phosphate can be removed by the Asp nucleophile thus phosphorylating the enzyme 
and releasing product Man-1-P. The phosphoryl transfer chemistry is facilitated by the 
Aspn+2 which acts as a general acid/base to deprotonate the sugar hydroxyl 
nucleophile/leaving group (Figure 2.6c) (Dai et al. 2006). 
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Figure 2.6 Proposed mechanism of catalysis in PMM1 mutase (b) and phosphatase (c) 
activity. (a) is the activation step in mutase activity by forming the active phosphorylated 
Asp (phospho-Asp) where the phosphate is transferred from Glc-1,6-P2.  In the 
phosphatase reaction, (a) is the first step of catalysis.  
 
In summary, previously reported kinetic data show PMM1 and PMM2 are equally 
efficient in phosphomannomutase activity towards glucose-1 phosphate and mannose-1 
phosphate, however PMM2 exhibits unobservable phosphatase activity and mutase activity 
is minimally affected by saturated IMP.   This project seeks to determine the structural 
differences between the two isozymes that allow only the PMM1 isozyme to bind IMP and 
switch the activity from mutase to phosphatase.  In this chapter, the structure of PMM1 in 
complex with IMP is determined along with other structurally guided experiments to 
understand the differential preference in substrates and effector, IMP, as well as 
conformational changes that allow for such chemistries to occur.   
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2.2 Materials and Methods 
2.2.1 Materials 
 Except where indicated, all chemicals were obtained from Sigma-Aldrich. Primers, 
T4 DNA ligase, restriction enzymes, and expression vectors were from Invitrogen.  
Quikchange II for site-directed mutagenesis was purchased from Agilent.  The Qiaprep 
Spin Miniprep Kit was from Qiagen. Host cells, DH5-alpha and SoluBL21, were purchased 
from NEB and Genlantis, respectively. The BioMol green phosphate assay kit was 
purchased from BioMol International, LP. The αPMM1 and αPMM2 genes were subcloned 
from commercially available cDNA (Silvaggi et al. 2006).   
 
2.2.2 Preparation of constructs  
 Constructs were made and obtained by former post-doc, Dr. Nicholas Silvaggi.  
The cDNA encoding the PMM1 gene was purified from the host cells purchased from 
ATCC (ATCC 7483527). Oligonucleotide primers (5_-
CGCGGACCTGCAGCCATGGCA, and 5_ ACACACAGATGTGGGATCCGGTCA), 
containing the restriction endonuclease cleavage sites NcoI and BamHI, were used to 
amplify the α-PMM1 open reading frame. The α-PMM1 gene was cloned into pET-SUMO 
vector to contain an N-terminus 6x His epitope and SUMO fusion protein.  The pET-
SUMO_α-PMM1 plasmid was transformed into Escherichia coli DH5α competent cells 
(Silvaggi, unpublished results).   PMM1 mutants (R180T, R183I, M186Q, R180T/R183I) 
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were generated using Agilent’s QuikChange II kit.  The purified plasmid was sequenced 
by Genewiz. 
 
2.2.3 PMM1 and PMM2 expression and purification 
Both human PMM1 and PMM2 were purified from E. coli SoluBL21-Rosetta2 
containing pET-SUMO-pmm1 and pET-SUMO-pmm2 fusion plasmid.  Cells were grown 
in Luria broth containing 35 μg/ml chloramphenicol and 50ug/ml kanamycin at 37 ˚C and 
induced at OD600 ~0.6 with 1 mM isopropyl β-D-thiogalactopyranoside (IPTG) for 4 hours.  
Cells were harvested by centrifugation and lysed by high-pressure mircrofluidizer.  
Following high speed centrifugation of lysate, supernatant was loaded onto a GE 5 mL 
HisTrap HP Ni2+ column, and SUMO-PMM1 was eluted by a step-wise increase of 
imidazole concentration between buffer A and B using FPLC (buffer A: 50 mM Tris pH 
8.2, 500 mM NaCl, 5 mM MgCl2, 5 mM DTT, 10mM imidazole; buffer B: 500 mM 
imidazole).  The N-terminus SUMO protein was cleaved by incubation with SUMO 
protease34 at 4˚ C for up to 12 h (concentration of SUMO protease was 0.5 mg/mL, purified 
protein concentration at ~5 mg/mL, incubation with fusion protein at 1:400 dilution).  
Separation of PMM1 and SUMO was performed by size exclusion chromatography using 
GE Sephacryl S-100 HR. Finally, purified PMM1 was dialyzed in 50 mM Hepes pH 7.2, 
5 mM MgCl2 and 1 mM DTT for storage, or 10 mM Hepes pH 7.5, 100 mM NaCl, 5 mM 
MgCl2 for crystallization. Preparation of PMM2 protein followed the same protocol as 
PMM1.  
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Figure 2.7 a. Coomassie stained SDS-PAGE of a typical PMM1 purification with fractions 
labeled above. b. Purified PMM2 after separation from SUMO fusion protein.  Both PMM1 
and PMM2 and >90% pure. 
 
2.2.4 Preparation of SUMO protease 
The expression and purification of SUMO protease protocol followed the published 
work from Weeks, S.D. 2006 with a few modifications (Weeks, Drinker, and Loll 2007).  
The protease catalytic domain of Ulp1 from S. cerevisiae, dtUDI gene containing a His6 
tag was cloned into pSUPER vector.  The vector was transformed into Rosetta 2-BL21 
(DE3 pLysS) E. coli cells and plated onto ampicillin and chloramphenicol containing LB 
plates.  Colonies were inoculated in ZYP-5052 rich media for auto-induction (media recipe 
in Appendix) (Studier 2005).  Cells were grown and expressed at 28 ˚C for 20 hours prior 
to harvesting by centrifugation. 
 
Purified 
PMM2 
a. b. 
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Harvested cells were lysed through a high-pressure cell at 18,000 psi using a 
Microfluidizer M110-P.  Membrane and cytosolic fractions were separated by 
ultracentrifugation (Optima L-90K Ultracentrifuge, Beckman Coulter) at 38,000 rpm for 
30 min.  The soluble fraction containing SUMO protease was purified using FPLC by 
passing supernatant through a HisTrap column (GE Healthcare Life Sciences) using a 
gradual increasing in imidazole concentration (25 mM to 300 mM).  Purified protein was 
stored in buffer containing 50 mM NaHPO4, 250 mM NaCl, 10% glycerol, 5 mM βME pH 
8.0.  The cleavage of the SUMO domain from PMM-SUMO fusion protein was optimized 
under various conditions (ie. temperature, incubation time, concentration) (Figure 2.8). 
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Figure 2.8  SDS-PAGE of SUMO tag cleavage.  The gel shows that all tested dilutions of 
fusion protein to SUMO protease resulted in cleavage.  Concentration of purified protein 
was 5 mg/ml and protease concentration was 0.5 mg/ml.  
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2.2.5 Site-directed mutants 
A total of six variants containing site-specific mutations were generated—five 
PMM1 variants and one PMM2 variant.  Variants were made using reagents from Agilent’s 
QuikChange II kit.  Primer oligonucleotides were purchased through Life Technologies.  
The primer sequences used to generate the below site-directed mutants are listed in Table 
2.2. 
Protein Mutation  Primer sequence 
PMM1 R180T/R18
3I 
F 5'- GCT GGC AAA GGG CTG ACG TTC TCT ATA 
GGA GGC ATG ATC AGC -3' 
  R 5'- GCT GAT CAT GCC TCC TAT AGA GAA CGT 
CAG CCC TTT GCC AGC -3' 
 R183T F 5'- AGG GCT GAG GTT CTC TAT AGG AGG CAT 
GAT CAG C -3' 
  R 5'- GCT GAT CAT GCC TCC TAT AGA GAA CCT 
CAG CCC T -3' 
 R180I F 5'- GCT GGC AAA GGG CTG ACG TTC TCT CGA 
GGA -3' 
  R 5'- TCC TCG AGA GAA CGT CAG CCC TTT GCC 
AGC -3' 
 M186Q F 5'- GTT CTC TCG AGG AGG CCA GAT CAG CTT 
TGA CGT -3' 
  R 5'- ACG TCA AAG CTG ATC TGG CCT CCT CGA 
GAG AAC -3' 
 R180K/R1
83K 
F 5'- GCT GGC AAA GGG CTG AAG TTC TCT AAA 
GGA GGC ATG ATC -3' 
  R 5'- GAT CAT GCC TCC TTT AGA GAA CTT CAG 
CCC TTT GCC AGC -3' 
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Table 2.1 Primers used for site-directed mutagenesis to introduce listed single and double 
amino-acid mutations. F for forward primer, R for reverse primer. 
 
2.2.6 Thermofluor Assay 
Purified proteins of wild-type PMM1 and PMM2 were subjected to a protein 
solubility screen via a thermofluor assay in order to determine a more protein stabilizing 
buffer solution.  The thermofluor assay is a high-throughput assay that measures thermal 
unfolding (determining the melting temperature, Tm). In thermofluor, protein unfolding is 
measured using a fluorescence probe called SYPRO Orange (Invitrogen).  This 
hydrophobic dye fluoresces upon binding to hydrophobic pockets of proteins which are 
exposed in the process of protein unfolding due to increased temperature. Used together 
with a buffer screen thermofluor allows the determination of the stability of a protein under 
varying conditions.  The screen contains 96 different conditions with varying buffer 
reagents, pH, salts and glycerol (Niesen, Berglund, and Vedadi 2007).  It is assumed that 
the buffer condition that yields the highest Tm is the condition in which the protein is most 
stable.  These experiments are carried out using a real time PCR instrument (Eppendorf 
Mastercycler).  The protein is prepared to 20 μM in water and a 2X SYP O Orange is 
PMM2 T171R/I17
4R 
F 5'- GCT GGA AAA GGC CTC AGG TTT TCC CGA 
GGA GGC CAG ATC AGC -3' 
  R 5'- GCT GAT CTG GCC TCC TCG GGA AAA CCT 
GAG GCC TTT TCC AGC -3' 
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added.  The protein-dye mixture is added to 96 different buffers resulting in 10 μM protein 
and 50 μM buffer solutions and 1X SYP O Orange dye.  The 96-well plate is heated at a 
rate of 1 ˚C per minute over a linear range (20 ˚C to 99 ˚C) (Figure 2.9) and fluorescence 
intensity is measured in real time.  Fluorescence is measured through interference 
excitation (492 nm) and emission (568 nm) filters.  The derivative of the fluorescence 
intensity change over time is plotted as a function of temperature (˚C).  
 
 
Figure 2.9 Thermofluor experiment temperature over time.  Each segment represented by 
the vertical lines is a step set for the PCR thermocycler instrument.  The PCR heat block is 
first set to 20.0 ˚C at the beginning of the experiment.  After a 15 s hold at 20.0 ˚C, a linear 
increase in temperature over 20 min to reach 95 ˚C is started and fluorescence is measured 
in real time.  
1
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 The thermofluor assay was first tested for both PMM1 and PMM2 to find an 
optimal buffer which may contribute to success in crystallization and reduce aggregation.  
Results from the assay showed that both enzymes not only require Mg2+ for catalytic 
activity, but Mg2+ is also important for protein stability, especially in PMM1.  PMM1 
solubility screen showed Tm of most conditions to be in the range of 40˚C to 55˚C (Figure 
2.10b), however without Mg2+, the Tm varied over a much wider range (25 ˚C to 50 ˚C) 
(Figure 2.10a).  A similar trend is seen for PMM2 where addition of Mg2+ shifted the Tm 
up by ~5 ˚C for all buffer conditions (Figure 2.10c and 2.10d).  In all cases, the buffer 
conditions that resulted in the highest Tm were buffers containing sodium phosphate, at 
~54-58 ˚C for PMM1 and ~59-61 ˚C for PMM2.  These buffers were eliminated because 
of possible competition of phosphate with substrate and activators of the mutase.  The next 
best buffer comprised 50 mM HEPES pH 7.5 and 100 mM NaCl and yielded a Tm ranging 
~51-53˚C for PMM1 and ~57-59˚C for PMM2.  Hence this buffer was used for all future 
studies with the addition of 5 mM MgCl2 and 2 mM β-mercaptoethanol.  
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a. PMM1 without Mg2+ 
b. PMM1 with 5 mM Mg2+ 
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Figure 2.10 Thermofluor assay by real time PC . a. Tm curves for PMM1 without Mg2+, 
b. PMM1 with 5 mM Mg2+, c. PMM2 without Mg2+, d. PMM2 with Mg2+.  Experiments 
were conducted using 10 μM enzyme. 
 
 
c. PMM2 without Mg2+ 
 
d. PMM2 with 5 mM Mg2+ 
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 2.2.7 Steady-State Kinetics 
Kinetic assays measuring α-PMM1 phosphoglucomutase activity were carried out 
at 25 ˚C in 50 mM Na+ Hepes, pH 6.5, 10 mM MgCl2.  The initial rate at which α-PMM1 
catalyzed the conversion of α-Glc-1-P to Glc-6-P was measured by a coupled reaction 
containing Glc-6-P dehydrogenase and reduction of NADP+ was monitored by increase in 
absorbance at 340 nm (Δϵ = 6.2 mM-1 cm-1).  Assays were performed in 1-ml quartz cuvette 
containing 50 μM α-Glc-1,6-P2, 0.2 mM NAPD+, 5 units/ml Glc-6-P dehydrogenase.  The 
kcat and Km values were determined by fitting the data to the Michaelis-Menten equation,  
V0  = Vm[S]/(Km + [S])   Equation 2.1 
where [S] is the α-Glc-1-P concentration,V0 is the initial velocity, Vm is the maximum 
velocity, and Km is the Michaelis constant. The kcat was calculated from the ratio of Vmax 
and the α-PMM concentration.   
Phosphoglucomutase inhibition constant by IMP was determined by the equation  
Vappmax = Vmax/(1+[I]/KI)    Equation 2.2 
where [I] is the concentration of IMP, and KI is the inhibition constant.  Inhibition assays 
were similar to the coupled assay described above with the exception that 50 μM α-Glc-
1,6-bisP was not used as the activator.  Instead, 2.5 mM fructose-1,6-P2 was used to activate 
the enzyme.  (The kact of PMM2 by fructose-1,6BP is 480 μM (Wang and Silvaggi, 
unpublished results).) A bisphosphorylated sugar is required to “activate” the enzyme by 
supplying a phosphate to the catalytic residue Asp19 to form the phosphoenzyme (Figure 
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2.3a).  In the presence of IMP, however, PMM1 uses α-Glc-1,6-P2 as a substrate instead of 
an activator by converting it to Glu-6-P, which, in the assay reacts with Glc-6-P 
dehydrogenase and leads to reduction of NADP+.  Therefore, a different bisphosphorylated 
sugar is required for activation in order to avoid interference from the phosphatase activity.  
Fructose-1,6-P2 was shown to be able to provide the phosphate for formation of the 
phosphoenzyme, thus it was used as an activator for assaying the inhibition of mutase 
activity by IMP.  
The rate of PMM1 phosphatase activity (α-Glc-1,6-P2 to Glc-6 P and Pi) was 
determined using a colorimetric quantitation of phosphate assay, BIOMOL GreenTM 
Reagent (Enzo Life Sciences), a molybdate/malachite green-based reagent to 
simultaneously quench the reaction and begin color development.  Absorbance at 620 nm 
was measured using a 96-well plate reader and quantitation of phosphate hydrolysis was 
calculated from a phosphate standard curve.  The assay was prepared with 0.1 mM IMP in 
a buffer solution containing 100 mM Hepes, pH 7.2, 2 mM MgCl2, and 2 mM β-
mercaptoethanol.  Initial velocity was determined by quenching 50 μl of reaction into 100 
μl BIOMOL GreenTM Reagent in 15 second intervals from time point 0 to 5 minutes, done 
in triplicate.  The kcat and KM constants were determined using the Michaelis-Menten 
equation mentioned above.  Activation constant by IMP, kact
IMP, was determined by varying 
concentration of IMP (0 – 50 μM for wild-type PMM1), and using the equation  
V0  = Vm[A]/( kact
IMP + [A])    Equation 2.3 
where [A] is the concentration of IMP. 
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2.2.8 Crystallization and structure of PMM1 
Crystallization conditions are as described by N. Silvaggi et al. (Silvaggi et al. 
2006).  Experiments performed in an effort to co-crystallize PMM1 with ligand included 
the Hampton Research high-throughput crystallization screens plus ligand (IMP, Glc-1,6-
P2, Glc-6-P +IMP+VO4, IMP + VO4).  Ligand soaking experiments were also performed 
by varying ligand concentration and time of soaking before cryo-cooling.  Twenty-two data 
sets at 2.5 Å resolution or higher were collected. 
PMM1 with IMP crystal was obtained by soaking with 200mM IMP for 3.5 hours 
prior to cryo-cooling.  Data was collected using the remote access beamline 12-2 at 
Stanford Synchrotron Radiation Lightsource (SSRL).  Resolution of data was 1.93 Å.  
Other crystallographic data information is listed in Table 2.3. 
 
2.2.9 X-ray data: Collection, Integration, Scaling 
PMM1 crystals were grown in 20% polyethylene glycol 3350, 0.15 M DL-malate, 
pH 7.0, 50 mM MgCl2, and 8 mM  β-mercaptoethanol by the hanging-drop vapor diffusion 
method (Silvaggi et al. 2006).  PMM1 with IMP crystal was obtained by soaking with 200 
mM IMP for 3.5 hours prior to flash-cooling.  Drops were formed by mixing 1 μl of well 
solution with 1 μl of 15 mg/ml purified protein. Diffracting crystals formed after 2 rounds 
of micro-seeding after 2 days at 17 ˚C (Figure 2.11a).  Crystals were transferred to 
paratone and flashed-cooled in liquid N2.  X-ray diffraction data was collected at 100 K via 
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remote access to SSRL Beamline 12-2.  PMM1 in complex with IMP crystallized in space 
group P43212 with unit-cell dimensions a=b=52.17 Å, c=214.48 Å.  Crystal size was 0.7 x 
0.3 x 0.3-mm and diffracted to 1.92 Å resolution. Data set was indexed, integrated and 
scaled in autoXDS (Gonzalez, A and Tsai 2010). 
Crystals of PMM1 variants M186Q, R183I, R180K/R183K grew in the same 
condition as those of wild-type PMM1. Crystals of mutant R180T/R183I were grown in 
the same condition with the addition of 0.05 M L-lysine.  Although there is no density for 
L-lysine, the positively charged residue appears to improve crystal formation.  Other 
positively charged compounds were also used to improve crystallization including arginine 
and guanidine (Figure 2.11b).  Data sets for R180T/R183I and R180K/R183K were 
collected from National Synchrotron Light Source (NSLS) at Brookhaven National 
Laboratory (BNL) on beamline X-25, and data set for R183I and M186Q were collected 
from Advanced Photon Source (APS) at Argonne National Laboratory (ANL) on beamline 
NE-CAT.  Data Collection and refinement statistics for the X-ray crystal structures of 
variants are presented in Results.  The R180T mutants did not yield crystals.  
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Lysine  Arginine Guanidine 
0.0 M 
0.05 M 
0.10 M 
0.15 M 
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Figure 2.11 Crystals of optimized wt PMM1 (top) and crystals of R180T/R183I variant 
with varying concentrations of positively charged additives. 
 
2.2.10 Structure Refinement: PMM1 liganded model 
Phases were calculated for the structure determination of PMM1 in complex with 
IMP by molecular replacement using the wild-type PMM1 structure (2FUC). Similar to 
the native PMM1 structure, the first 11 residues of the N-terminus and the last 6 residues 
on the C-terminus were disordered. An initial model was built using Phenix AutoBuild 
(Adams et al. 2010) and improved by manual rebuilding in the graphics suite COOT (P. 
Emsley, B. Lohkamp, and Cowtan 2010).  The model was refined in PHENIX Refine.  
Iterative cycles of restrained refinement in PHENIX Refine and rebuilding in COOT 
ultimately yielded a model containing 240 of 262 residues, 307 water molecules, and 2 
Mg2+ ions. (The quality of the model was assessed by MOLPROBITY (23), and 235 
residues (96.7%) were in the favored regions, 7 residues were in the additionally allowed 
regions, and no residues were in the disallowed regions.)  After rigid body refinement in 
PHENIX Refine, the electron density for inosine-monophosphate (IMP) was well defined.  
Prior to fitting of the IMP ligand, the data obtained an R-work of 0.23 Å and R-free of 0.18 
Å.  Data collection and refinement statistics for PMM1-IMP models is reported in Table 
2.1.  Structures of PMM1 mutants were processed in the same manner. 
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2.2.11 PMM SAXS and WAXS data 
SAXS experiments were performed using beamline X9A at NSLS, with a 
wavelength of 0.918 Å and beam energy of 13.5 keV.  Data were initially collected with 
varying concentrations of protein to determine optimal concentration and examine 
concentration-dependent changes.  The scattering curve and radius of gyration (Rg) did not 
exhibit change within the tested concentration range between 1.25 – 28 mg/mL indicating 
a stable dimer formation in solution.  The remaining data were collected at a protein 
concentration of 10 mg/mL in a buffer solution containing 50 mM HEPES, 100 mM NaCl, 
5 mM MgCl2, 1 mM βME at pH 7.5 and a variety of ligands at a concentration of 10 mM 
at 14 ˚C.  Sample-to-detector distance for SAXS data collected on a MarcCCD 165 was 
3.4 m and WAXS data were collected simultaneously at 0.47 m from the sample.  The 
wavelength of λ = 0.98 Å and sample-to-detector distance of resulted in a resolution range 
of 0.0064 <q = 4π/λ <2.0, where q= 4π sinθ/λ and 2θ is the scattering angle. A 20 μL sample 
volume was continuously loaded in a 1 mm diameter capillary and exposed to X-rays for 
30 s.  Each sample was collected in triplicate and averaged.  The buffer component of the 
scattering was removed by subtracting the scattering data from a matched buffer sample to 
produce the 1D scattering curve of the macromolecule.  The scattering intensity 
normalization and radius of gyration (Rg) was determined using Guinier approximation 
calculations analysis were carried out in Primus (Konarev et al. 2003) of the ATSAS suite 
(28).  The Rg was determined using Guinier analysis of low resolution data by the Guinier 
approximation, 
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   I(q) = I(0) exp(-q2Rg2/3)  Equation 2.4 
with a qRg limit of 1.3.  The molecular envelop of IMP bound PMM1 was generated by 
ab-initio shape reconstruction in DAMMIN. 
 
2.2.12 STD-NMR 
Saturation-Transfer Difference (STD) NMR is a ligand observed NMR technique 
used to study protein-ligand interactions.  The experiment is based on the transfer of 
saturation from the receptor to a bound ligand by selectively irradiating on the receptor 
resonances and subsequent transfer of saturation by spin diffusion from the receptor to the 
ligand in the event of binding.  A second  “off resonance” spectrum  must be obtained as a 
control by saturating a region of the spectrum that does not have any signal for the receptor, 
usually at 40 ppm 1H frequency.  The difference between the off and on resonance spectra 
results in a saturation transfer difference (STD) spectrum showing peaks where saturation 
transfer occurred. The intensity of the STD effect can be calculated as shown in equation 
5: 
I(STD) = I(0)-I(sat)    Equation 2.5 
where I(0) and I(sat) are the signal intensities of the off and on resonance spectra, 
respectively. I(STD) is the intensity difference between the on and off resonance signal. 
NMR experiments was carried out on a Bruker DMX 500 (11.7 Tesla) MHz 
spectrometer using the software XWINNMR for analysis.  A total of three spectra were 
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collected to observe ligand binding to PMM1-IMP alone, IMP with wt PMM1, and IMP 
with  180T/ 183I variant. All samples (700 μl) were prepared in a HEPES storage buffer 
consisting of 50 mM Hepes pH 7.2, 5 mM MgCl2 1 mM DTT and 10% D2O.  Samples 
containing 5 μM of protein and 0.5 mM of the ligand, IMP, were loaded into 5 mm NM  
tubes (Wilmad laboratory glass).  Saturation of the protein is achieved by repetitive 
irradiation of a Gaussian shaped pulse with 40 ms duration during the recycle delay 
between 0 and 1 ppm for the on-resonance and 40 ppm for the off-resonance spectrum.  
 
2.2.13 T2 Relaxation NMR: 
The NMR experiment to measure the transverse relaxation time (T2) is a fairly 
simple one-dimensional experiment that can be used to measure ligand-observed changes 
in the NMR signal relaxation rate of small molecules upon binding to a larger receptor.  
This technique is dependent on the molecular rotational correlation time (τc) and thus the 
molecular weight.  The higher the molecular weight, the longer the τc and the shorter the 
T2.  Thus, a small molecule will have much slower relaxation time (longer T2 at about 1-2 
seconds) compared to a protein macromolecule (relaxation time of approximately 1-50 
ms).  In a ligand-binding experiment using T2 relaxation, the transient binding (kon and 
koff) of the ligand to the protein causes the ligand to adopt a more protein-like relaxation 
time, thus increasing to a rate of relaxation which is dependent on the Kd of the ligand.  
Thus, the ideal Kd concentration for T2 relaxation ligand-binding NMR is within the low 
micromolar range. 
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NMR spectrum was collected at Boston University Medical Campus on the Bruker 
DMX 500. Purified protein was prepared to a final concentration of 50 μM with saturating 
ligand concentration of 0.9 mM IMP in storage buffer (above) and transferred to 5 mm 
NMR tubes (Wilmad laboratory glass).  NMR spectra were acquired with 16 scans and a 
recycle delay of 1 s. A typical 90˚ and 180˚ pulse length were 10 and 20 μs, respectively.   
 
2.3 Results and discussion 
2.3.1 Overall structure 
The structure of PMM1 in complex with IMP was crystallized in the open 
conformation and determined to 1.93 Å resolution (statistics of structure provided in Table 
2.3).  The electron density omit map with the ligand, IMP, modeled in is shown in Figure 
2.12.  The liganded protein was crystallized in the same condition as the unliganded 
reported in Silvaggi et al. (Silvaggi et al. 2006) in the space group, P43212, with unit cell 
dimensions a = b = 52.2 Å, c = 214.5 Å.  PMM1 in complex with IMP has a r.m.s.d. of 
0.72 Å compared to the unliganded structure (2FUC).  PMM1 is comprised of a C2b cap 
type within the HAD superfamily, characterized by a 100 amino-acid long cap domain 
(residues 95-194 of PMM1) including α-helices and β-sheets in a ααββααββ orientation 
inserted between β5 and α7 (or motifs 2 and 3) of the  ossmann core domain.  The core 
domain (residues 1-90 and 198-262) exhibits a typical Rossmann fold consisting of 6 
parallel β-sheets (β1-β5 and β10-β11) with a helix enclosed by 5 α-helices (α1-α2 and α7-
α9).  The cap and core are connected by a hinge region composed of residues 91-94 and 
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195-197 (Figure 2.4b).  The biological assembly of PMM1 is a dimer with the inter-
subunit interface located exclusively within the cap region, and more specifically the α3 
and α6 helix, which was determined in our previous paper (Silvaggi et al. 2006).  
The full protein structural alignment between the unliganded PMM1 with IMP and 
M1P bound enzyme differ minimally with r.m.s.d. of 0.60 Å and 0.53 Å, respectively.  The 
core domain structures align identically and the cap domain varies little with the exception 
of the ligand-binding loop region.  In the IMP bound enzyme, the loop is extended over a 
greater span of sequence by disrupting the bonds that form the β-sheets of the cap domain 
thus shortening the β8-strand (Figure 2.13).  We also compared the loop region of the M1P 
bound enzyme to that of the unbound enzyme and this loop is also extended however, to a 
smaller degree.  We propose that the flexibility in this loop is crucial for binding of IMP to 
the enzyme and altering its functionality to become a phosphohydrolase.   
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Data Collection 
Space group P43212 
Unit cell dimensions  
a=b, c (Å) 52.169 214.484 
α=β=γ (º) 90.0 
Resolution (Å)a 34.88  - 1.918 (1.986  - 1.918) 
Rsymm 0.01479 (0.1559) 
I/σI 30.32 (5.01) 
Completeness 98.20 (85.02) 
Redundancy 2.0 (1.9) 
  
Model Refinement 
Resolution (Å) 34.88  - 1.918 
No. of reflections 23,377 
Rwork / Rfree 0.1698/0.2237 (0.2034/0.2479) 
No. of non-H atoms  
Protein 1,969 
Ligands/ions 
25 
 
Solvent 307 
Ave. B factors (Å2)  
Protein 
22.6 
 
Ligands/ions 35.4 
Solvent 32.7 
R.M.S. deviations  
Bond lengths (Å) 0.007 
Bond angles (º) 1.05 
Estimated coordinate error (Å) b  
  
 
Table 2.2 Crystallographic data collection and model refinement statistics. 
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Figure 2.12 Stereo view of IMP ligand.  The IMP model (shown as sticks, teal) with 
electron density from the simulated annealing composite omit 2FoFc map contoured at 
1.0σ level (gray wire frame). The image was rendered using Pymol. 
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Figure 2.13 Superimposition of unbound PMM1 (2FUC) in purple and PMM1 bound to 
IMP in salmon.  Structures have r.m.s.d. of 0.60 Å.  Inset displays distal phosphate binding 
loop rotated 90˚ along the x-axis to show the disruption of the β-strand due to IMP binding. 
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2.3.2 IMP binding to the substrate distal phosphate binding site is competitive with 
respect to substrate 
The structure of PMM1 in complex with IMP was solved showing IMP bound at 
the cap domain, sharing the same binding site as substrates Man-1-P (2FUE).  From our 
structural analysis of HADSF mutases, we posit that the cap domain makes the initial 
binding contact to substrate, being responsible for substrate recruitment and recognition 
(Silvaggi et al. 2006; Lahiri et al. 2004).  The site of phosphate binding to the cap is termed 
the distal phosphate binding site.  We have shown previously that the side chains involved 
in H-bonding with the substrate phosphate moiety of Man-1-P includes Arg143, Arg150, 
and Ser188, and amide backbone of Met186(Silvaggi et al. 2006) (Figure 2.14a).   In our 
structure of IMP bound to PMM1, the phosphate moiety of IMP is bound at the same site.  
Additionally, the inosine moiety forms H-bonds with side chains of, Ser182, Asp190, 
Asn137, and Arg132 and the backbone N of Gly184 (Figure 2.14b).  Surprisingly, these 
residues are conserved in PMM2 with the exception of Met186, which is Gln177 in PMM2. 
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Figure 2.14 Residues within hydrogen bonding distance of Man-1-P (a) and IMP (b).  Side 
chains labeled in blue form H-bonds with the phosphoryl moiety of ligand and side chains 
labeled in black form H-bonds to either the sugar (a) or nucleotide (b) moiety of ligand.  
Side chains that are colored dark green in (a) and dark pink in (b) are residues that do not 
participate in H-bonds to their respective ligands. 
 
2.3.3 Sequence alignment of PMM homologs identifies differential conservation of 
residues between PMM1 and PMM2 in the IMP binding loop region 
Because residues that interact in H-bonding to the effector, IMP, were conserved 
in both PMM1 and PMM2, we looked for differences between PMM1 and PMM2 beyond 
H-bonding distance.  The sequence of β8 and the extended loop caused by ligand binding 
was analyzed.  This region is mostly conserved with three striking differences, where 
a. b. 
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Arg180, Arg183, and Met186 in PMM1 are Thr171, Ile174, and Gln177 in PMM2, 
respectively.  Furthermore, orthologs from a BLAST search of PMM1 and PMM2 showed 
these were conserved differences (Figure 2.15).  We hypothesized that the positively 
charged residues play an important role in IMP binding and the Thr171 and Ile174 side 
chains in PMM2 contribute to the stability of the β-strand and prohibits the flexibility 
required to accommodate a purine nucleotide.  The location of these residues on the loop 
is displaced in Figure 2.16.  
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Figure 2.15. Full sequence alignment of PMM1 and PMM2 isozymes through BLAST 
search, sequence alignment made with Clustalw and figure generated using EsPript3.0.  
Region boxed in green represents the substrate binding loop sequence showing conversed 
differences between PMM1 and PMM2 isozymes. 
 
 
  
Figure 2.16 Ligand binding loop with IMP bound.  The protein molecular surface 
electrostatics displayed as semitransparent surface with the loop displayed as cartoon and 
resides that differ from PMM2 shown as sticks.  
 
 
R180 
R183 
M186 
84 
 
2.3.4 Structures of PMM1 variants 
PMM1 variants were generated to mimic the side chain residues of PMM2 within the 
substrate-binding loop.  These variants were tested for the ability to catalyze the 
phosphatase activity in order to probe the effects of each of the mutated residues.  First, to 
ensure that the single and double mutations generated did not affect the global structure the 
X-ray crystal structure of four PMM1 variants was solved, statistics show in Table 2.4.  
The overall structures showed no significant change from the wild-type PMM1 structure, 
with the exception of the mutated side chains.   
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Table 2.3 Data collection and refinement statistics for PMM1 variants. 
 R183I PMM1 M186Q R180T/R183I R180K/R183K 
Wavelength (Å) 0.9791  0.97917 0.9791  0.9791  
Resolution range 
(Å) 
42.11  - 2.07   
(2.144  - 2.07) 
41.41  - 2.07    
(2.144 - 2.07) 
49.94  - 2.43        
(2.517  - 2.43) 
49.28  - 2.244       
(2.324  - 2.244) 
Space group P 43 21 2 P 43 21 2 P 43 21 2 P 43 21 2 
Unit cell (a, b, c) 51.9, 51.9, 
216.1 
50.9, 50.9, 
213.6  
51.4, 51.4, 
214.4 
50.7, 50.7, 
213.4 
Total reflections 36218 (3220) 36126 (3472) 44224 (4289) 28360 (2737) 
Unique 
reflections 
18258 (1670) 18078 (1746) 11589 (1109) 13960 (1373) 
Multiplicity 2.0 (1.9) 2.0 (2.0) 3.8 (3.9) 2.0 (2.0) 
Completeness 
(%) 
96.04 (91.13) 99.81 (99.49) 99.81 (99.64) 98.41 (96.29) 
Mean I/sigma(I) 9.08 (3.68) 15.17 (4.74) 21.22 (7.46) 9.62 (1.88) 
Wilson B-factor 20.27 24.53 42.29 35.61 
R-merge 0.03963 
(0.1752) 
0.02169 
(0.1504) 
0.05499 
(0.1759) 
0.02972 
(0.2152) 
R-meas 0.05605 0.03067 0.06392 0.04203 
R-work 0.1692 
(0.1969) 
0.1911 
(0.2221) 
0.2085  (0.2496) 0.2166 
(0.2565) 
R-free 0.2121 
(0.2701) 
0.2373 
(0.2637) 
0.2757  (0.3720) 0.2739 
(0.3155) 
Number of atoms 2304 2221 2036 2087 
  
macromolecules 
1966 1973 1959 1962 
  ligands 2 2 2 2 
  water 336 246 75 123 
Protein residues 245 245 245 245 
RMS(bonds) 0.007 0.007 0.008 0.008 
RMS(angles) 1.01 1.09 1.14 1.13 
Ramachandran 
favored (%) 
98 98 95 95 
Ramachandran 
outliers (%) 
0 0.41 0.41 0.82 
Clashscore 2.84 3.62 4.92 6.72 
Average B-factor 15.70 26.2 36.40 31.80 
  
macromolecules 
14.20 25.4 36.40 31.70 
  ligands 11.90 21.6 32.80 28.60 
  solvent 24.60 32.2 35.50 33.00 
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2.3.5 Steady-State kinetics 
The rate at which PMM1 catalyzed the conversion of Glc-1-P to Glc-6-P was measured by 
a coupled reaction containing Glc-6-P dehydrogenase and reduction of NADP+ was 
monitored by increase in absorbance at 340 nm.  To start, kinetic results were compared 
with published data (Table 2.5) (Silvaggi et al. 2006). 
 Published Reproduced 
kcat  (s
-) 2.85 ± 0.06 0.98 ± 0.05 
Km (μM) 7.5 ± 0.8 13.3 ± 2.0 
kcat/Km (M
-1s-1) 3.8 x 105 7.4 x 104 
 
Table 2.4 Assay contains saturating concentration of Glc-1,6-P2 at 50 μM to activate 
enzyme. 
 
Next, to determine whether PMM1 was specific for the C1 or C6 position phosphate 
hydrolysis of Glc-1,6-P2 in the phosphatase reaction, the kinetics of the reaction was 
measure using two assays.  In a BioMol Green assay, the total amount of phosphate release 
was measured and kcat/Km was determined to be 4.26 x 10
4 M-1s-1 (Table 2.6).  Separately, 
a coupled enzyme assay measuring the reduction of NADP+ to NADPH by G6PDH 
measures the production of Glc-6-P.  The kcat/Km of the coupled assay was determined to 
be 4.91 x 104 M-1s-1, which is comparable to the rate determined for phosphate release by 
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the BioMol Green assay.  Thus, PMM1 preferentially hydrolyzes the C1 position phosphate 
group to produce Glc-6-P and Pi, which is in agreement with its role of glycolytic rescue. 
 
Table 2.5  Determining specificity for phosphate release.  Two assays used to measure 
PMM1 phosphatase activity—measure of Glc-6-P release by G6PDH coupled enzyme 
assay and measure of phosphate release by BioMol Green reagent.  Similar kinetic 
parameters indicate that PMM1 hydrolyzes specifically the C1 position phosphate of Glc-
1,6-P2. 
 
We hypothesized that the positively charged residues conserved in PMM1 but not 
PMM2 may play a role in IMP binding and the hydrophobic Thr171 and Ile174 side chains 
conserved in PMM2 but not PMM1 contribute to the stability of the β-strand and prohibit 
the flexibility required to accommodate a purine nucleotide.  Five site-directed mutants of 
PMM1 and one of PMM2 were generated based on this hypothesis and the importance of 
each residue was assessed by testing the enzyme variants for IMP binding and phosphatase 
activity (Table 2.7).  Single-site mutations of PMM1 were made to replace the arginines 
and methionine with the corresponding PMM2 side chains—R180T, R183I, and M186Q.  
Two double mutants were generated—R180T/R183I to assess the additive effect of 
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replacing both arginines with the PMM2 counterparts, and R180K/R183K to test if the 
charge is key to IMP binding.  Finally, T171R/I174R mutations were generated in PMM2 
to test whether these two residues were sufficient to allow IMP binding.  For each variant, 
we determined the kinetic constants for the mutase activity to confirm that the protein was 
properly folded and active.  The kcat and Km for mutase activity of all variants did not differ 
significantly from those of wild-type PMM1 (0.5-2X in kcat and 0.5-5X in Km).  PMM2 
kinetics were also determined to confirm previously reported values (Silvaggi et al. 2006).  
Notably the T171R/I174R PMM2 variant failed to yield any detectable mutase activity nor 
did it acquire phosphatase activity.  
Phosphatase activity in the presence and absence of IMP was measured for each 
construct.  For wild-type PMM1 phosphatase activity increased by two orders of magnitude 
in kcat/Km in the presence of saturating IMP (100 µM), reflecting an increase in the turnover 
rate (kcat) without a significant change in Km.  In the absence of IMP, kcat for Glc-1,6-P2 
hydrolysis was 0.018 ± 0.002 s-1, and increased by 78-fold to 1.4 ± 0.05 s-1 in the presence 
of 100 μM IMP.  All single mutants,  180T,  183I, and M186Q, exhibited similar kcat and 
Km values for phosphatase activity compared to wild-type in the presence and absence of 
IMP.  However, the phosphatase activation constant, Kact
IMP, differed drastically.  The IMP 
concentration required for half the maximum phosphatase activity increased by 120-fold 
for R183I, 9-fold for R180T and 5-fold for M186Q. This is in agreement with the inhibition 
constants of IMP, Ki
IMP, determined for PMM1 mutase activity (Table 2.7).  The Ki
IMP for 
wild-type PMM1 is similar to the phosphatase Kact
IMP, at 2.0 ± 0.3 μM.  The same trend is 
observed in the PMM1 variants where the R183I variant was most detrimental to inhibition 
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of mutase activity by IMP, increasing the Ki
IMP to 350 ± 25 μM, a 175-fold increase.  
PMM1 variants R180T and M186Q exhibited minimal change in Ki
IMP compared to wild-
type, where Ki
IMP are 2.3 ± 0.23 μM and 2.8 ± 0.28 μM, respectively.  Thus, the role of 
these residues appears to be in binding, not in the catalysis of phosphohydrolase activity.     
Next, we tested whether there were synergistic effects from mutating both arginine 
residues to R180T/R183I.  Phosphatase activity in the R180T/R183I variant reflected a 
severe loss of IMP-dependent activation.  While kcat remained relatively unchanged in the 
absence of IMP, Km increased 3-fold.  Most notable, however, at saturating IMP 
concentration (4 mM IMP), kcat decreased 9-fold and Km increased 3-fold.  Since 
phosphatase activity is changed to a small extent, but large amounts of IMP are required 
for activation, we posit that the positively charged electrostatics around the cap-core 
interface appear to play an important role in IMP binding.  To test this hypothesis, we made 
a second double mutant to replace the arginine residues by positively charged residues, 
R180K/R183K.  As expected, kcat, Km, and Kact
IMP remained comparable to wild-type with 
high binding affinity for IMP (Table 2.8).  In both double mutants, the Ki
IMP values for 
inhibition of the mutase activity were in agreement with Kact
IMP for the phosphatase 
activity.  Whereas, the R180T/R183I variant showed an increase by 390 fold and 560 fold 
in Ki
IMP and Kact
IMP, respectively, the R180K/R183K variant remained unchanged 
compared to wild-type. 
Additionally, the PMM2 variant containing double mutations T171R/I174R were 
made to test if a gain of function could be achieved in which PMM2, like PMM1 would 
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bind IMP and allow Glc-1,6-P2 hydrolysis.  Unfortunately, this variant was inactive for 
mutase and phosphatase activity, although purification, gel filtration, and SAXS 
experiments showed that the majority of protein was soluble and folded. 
 Mutase (G1PG6P) 
 kcat Km  kcat/Km Ki
IMP 
WT PMM1 1.3 ± 0.04  s-1 19 ± 2.1 μM 6.8 x 104  M-1s-1 2.0 ± 0.3 μM 
R180T/R183I mutant 1.6 ± 0.05 s-1 17 ± 2.1 μM 9.4 x 104  M-1s-1 780 ± 47 μM 
R183I mutant  1.0 ± 0.02 s-1 8.0 ± 0.7 μM 1.3 x 105 M-1s-1 350 ± 25 μM 
R180T mutant 0.9 ± 0.03  s-1 28 ± 2.8 μM 3.2  x 104 M-1s-1 2.3 ± 0.23 μM 
M1 86Q mutant 1.1 ± 0.06 s-1 10 ± 2.0 μM 1.1  x 105 M-1s-1 2.8 ± 0.28 μM 
R108K/R183K mutant 2.1 ± 0.19 s-1 13 ± 3.8 μM 1.6 x 105 M-1s-1 2.0 ± 0.29 μM 
WT PMM2 1.0 ± 0.06 s-1 8.0 ± 1.8 μM 1.3 x 105 M-1s-1 > 4 mM 
T171R/I174R PMM2 --- --- ---  
 
Table 2.6 Steady-state kinetic constants.  The steady-state kinetics measured for PMM1, 
PMM1 mutants and PMM2 for mutase activity converting Glc-1-P to Glc- 6-P at pH 7.2 
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and 25 ˚C.  Determined using a G6PDH coupled assay. (See Methods section 2.2.7 for 
detail). 
 
Figure 2.17  Lineweaver-Burk plot of PMM and all variants.  Inhibition constants 
calculated from two to three IMP inhibitor concentrations.  Curves generated using 
GraphPad Prism.  
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 Phosphatase  activity (0 μM IMP)  
 kcat Km  kcat/Km KactIMP [IMP] 
WT PMM1 0.018 ± 0.002 s-1 18 ± 2.0 μM 1.0 x 103  M-1s-1   
R180T/R183I  0.022 ± 0.008 s-1 54 ± 7.0 μM 4.0 x 102  M-1s-1   
R183I  0.011 ± 0.003 s-1 16 ± 1.8 μM 6.7 x 1 02 M-1s-1   
R180T  0.024 ±0.001 s-1 14 ± 2.4 μM 1.7 x 103 M-1s-1   
M186Q  0.014 ± 0.008 s-1 14 ± 2.7 μM 1.0 x 103 M-1s-1   
R108K/R183K  0.03 ± 0.002 s-1 13 ± 2.7 μM 1.5 x 103 M-1s-1   
wtPMM2 --- s-1  --- μM --- M-1s-1   
 Phosphatase activity (at concentration of IMP yielding 
maximal phosphatase activity) 
  
WT PMM1 1.4 ± 0.05 s-1 8.5 ± 1.0 μM 1.6 x 105 M-1s-1 1.5 ± 0.2 μM 100 uM 
R180T/R183I  0.16 ± 0.006 s-1 21 ± 2.5  μM 7.6 x 103 M-1s-1 760 ± 55 μM 2 mM 
R183I  1.1 ± 0.4 s-1 10 ± 1.7 μM 1.1 x 105 M-1s-1 180 ± 27 μM 2 mM 
R180T  3.1 ± 0.13 s-1 17 ± 2.1 μM  1.8 x 105  M-1s-1 14 ± 2.8 μM 100 uM 
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M186Q  3.5 ± 0.25 s-1 19 ± 3.9 μM 1.8  x 105 M-1s-1 7.0 ± 1.8 μM 100 uM 
R108K/R183K  2.2 ± 0.09 s-1 13 ± 1.9 μM  1.7 x 105 M-1s-1 1.9 ± 0.27 μM 100 uM 
wtPMM2 --- s-1  --- μM --- M-1s-1 > 4 mM 2 mM 
 
Table 2.7  Steady-state kinetic constants.  The steady-state kinetics measured for PMM1, 
PMM1 mutants and PMM2 for phosphatase activity converting Glc-1,6-P2 to Glc-6-P at 
pH 7.2 and 25 ˚C.  Determined using BioMol Green phosphate quantification assay. (see 
Methods section 2.2.7 for detail). 
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Figure 2.18  Activity curves measuring phosphatase activity.  The first two rows (no IMP 
and saturating IMP) show the Michaelis-Menten curves for each enzyme.  The last row 
([IMP] activation) show curves measured to calculate the activation constants of IMP. 
 
 
 Ki
IMP Kact
IMP 
WT PMM1 2.0 μM 1.5 μM 
R180T/R183I mutant 780 μM 760 μM 
R183I mutant  350 μM 180 μM 
R180T mutant 2.3 μM 14 μM 
M186Q mutant 2.8 μM 7.0 μM 
R108K/R183K mutant 2.0 μM 1.9 μM 
WT PMM2 > 4 mM > 4 mM 
T171R/I174R PMM2  --- --- 
 
Table 2.8 Side by side comparison between the inhibition constant of mutase activity, 
Ki
IMP, and the activation of the phosphatase activity, Kact
IMP, by IMP.  The Ki
IMP and Kact
IMP 
show similar trend in the different PMM1 variants suggesting that the same IMP binding 
site causes inhibition of mutase and activation of phosphatase activity.  
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2.3.6 Conformational changes in PMM1 and PMM2 induced by ligand binding 
SAXS experiments were performed to analyze the interdomain motion of PMM1 
and PMM2 upon ligand binding.  A range of protein concentrations (1.25 mg/mL to 28 
mg/mL) were first measured for PMM1 without ligand to assess the concentration 
dependence of the observed conformation and potential for dimerization (PMM1 and 
PMM2 are dimeric (Silvaggi et al. 2006)).  The Guinier plot showed acceptable linearity 
in the low resolution scattering range for determination of the radius of gyration (Rg) 
(Figure 2.19).  At all concentrations, the Rg remained relatively unchanged (Rg 33.4 ± 0.21 
Å) consistent with a stable dimeric state independent of concentration.  Unliganded PMM2 
at 10 mg/mL had a Rg of 28.1 ± 0.14 Å.  The calculated molecular envelope of PMM1 
superimposes well with crystallographic structure confirming that the dimer interface 
between the cap domains observed in the crystal structure exists in solution (Figure 2.20).   
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Figure 2.19 Guinier plot of concentration dependence of PMM1.  Calculated Rg were the 
same for all concentrations. 
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Figure 2.20 Calculated molecular envelope of PMM1 using DAMMIN with the crystal 
structure superimposed with the crystallographic dimer structure showing the dimer 
interface at the cap domain. 
 
We next examined the effects of ligand binding on the conformation of PMM. In a 
theoretical scattering curve generated from X-ray crystal structures in FoXS (Schneidman-
Duhovny et al. 2013; Schneidman-Duhovny, Hammel, and Sali 2010), the unliganded 
PMM1 from Leishmania mexicana (2I54) (Kedzierski et al. 2006) dimer had Rg = 27.2 Å, 
and the “closed” PMM1 conformation bound to Glc-1,6-P2 (2I55) had an Rg = 24.4 Å— 
predicting a ~2.8 Å difference between the “open” and “closed” conformation (Figure 
2.21).  For the wild-type PMM1, PMM2, and the R180T/R183I PMM1 variant, we 
observed smaller radii of gyration when bound to ligands that mimic the transition state 
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complex—ie.VO4 + Glc-1-P and VO4 + Glc-6-P (Figure 2.22c) compared to the 
unliganded enzymes.  These differences are comparable to that calculated for L. mexicana 
PMM1 in the bound and unbound states.  Additionally, the presence of a phosphate mimic 
(VO4
-3) induced cap closure as well.  PMM1 without ligand bound has a Rg of 33.5 (±0.21) 
Å.  Upon addition of saturating ligand concentrations for all combinations that include 
either VO4
-3 or IMP resulted in Rg between 29.3 (± 0.17) and 30.5 (± 0.23) Å, which is 
consistent with the ligand induced change observed in the calculated Rg from L. mexicana 
PMM1 structures.  The Rg for unliganded R180T/R183I PMM1 variant is 31.3 Å and wild-
type unliganded PMM2 is 28.7 Å.  The addition of ligands to the R180T/R183I variant and 
WT PMM2 behaved similarly.  The Rg was reduced in all cases where VO4
-3 is present to 
suggest that VO4
-3 alone is sufficient in inducing a closed conformation.  However, in both 
the PMM1 variant and WT PMM2, the presence of IMP did not induce a significant change 
compared to its respective Rg measured for the absence of IMP.  Notably this indicates that 
IMP binding is sufficient to induce a conformational change in WT PMM1 but appears to 
have minimal effect on the PMM1 variant or WT PMM2.  The presence of IMP resulted 
in a 0.1 Å and 0.6 Å difference in the Rg of PMM1 variant and PMM2, respectively, 
suggesting that IMP either does not bind or binds but does not induce a closed “catalytically 
competent” conformation.  To confirm that the decrease in Rg is a result of proper ligand 
binding, we use glucose alone as a negative control.  Since glucose does not contain a 
phosphate or phosphate analog moiety, we expect that the addition of glucose would 
behave in the same manner as the unliganded protein.  As expected, the Rg remained 
unchanged compared to no ligand added and was comparable to the IMP added in the 
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PMM1 variant and PMM2.  It should be noted that PMM2 and R180T/R183I PMM1 
produced an ideal SAXS scattering curve.  However, WT PMM1 consistently showed a 
subtle amount of aggregation despite all efforts to remove aggregated material (Figure 
2.22a and b).  The level of aggregation and calculated Rg in each experiment is highly 
reproducible which leads us to believe that the changes observed in the Rg with and without 
ligand is a true reflection of ligand-induced conformation change.   
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Figure 2.21  Theoretical SAXS curves of known PMM structures generated using FoXS—
human PMM1 (2FUC), human PMM2 (2AMY), L. Mexicana PMM1 in complex with Glc-
10000
100000
1000000
10000000
100000000
0 0.1 0.2 0.3 0.4 0.5 0.6
I(
q
)
q (1/Å)
2FUC dimer
2AMY dimer
2I55 dimer
2I54 dimer
102 
 
1,6-P2 which forms the cap-core closed conformation (2I55), and L. Mexicana PMM1 
unliganded in the open conformation (2I54). 
  
Figure 2.22  SAXS experiments of wt PMM1, wt PMM2 and R180T/R183I PMM1 
variant.  a. scattering curve along q within range of detector.  b. Guinier plot for the three 
enzymes.  c. Radius of gyration of the three enzymes in presence of different ligands.     
 
a. 
b. 
c. 
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 WT PMM1 R180T/R183I PMM1 PMM2 
no ligand 33.5 ± 0.21 31.3 ± 0.19 28.7 ± 0.18 
VO4, G1P 29.4 ± 0.159 29.3 ± 0.16 27 ± 0.22 
VO4, G6P 29.3 ± 0.17 29.5 ±0.16 27.1 ± 0.22 
VO4, IMP 29.4 ± 0.16 30 ± 0.15 27.3 ± 0.18 
Glucose 33.3 + 0.60 31.4 ± 0.19 28.3 ± 0.19  
IMP 30.5 ± 0.23 31.2 ± 0.22 28.3 ± 0.19 
VO4 30.4 ± 0.44 30.2 ± 0.19 27.2 ± 0.22 
 
Table 2.9 SAXS data corresponding to the bar graph in Figure 2.22c. 
 
2.3.7 STD-NMR confirms IMP binding to PMM1 
 Saturation transfer difference (STD) NMR was used to confirm protein-ligand 
interactions of IMP with wt PMM1 but not with R180T/R183I variant.  We have indirectly 
shown that IMP binding to R180T/R183I is severely impaired via kinetics because these 
mutations abolish the activation of the phosphatase reaction and inhibition of a mutase 
reaction.  Furthermore, we have demonstrated with SAXS experiments that the presence 
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of IMP causes a significant conformational change as observed by the change in Rg of wt 
PMM1 but minimal change in the Rg of the R180T/183I variant.  Here, we use STD-NMR 
to confirm a direct interaction between the protein and ligand.   
 A total of five spectra were collected.  Data were first collected on the ligand 
alone to determine peaks observed from the ligand (Figure 2.23, red arrows).  STD NMR 
spectra were recorded on samples containing IMP and the variants of the PMM proteins.  
The STD NMR spectra are shown in Figure 2.23.  Ligand peaks that are observable in the 
saturation transfer difference spectra signify a saturation transfer from the protein to the 
ligand due to protein-ligand interactions.  Hence, our difference spectra of the IMP and wt 
PMM1 sample demonstrates saturation transfer and binding to PMM1.  However, the 
difference spectrum of IMP with double mutant (R180T/R183I) PMM1 variant exhibited 
undetectable ligand peaks, indicating that there is no significant interaction between IMP 
and the mutated protein. 
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Figure 2.23 STD-NMR spectra.  Top spectrum of IMP alone.  IMP + wtPMM1 and IMP 
+ R180T/R183I PMM1 are the saturation transfer difference spectra in presence of wt 
PMM1 and R180T/R183I variant, respectively.  STD-NMR experiments used 5 μM 
enzyme and 0.5 mM IMP ligand. 
 
2.3.8 T2 relaxation NMR determine IMP binding efficiency in PMM1, PMM2 and 
variants 
 T2 relaxation time measurement of small molecules by NMR is another method 
frequently used for ligand-receptor interaction measurements by exploiting the change in 
relaxation rate of a small molecule when bound to a protein molecule.  The relaxation time 
of the ligand is compared to that of the ligand in presence of a receptor protein.  A total of 
Ligand (IMP) 
IMP + wtPMM1 
IMP +  
R180T/R183I PMM1 
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5 samples were measured, including free IMP ligand and 4 samples of protein-ligand 
mixtures.  Relative signal intensity is plotted as a function of time (s) (Figure 2.24).  At 
0.32 s, the free ligand 1H NMR signals were reduced by 30%, whereas the mixture of IMP 
with wt PMM1 (with an affinity of 2 μM) signals was reduced by 70%.  As we expected, 
the mixture containing IMP and R180T/R183I variant exhibited a nearly identical 
relaxation curve as the free ligand curve, demonstrating little to no ligand interactions with 
this variant.  To our surprise, however, experiments containing IMP with wt PMM2 
resulted in a 40% signal reduction by 0.32 s— a 10% increase in relaxation time. This 
demonstrates that IMP is interacting with PMM2, however, the interaction is much weaker 
than that shown for PMM1.  Furthermore, the T171R/I174R PMM2 variant (which resulted 
in a catalytically dead enzyme), exhibited a faster relaxation rate compared to the free 
ligand.  At 0.32 s, signal was reduced by 43%, which is further exemplified at 0.64 s in 
which the signal was reduced by 70%.  Taken together, the data show that IMP binds most 
efficiently to wt PMM1 and that R180 and R183 are necessary for IMP binding in PMM1.  
Mutations engineered into PMM2 to introduce the two conserved arginines significantly 
increased the rate of relaxation of IMP, further supporting the importance of the two side 
chains in IMP binding.  Additionally, wt PMM2 exhibited some degree of IMP binding.  
These results lead to our hypothesis that in the case of wt PMM2 and mutant PMM2, IMP 
does bind to the protein but does not induce a conformational change resulting in a 
catalytically competent conformer.  
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Figure 2.24  T2 relaxation curves for IMP alone and in presence of PMM variants. The 
different relaxation behavior of IMP can be used to investigate interaction with receptor 
proteins present in the solution.  Curves were fitted using a one phase exponential decay 
equation, Y = (Y0 – NS)*exp(-K*X) + NS, where Y0 is the binding at time zero, NS is 
binding at infinite times, and K is the rate constants in inverse units of the Y axis.  Curves 
were generated using GraphPad Prism.  T2 relaxation experiments used 50 μM enzyme 
and 0.9 mM IMP ligand.  
 
2.4  Conclusions 
IMP binds PMM1 with high affinity and converts the enzyme activity from that of 
a mutase to a phosphatase, while PMM2 activity is unaffected by IMP.  The structure of 
PMM1 in complex with IMP was solved to 1.92 Å resolution showing IMP binding at the 
distal phosphate binding site, making hydrogen bond interactions with residues Arg143, 
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Arg150, Ser188, and Met186 (Figure 2.14) which are all involved in substrate binding and 
are also conserved residues in PMM2.  Taken together, kinetics experiments and other 
biophysical tools used to studying IMP binding gave insight to the mechanism of IMP 
dependent phosphatase activity and the specific structural features that allow high affinity 
IMP binding.  In our model of IMP induced phosphatase activity, IMP binding to the cap 
domain induces a conformational change in which the cap domain closes upon the active 
site of the core domain, similar to the change observed upon substrate binding.  However, 
when substrate is brought in close proximity to the active site, the C6 hydroxyl group of 
the hexose phosphate, Glc-1-P or Man-1-P, is in perfect alignment to the phosphoaspartate 
group for phosphoryl transfer from the enzyme to substrate.  IMP lacks a hydroxyl group 
to perform nucleophilic attack at the phosphate phosphorus during catalysis but the closing 
of the enzyme prepares the active site for phosphoryl transfer (Figure 2.25).  Hence, we 
propose that a water molecule, instead of a substrate, is activated to hydrolyze the 
phosphoaspartate in the presence of IMP (Figure 2.25b).  Subsequently, Glc-1,6-P2 
binding affords the phosphorylation of the nucleophile allowing PMM1 to effectively act 
as a Glc-1,6-P2 phosphatase.   
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Figure 2.25  Schematic of substrate bound vs. IMP bound PMM1.  Both (a) substrate and 
(b) IMP binds to the distal phosphate binding site of the cap domain in the same way and 
induces a conformational change.  When a substrate is bound (a), a hydroxyl group aligns 
to the phospho-asp for phosphoryl transfer, but IMP (b) cannot receive the hydroxyl group 
so it is transferred onto a water molecule. (c)  Complete model of how PMM1 switches 
between mutase and phosphatase activity.  In the absence of IMP, PMM1 stays in an 
activated, phospho-asp, state to accept monophosphorylated sugar substrates.  However, in 
the presence of IMP, the phosphoasp is continuously hydrolyzed by water so the enzyme 
is trapped in the “activating” step, resulting in phosphatase activity.  
 
The presence of IMP activates a phosphatase activity which hydrolyzes Glc-1,6-P2 
to Glc-6-P.  Thus the phosphate donor (or coactivator) Glc-1,6-P2 in the mutase reaction 
becomes the substrate in the phosphatase reaction.  Alternatively, we can consider the 
coordinated water molecule that participates in phosphate hydrolysis to be a secondary 
substrate in the phosphatase reaction.  In this model, the Glc-1,6-P2 is the phosphpryl donor 
and both the mutase and phosphatase reactions begin with the phosphoenzyme.  The kinetic 
mechanism of PMM1 is described in Figure 2.26.  In this scheme, IMP can be bound to 
two forms of PMM1—the unphosphorylated and phosphorylated state of the protein, EA 
and EpA, respectively.  In the EA bound state, where E is the unphosphorylated PMM1 and 
A is IMP, IMP behaves as a non-competitive inhibitor of the mutase activity by preventing 
activation of the enzyme but does not affect the mutase activity as the enzyme is not primed 
to perform mutase activity.  IMP can also bind the phosphorylated state of the enzyme, Ep, 
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in which it behaves as a competitive inhibitor of the mutase activity by directly inhibiting 
the site of substrate (either G6P or G1P, S1) binding.  Simultaneously, as mutase activity 
was inhibited, activation of phosphatase activity was observed where the activation 
constant of Glc-1,6-P2 hydrolysis, Kact, is comparable to the inhibition constant of mutase 
activity, Ki.  This suggests there is one binding site on PMM1 which affects both the mutase 
and phosphatase reactions.  In the EpA form, the enzyme competitively inhibits mono-
phosphorylated sugar substrate (S1) binding, and instead allows a water molecule to bind 
at the active site to serve as a substrate for phosphoryl transfer. 
 
Figure 2.26 Kinetic scheme of PMM1 mutase and phosphatase reaction.  Enzyme 
activation is achieved by forming the active PMM1 state in which a bisphosphorylated 
sugar, Glc-1,6-P2 (B), donates a phosphate to the catalytic Asp nucleophile to form the 
phosphoenzyme (Ep).  The mutase activity (top) results from the formation of the Michaelis 
complex between phosphoenzyme (Ep) and substrate, Glc-1-P or Glc-6-P (S1), and a 2-step 
catalytic reaction results in the Ep form of the enzyme and product, Glc-6-P or Glc-1-P 
(P1).  The effector, IMP (A), can bind both the E and Ep state.  However, when the EpA 
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state is achieved, a water molecule can act as a substrate to hydrolyze Ep forming the EAP2 
complex where P2 is PO4
-3.  Subsequently, dissociation produces the unphosphorylated 
enzyme (E), IMP (A), and the product, PO4
-3 (P2).  The order of dissociate, however, is 
unclear, as represented by the dotted lines. 
 
If we consider only the IMP-dependent phosphatase reaction described in scheme 
(Figure 2.27)  where Glc-1,6-P2 (B)  is the substrate to produce Glc-6-P (Q) and Pi (P) in 
the reaction B  Q + P, and the effector IMP is A, the following steady-state rate equation 
was derived (Equation 2.6) using the King-Altman method from BioKin Ltd 
(www.biokin.com/long-altman/) (King, E.L. and Altman, 1956), 
 
Figure 2.27  Schematic of IMP-dependent PMM1 phosphatase activity modified from 
Figure 2.26 to isolate only the phosphatase activity.  
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v = N/D = d[P]/dt = + k+4 [EPA]'  Equation 2.6 
 
where d[P] = (k+1k+2k+3k+4k+5)[S][A] 
and dt = (k-1 k+3 k+4 k-5 + k+2 k+3 k+4 k-5)[A]
2 + (k+1 k+3 k+4 k+5 + k+1 k+2 k+3 k+5 + 
k+1 k+2 k+3 k+4)[S][A] + (k-1 k+3 k+4 k+5 + k+2 k+3 k+4 k+5) [A] + (k+1 k+2 k-3 k+5 + k+1 
k+2 k+4 k+5) [S] 
From this rate equation, an equation to describe the PMM1 phosphatase reaction in terms 
of kcat, Km, and Vmax can be derived to understand the theoretical behavior of PMM1 
mutase/phosphatase activity in infinite concentration of IMP.   
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Chapter 3: 
Structural analysis of Hotdog Fold thioesterases: generating a Michaelis complex 
mimic 
 
3.1 Introduction    
3.1.1 Mechanisms of hotdog fold catalysis 
Thioesters are required for a wide range of essential cellular processes including 
energy production, signal transduction, membrane biogenesis and gene regulation (Hunt 
and Alexson 2002; Resh 1996; Hertz et al. 1998). Thioesters are derived from, and function 
as activated forms of organic acids. In metabolism they serve as acyl donors as well as 
substrates in Michael addition, Claisen condensation, and β-elimination reactions (Ordine 
et al. 1994; Heath and Rock 2002; Amyes and Richard 1992).  The formation of thioesters 
from coenzyme A (CoA) or pantetheine-charged acyl carrier protein (holoACPs) and 
organic acids is catalyzed by ATP-dependent ligases or synthetases (Schmelz and Naismith 
2009).  A detailed discussion of hotdog thioesterase functions can be found in Chapter one 
section 1.3. 
              Hotdog-fold thioesterases are known to utilize an active site carboxylate residue 
(Glu or Asp) in catalysis. Mechanistic studies directed at the hotdog-fold thioesterases from 
evolutionary distant organisms (Zhuang et al. 2012; Song et al. 2012; Cao et al. 2009; Song 
et al. 2006) have revealed that the catalytic carboxylate functions as a nucleophile in a two-
step pathway involving the intermediacy of a mixed anhydride intermediate (Figure 3.1a) 
or alternatively in single-step process, as a general base, responsible for the activation of 
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the water nucleophile (Figure 3.1b). However, for any given thioesterase, the task of 
distinguishing between these two pathways can be quite difficult owing to the limitations 
of the mechanistic probes currently available. Traditionally, these mechanisms have been 
determined by a combination of kinetic and structural analyses (Cao et al. 2009; Song et 
al. 2006; Kotaka et al. 2009; Song et al. 2012). 
 
     
Figure 3.1 Hotdog fold thioesterases can catalyze the hydrolysis of thioesters a. by base 
catalysis where the water oxygen (red) is transferred to the organic acid, or by b. 
nucleophilic catalysis where the carboxylate side-chain oxygen (blue) or water (red) is 
transferred to the organic acid (the complete transfer of the carboxylate oxygen is shown).   
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3.1.2 Experimental Methods and Pitfalls of Mechanistic Determination 
Efforts to distinguish between the mechanisms with kinetic analysis alone can lead 
to ambiguous results.  An example of such ambiguity can be found in an experiment that 
utilizes 18O incorporation to decipher base or nucleophilic hydrolysis, an experiment that 
has been commonly used on thioesterases (Song et al. 2012; Zhuang et al. 2012).  In the 
experiment, 18O labeled water is used to label the acid product formed from hydrolysis.  If 
the reaction mechanism proceeds through the base model as outlined in Figure 3.1a then 
complete 18O incorporation would occur.  However, if the reaction mechanism proceeds 
through the nucleophilic model as outlined in Figure 3.1b, a potential mixture of 16O and 
18O would result, although complete 18O incorporation may still occur if the hydrolysis of 
the acyl carbonyl is preferred.  Therefore, if complete incorporation of 18O is observed then 
the results cannot suggest one mechanism over the other.  Likewise, using mutagenesis to 
inactivate the general acid/base residue may result in decreased activity rather than no 
activity because water molecules may still be present and weakly activated by surrounding 
charged residues.  Structural information can help resolve the ambiguity by determining 
the proximity and position of putative enzyme nucleophiles versus ordered water molecules 
relative to the substrate carbonyl. Therefore, structural information paired with kinetics can 
give us a clearer and absolute understanding of the mechanism.   
In order to obtain a snapshot of the active site conformation of the enzyme, two 
approaches can be taken—the enzyme can be inactivated by mutating the active-site 
residues and crystallizing with substrate (Dias et al. 2010; Thoden et al. 2002), or the wild-
type enzyme can be crystallized with a substrate analog that serves as an inhibitor and 
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prevents chemistry (Cao et al. 2009; Wu et al. 2014; Thoden et al. 2003; Kotaka et al. 2009; 
Dias et al. 2010). However, each approach has drawbacks.  For example, a mutation in the 
active site can affect binding of important solvent molecules leading to uncertainty in 
assignment of an acid-base mechanism.  Alternatively, to the extent that a substrate analog 
is not isosteric and isoelectronic with the substrate, binding to the enzyme will result in a 
different ligand-binding conformation and active-site environment, including both enzyme 
residues and ordered solvent.  One acyl-CoA substrate analog which has proven useful in 
the past utilizes the incorporation of a thioether moiety with a methylene between the 
carbonyl and sulfur atom (Figure 3.2).  Although insusceptible to hydrolysis, the 
methylene incorporates additional atoms and changes the electrostatic properties of the 
analogs compared to the original substrate.  Other inhibitors such as fluoroacetyl 
carba(dethia)-pantetheine (FacCPan) and fluoroacetyl oxa(dethia)-pantetheine (FacOPan) 
have been used in co-crystallization studies of the hotdog fold thioesterase Flk (Dias et al. 
2010).  FacCPan replaces the sulfur atom with a carbon forming a flouracetone moiety and 
FacOPan replaces the sulfur atom with oxygen forming an ester.  Both compounds are 
insusceptible to hydrolysis but neither FacCPan nor FacOPan possess the diphospho-
nucleotide, which arguably, could alter the binding properties.  Other acyl-CoA analogs, 
for example octyl-CoA, have been synthesized for the study of redox reaction in acyl-CoA 
dehydrogenase (Rudik and Thorpe 2001).  However, the missing carbonyl of the thioether, 
as compared to the thioester, may result in an altered binding of the substrate in 
thioesterases. The most promising thioesterase inhibitor is a single-atom replacement that 
substitutes the sulfur atom with oxygen while keeping the remaining molecule intact.  
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Synthesis of crotonyl-oxyCoA has been reported (Dai, Feng, and Tonge 2001) and used to 
kinetically characterize the enzyme enoyl-CoA hydratase (Feng et al. 2002) however, its 
use in crystallography has not yet become commonplace. 
 
 
 
Figure 3.2 Structural representation of benzoyl-CoA (top), benzoyl-OdCoA (middle) and 
phenacyl-CoA (bottom). 
 
3.1.3 YdiI and YbdB (EntH) of E. coli 
The E. coli genome encodes for nine hotdog-fold thioesterases—YciA, YbgC, 
YbaW, PaaI, YbdB, YigI, YiiD and TEII, most of which have been, to some extent, 
biochemically characterized.  Two of these genes, YdiI and YbdB, are close paralogs, 
having 60% sequence identity.  Both enzymes have recently been functionally and 
structurally characterized.  Despite the similarity in sequence and structure, the enzymes 
participate in different cellular functions and do not appear to have overlapping substrate 
preferences (Latham et al. 2014).  The YbdB thioesterase serves a proofreading role in the 
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biosynthesis of enterobactins and YdiI hydrolyzes the 1,4-dihydroxynapthioyl-CoA 
intermediate of the menaquinone biosynthetic pathway(Latham et al. 2014; Widhalm et al. 
2009; M. Chen et al. 2013a). 
The hotdog-fold thioesterase YbdB (also known as EntH) is part of the enterobactin 
synthesis pathway.  Enterobactin is a siderophore (an iron-chelating molecule) synthesized 
by E.coli that is under the control of the ferric uptake regulator (Fur).  Enterobactin is 
synthesized and released by E. coli during iron-depleted conditions to scavenge for 
exogenous iron (Barry SM 2009).  The gene cluster that encodes for the enzymes involved 
in enterobactin synthesis is the entCEBAH cluster.  The pathway for enterobactin synthesis 
is depicted in Figure 3.3a, starting with chorismate to form 2,3-dihydroxybenzoate (2,3-
DHB) catalyzed by the enzymes EntC, EntB and EntA, which then forms an amide linkage 
with L-serine (2,3-DHB-Ser) catalyzed by EntD, EntE, EntF and EntB.  Three molecules 
of 2,3-DHB-Ser undergo intermolecular cyclization to produce one molecule of 
enterobactin (Gehring, Mori, and Walsh 1998).  While YbdB is not an essential step within 
the biosynthesis pathway, it plays an important proofreading or rescue role.  The 
physiological substrate of YbdB is mischarged holoEntB (Guo et al. 2009; Leduc, Battesti, 
and Bouveret 2007; D. Chen et al. 2009), which is formed by the EntD catalyzed reaction 
of an acyl-CoA or aroyl-CoA with EntB instead of CoA, or by the ATP-dependent 
holoEntE catalyzed aroylation with a (hydroxyl)benzoate instead of the native substrate 
2,3-DHB (Figure 3.3b).  However, from in vitro substrate activity screening, YbdB 
appears to be a promiscuous enzyme with some activity for acyl-CoA thioesters and high 
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activity for benzoyl-holoEntB and benzoyl-CoA substrates (Wu et al. 2014; Latham et al. 
2014).  
 
 
Figure 3.3 Biosynthetic pathway of enterobactin in E. coli.  (a)  Pathway of 2,3-DHB 
synthesis from EntC, EntB and EntA (top), charging of EntB and EntF with CoA to form 
EntB(F)-phosphopantetheine (holoEntB(F)) via EntD (middle), and synthesis of the final 
enterobactin product from ligation of three molecules of 2,3,-DHB-Ser (bottom). (b)  
a.  
b.  
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Proofreading mechanism cataylized by YbdB when EntB is mischarged with an acyl/aroyl-
CoA or (hydroxyl)benzoate.  Figure taken from Latham, J.A. et al. (Latham et al. 2014). 
 
E. coli YdiI was recently reported to be the missing thioesterase in the menaquinone 
biosynthesis pathway, though the ydiI gene encoding the thioesterase is not colocalized 
with the menaquinone gene cluster in the E. coli genome.  However, previous knockout 
experiments confirmed the involvement of YdiI in the production of napthoquinone, a 
precursor of menaquinone (M. Chen et al. 2013b).  The pathway for menaquinone (Figure 
3.4) converts chorismate to 2-succinyl-5-enolpyruvyl-6-hydroxyl-3-cyclohexene-1-
carboxylate via MenF and MenD.  Subsequent steps catalyzed by MenH, MenC, and the 
ATP-dependent ligase MenE, produce o-succinylbenzoyl-CoA.  A cyclization step occurs 
via MenB to produce 1,4-dihydroxy-2-naphthoyl-CoA, followed by a hydrolysis step by 
the hotdog thioesterase YdiI to release one unit of CoA and 1,4-dihydroxyl-2-naphtholic 
acid.  Lastly, MenA and MenG transferases catalyze the final steps of menaquinone 
production. 
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Figure 3.4 Menaquinone biosynthetic pathway.  Reaction steps catalyzed by enzymes 
encoded by the men gene cluster (in blue) and YdiI hotdog thioesterase is the 7th step in the 
pathway catalyzing the hydrolysis of 1,4-dihydroxy-2-naphthoyl-CoA to 1,4-dihydroxyl-
2-naphtholic acid an CoA. Figure taken from Latham, J. et al. (Latham et al. 2014). 
 
3.1.4 PA hotdog-fold thioesterase (PA1618) 
The thioesterase PA1618 from Pseudomonas aeruginosa is an apparent ortholog of 
the Escherichia coli K-12 thioesterase YdiI and E. coli YbdB with moderate sequence 
identity of 52% and 45%, respectively (Figure 3.5).  Based on sequence alignments and a 
BLAST search of YdiI and YbdB homologs, PA1618 appears to be more closely related to 
YdiI.  PA1618 contains the ten conserved amino-acid markers that distinguish YdiI from 
YbdB.  These markers include Gln48, His54, Glu63, and Ser/Thr64 among the active site 
residues, and Met40, Val41, Pro49, Phe/Tyr50, Ser/Thr67 and His89 as other conserved 
residues in YdiI homologs.  In most, but not in all cases, species that contain the gene 
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homologous to ydiI also encode genes for the menaquinone pathway, suggesting that YdiI 
is specific for the role of menaquinone biosynthesis (Latham 2012).  However, a YdiI 
homolog, PA1618, was identified in a BLAST search from Pseudomonas aeruginosa in 
which the menaquinone pathway is absent.  PA1618 is thus a homolog of YdiI with no 
known in vivo function.  This project sprung from an interest in understanding the role of 
a YdiI homolog in an organism that does not possess the menaquinone pathway. 
 
The goal of this study was to uncover the possible in vivo function utilizing in vitro 
substrate screening and kinetics, supported in part by identifying specificity determinants 
and mechanism via substrate complexes.  To enable the latter, a new, more isosteric and 
isoelectronic inhibitor was designed for thioesterases, oxydephosphocoenzyme A 
(benzoyl-OdCoA). In this Chapter, we report five structures of the P. aeruginosa hotdog 
fold thioesterase PA1618, two of which are in complex with the substrate analog phenacyl-
coenzyme A (phenacyl-CoA) and benzoyl-OdCoA.   
124 
 
 
Figure 3.5 EsPript 3.0 generated image of the sequence alignment between PA1618, E. 
coli YdiI and E. coli YbdB showing the secondary structure (generated from PDB ID: 
4KUQ), conserved residues (white font) and similar residues (red font).  The catalytically 
active resides Glu64 and Gln49 are conserved. 
 
3.2 Materials and Methods 
3.2.1 Materials 
High-throughput sparse factorial crystallization screens used to identify initial hits 
were purchased through Hampton Research including the PEGRx screen, PEG/Ion screen, 
Index screen, and SaltRx screen.  Reagents for crystallization were purchased through 
Hampton Research.  Benzoyl-CoA was purchased through Sigma Aldrich.  Other ligands 
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(4-hydroxybenzoyl-CoA, phenacyl-CoA, 4-hydroxyphenacyl-CoA, undecanone-CoA, 
benzoyl-Od-CoA and acetyl-Od-CoA) were synthesized by John Latham, a graduate 
student in the Dunaway-Mariano Lab (University of New Mexico).  Initial diffraction 
screening was carried out on our home source X-ray source (Bruker AXS), and data 
collection was carried out at Stanford Synchrotron Radiation Light Source (SSRL) and 
National Synchrotron Light Source (NSLS).  The DNA constructs containing wild-type 
PA1618 (UniProt # Q9I3A4) and site-directed variants were designed by John Latham and 
the E49A variant protein was prepared by John Latham. 
 
3.2.2 Preparation of PA1618 expression and purification 
The PA1618/ pET23a-transformed E. coli BL21(DE3) cells were grown 
aerobically at 37 oC in LB media containing 50 µg/ml ampicillin.  Production of C-terminal 
His6-tagged PA1618 was induced with 0.4 mM isopropyl-β-D-galactopyranoside (IPTG) 
once the cell density had reached A600 ~0.6.  Following a 12 h induction period at 19 
oC, 
the cells were harvested by centrifugation at 6,500 rpm for 10 min and then suspended in 
100 mL of 50 mM Tris buffer (pH 8.4), 50 mM imidazole, and 500 mM NaCl (Lysis 
Buffer).  The cells were lysed using a high-pressure mircrofluidizer at 1,800 psi and the 
lysate was centrifuged at 38,000 rpm for 45 min.  The supernatant was loaded onto a 5 mL 
HisTrap FF column (GE Life Sciences) and the column was washed at 4 oC with Lysis 
Buffer to remove non-tagged protein and then with 50 mM Tris (pH 8.4), 500 mM 
imidazole, and 500 mM NaCl (Elution Buffer) to elute the tagged protein.  Column 
fractions were monitored by measuring solution absorbance at 280 nm and by carrying out 
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SDS-PAGE analysis.  The desired fractions were combined and dialyzed at 4 oC against 
three changes of 1 L of 50 mM Tris (pH 8.4)/50 mM NaCl.  The homogeneity was 
confirmed by SDS-PAGE analysis. Each protein preparation yields ~25 mg protein/g of 
wet cells. 
 
3.2.3 Preparation of selenomethionine-substituted PA1618.  
PA1618 containing plasmid was transformed and expressed in methionine 
auxotroph B834(DE3) E. coli cells.  The cells were grown in 1 L PASM-5052 media 
containing 20X NPS (66g (NH4)2SO4, 136 g KH2PO4, 142 g Na2HPO4, 1 L of H2O), 50X 
5052 (250 g glycerol, 25 g glucose, 100 g lactose, 1 L of H2O), 20 mL of amino acids mix 
at 10 mg/mL (all 20 standard amino acids except Cys, Try, Met), metals (2 mM CaCl2, 5 
mM FeCl3, 1mM MnCl2, 1 mM ZnSO4, 0.2 mM CoCl2, 0.2 mM CuCl2, 0.2 mM NiCl2, 0.2 
mM Na2MoO4, 0.2 mM Na2SeO3, 0.2 mM H3Bo4), vitamins (0.02 mM of nicotinic acid, 
pyroxidine, thiamine, p-aminobenzoic acid, pantothenate; 0.5 uM of folic acid, and 
riboflavin), 1 mM MgSO4, 0.4 mL of L-methionine solution (1 g/40 mL H2O) and 5.0 mL 
of L-SeMet solution (1 g/40 mL H2O).  Cell growth and protein preparation followed the 
same protocol as above.  Purified protein was dialyzed in 50 mM sodium citrate buffer pH 
5.5 for crystallization, a buffer condition identified to have the greatest thermal stability 
based on a high-throughput fluorescence thermal shift assay (below). 
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3.2.4 Site Directed Mutagenesis.   
Mutant constructs E64A and Q49A were made and the mutant proteins were 
purified to >90% homogeneity (as determined by SDS-PAGE analysis) as described above 
in a yield of 25 mg protein/g wet cell paste.  This work was done by John Latham. 
 
3.2.5 Thermofluor assay for determination of optimal buffer 
Purified proteins were subjected to a protein solubility screen via a thermofluor 
assay in order to determine a more protein stabilizing buffer solution.  A description of the 
assay can be found in Chapter 2, section 2.2.6.  Wild-type PA1618 is a relatively stable 
protein with an average Tm of ~62 ˚C for buffer conditions in the screening assay (Figure 
3.6a).  The PA1618 variant containing Q49A shifted the average Tm to ~70 ˚C, creating an 
even more stable protein.  The buffer condition that resulted in the highest Tm is 50 mM 
sodium phosphate pH 7.0 (Tm = 70.0 ˚C) followed by 50 mM sodium citrate pH 5.5 (Tm = 
69.4 ˚C).  Due to the increased likelihood of obtaining salt crystal formation from sodium 
phosphate, we decided to use the latter buffer condition for crystallization experiments. 
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Figure 3.6  Thermofluor assay results for a. wild-type PA1618 and b. mutant Q49A.  Each 
peak represents the Tm of a different buffer condition.  (Details of the assay can be found 
in Chapter 2, section 2.2.6.) 
 
 
 
 
a
. 
b
. 
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3.2.6 Crystallization of PA1618 and variants  
A total of 5 structures are reported here—wild-type PA1618 unliganded structure, 
liganded structures complexed with phenacyl-CoA and benzoyl-OdCoA and unliganded 
structures containing the single site mutations Q49A and E64A.  In all cases, purified 
proteins were concentrated to 15 mg/mL in 50 mM sodium citrate buffer pH 5.5 before 
use. Initial crystallization conditions were identified using the Index Screen (Hampton 
Research). Crystals of the complex of PA1618 with phenacyl-CoA were obtained via co-
crystallization with 1 mM compound (Figure 3.7c) and crystals with benzoyl-Od-CoA 
(dephospho-3’ ribose) were obtained via soaking.  Previous datasets of PA1618 with 
benzoyl-OdCoA that were either co-crystallized or soaked for up to 2 days showed ligand 
binding of the pantetheine group but no density was present for the benzoyl moiety 
suggesting that the compound is not stable in the crystallization solution.  It should be 
noted, however, that the stability and reactivity of benzoyl-OdCoA with PA1618 was tested 
showing that the ligand was stable and inert for up to 48 hrs in 50 mM Hepes solution at 
25˚C (experiment performed by John Latham).  Thus, the benzoyl-Od-CoA bound structure 
was obtained by soaking with compound diluted in mother liquor to a final concentration 
of 2 mM for 3 hours prior to cryo-cooling.  All crystals were obtained using the hanging-
drop vapor diffusion method with 1.0 μl protein at 10-15 mg/ml and equal volume of well 
solution (plus 2 mM substrate analogue when included). Crystals of all proteins except the 
E64A variant were grown in 40% polyethylene glycol 400 (PEG400) and 0.1 M Bis-Tris 
pH 6.5.  Crystals of the E64A variant were grown in 40% PEG200, 0.1 M sodium acetate 
and 8 mM β-mercaptoethanol. Crystals of liganded and unliganded PA1618 grew as thin 
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sheets to dimensions of 0.7 x 0.4 x 0.02 mm in 1-2 days at 17 ˚C (Figure 3.7).  PA1618 
crystals were cooled in liquid nitrogen directly without additional cryoprotection.   
 
Wt PA1618 
(~0.4 x 0.1 x 0.02 mm) 
40% PEG400 
0.1M BisTris pH6.5 
Mutant PA1618 (Q49A) 
(~0.2 x 0.02 x 0.1 mm) 
40% PEG400 
0.1 M BisTris pH6.5 
Mutant PA1618 (E64A) 
(~0.2 x 0.02 x 0.1 mm) 
40% PEG200 
0.1 M sodium acetate 
8 mM β-mercaptoethanol 
Wt PA1618 
(~0.4 x 0.02 x 0.1 mm) 
1mM inhibitor 
 
40% PEG400 
0.1M BisTris pH6.5 
a. b. 
c. d. 
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Figure 3.7 Images of PA1618 crystals using 15mg/mL protein and condition labeled below 
each image. a. wild-type native PA1618 crystals.  SeMet replaced proteins yielded crystals 
of similar dimension.  Ligand soaking experiments used crystals of these dimensions for 
soaking of substrate analogs into wt protein crystals.  b. crystals of PA1618 variant Q49A, 
c. crystals of PA1618 variant E64A, and d. crystals of wt PA1618 co-crystallized with 
phenacyl-CoA inhibitor.  Approximate crystal dimensions are described in the figure. 
 
Crystal structures of PA1618 in complex with 4-hydroxyphenacyl-CoA and 
PA1618 variants (E64A and Q49A) in complex with benzoyl-CoA, 4-hydroxybenzoyl-
CoA and undecanone-CoA were attempted but were unsuccessful.  Efforts toward 
obtaining these complexes used both co-crystallization and soaking techniques with 1-2 
mM ligand.  Although crystals formed, either the addition of ligand severely decreased the 
quality of the crystal (Figure 3.8a and b) or the electron-density maps did not contain 
positive density for the entire ligand (Figure 3.8a and c, Figure 3.9a and b).   
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Figure 3.8 Images of crystals formed by co-crystallization with their respective ligands. a. 
Crystals formed from co-crystallization of wt PA1618 with 4-hydroyphenacyl-CoA were 
small compared to unliganded cyrstals.  b. Crystals of Q49A variant co-crystallized with 
benzoyl-CoA resulted in microcrystals and increased precipitation in the drops.  Crystals 
were too small to be picked up with a loop to test diffraction.  c. Crystals of Q49A variant 
co-crystallized with undecanon-CoA.  The crystals resulted in good diffraction, however, 
clear density corresponding to ligand was not observed. 
Q49A PA1618 
210uM protein 
1mM benzoyl-CoA 
50% PEG400 
0.1M BisTris pH6.5 
Wt PA1618 
210uM protein 
1mM 4-hydroxyphenacyl-CoA 
45% PEG400 
0.1M BisTris pH6.5 
Q49A PA1618 
210uM protein 
1mM undecanon-CoA 
50% PEG400 
0.1M BisTris pH6.5 
a
. 
b
. 
c. 
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Figure 3.9 Refined data from Q49A structures containing a. undecanone-CoA and b. 4-
hydroxyphenacyl-CoA.  Molecular representation is shown in lines and colored by peptide 
chains.  The electron density map (2FoFc in blue mesh, positive density in green and 
negative density in red) centers in the active site showing possible density for ligand.  Both 
Fo-Fc maps show partial density at the site of ligand binding however discontinuous 
density is not sufficient for modeling of ligands. 
 
3.2.7 X-ray data (Collection, Integration, Scaling) and phasing 
 PA1618 diffraction data was collected through remote access to SSRL beamline 
12-2 and processed using autoXDS (Gonzalez, A and Tsai 2010).  Data collection and 
Q49A with 4-hydroxyphenacyl-
CoA 
a. b. 
Q49A with undecanone-
CoA 
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processing statistics are provided in Table 3.1.  Phase information for PA1618 structure 
was determined using single wavelength anomalous diffraction (SAD) from Se, with 
anomalous signal to 2.0 Å.  Data was processed using autoXDS (Gonzalez, A and Tsai 
2010).  Thirty-one heavy atom selenium sites were found using PHENIX AutoSol (Adams 
et al. 2010), with a figure of merit of 0.44.  An initial model was built using PHENIX 
AutoBuild (Adams et al. 2010) in which 813/912 amino acids and 579 water molecules 
were built, with an initial R-work and R-free of 0.22 and 0.23, respectively.  Liganded and 
mutant structures of PA1618 were determined by molecular replacement with unligand 
SeMet PA1618.   
 
3.2.8 Model Building and Structure Refinement PA1618 complex structure 
refinement.   
The models were refined in PHENIX (Adams et al. 2010) with the maximum-
likelihood target and individual B-factor refinement. Ordered solvent molecules were 
added automatically in PHENIX and culled manually in the graphics program COOT (P. 
Emsley, B. Lohkamp, and Cowtan 2010). The final models were validated using the RCSB 
Validation Server. The dihedral angles of all residues are within the allowed region of the 
Ramachandran plot. Refinement statistics and model geometry for all five structures are 
listed in Table 3.1.  The final model of all PA1618 structures contains 6 subunits in the 
assymetic unit to form 2 “back-to-back” dimers and two flanking subunits (Figure 3.10).  
There are 2 active sites that lie at the opposing ends of the dimer interface, thus the 
assymetric unit contains 4 “complete” active sites within the “back-to-back” dimers.  
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Ligand was not modeled into the flanking monomers because the active sites are at a point 
of crystallographic symmetry, interfering with interpretation of the density.  PA1618 in 
complex with phenacyl-CoA contain 4 ligands-two bound at each dimer interface. The 
model of PA1618 in complex with benzoyl-Od-CoA contains 2 ligands- one bound at each 
dimer interface.   PA1618 mutants, E64A and Q49A, were co-crystallized with benzoyl-
CoA and undecanone-CoA, respectively.  However, ligands were excluded from the 
models due to the lack of continuous density for ligand at the active sites. 
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 PA1618 
(SeMet) 
PA1618+PA-
CoA 
 
PA1618+Ben
zoyl-O-CoA 
 
Q49A mutant 
 
E64A mutant 
 
PDB code 4KUQ 4KUR 4KUS 4KUU 4KUT 
wavelength 0.979 1.03 0.980 1.03 0.980 
resolution (Å) a 37.61  - 1.72 
 (1.81  - 1.72) 
47.79  - 1.62  
(1.7  - 1.62) 
37.53  - 1.72  
(1.82  - 1.72) 
47.64  - 2.02  
(2.10  - 2.02) 
67.93  - 2.30  
(2.38  - 2.30) 
space group C2221 C2221 C2221 C2221 C2221 
unit cell a, b, c 
(Å) 
101.65 
202.51  
90.99 
101.69  
202.01  
91.08 
103.03  
201.49  
91.74 
100.96  
201.56  
90.92 
99.72  
202.61  
91.57 
Rmerge ab (%) 0.069 (0.76) 0.047 (0.82) 0.078 (0.72) 0.091 (0.94) 0.07 (0.55) 
completenessa 97.94 (82.18) 99.18 (99.70) 97.85 (82.67) 98.99 (99.62) 97.57 (99.37) 
I/I(σ)a 35.97 
(15.21) 
12.28 
(1.54) 
18.23(2.65) 8.12 (1.58) 21.77 
(5.28) 
redundancya 6.5 (5.5) 4.4 (4.3) 12.6(10.7) 4.4 (4.4) 14.4 (14.1) 
total/unique 
reflections 
626184 / 
97075 
519112 / 
118644 
1238418 / 
98312 
60156 / 
5992 
598702 / 
4073 
Rcryst / Rfree c(%) 19.73/20.94 20.51/23.8
2 
18.87/22.37 20.32/23.27 22.12/27.6
7 
RMSD (bond 
length (Å) 
0.008 0.007 0.007 0.007 0.008 
RMSD (bond 
angles (º) 
1.17 1.32 1.19 1.09 1.08 
average B-
factors (Å2) 
28.00 26.10 23.7 34.00 43.50 
macromolecule  27.40 25.10 22.5 33.90 43.60 
         
inhibitor  
--- 37.30 40.86 --- --- 
         waters 35.20 33.10 32.5 36.20 40.30 
aValues for the highest resolution shell are given in parentheses. 
b Rmerge = ∑|Ii - Im|/∑Ii, where Ii is the intensity of the measured reflection and Im is the mean intensity 
of all symmetry-related reflections. 
c Rcryst = ∑Fobs| - |Fcalc/∑|Fobs|, where Fobs and Fcalc are observed and calculated structure factors. Rfree 
= ∑TFobs| - |Fcalc/∑T|Fobs|, where T is a test data set of 5% of the total reflections randomly chosen and 
set aside prior to refinement. 
d Ligands bound to the active site e ligands bound on the protein surface 
 
Table 3.1 Crystallographic data collection and refinement statistics for PA1618 X-ray 
structures. 
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Figure 3.10 The asymmetric unit cell comprises 6 monomeric units.  The four monomeric 
units (shown in magenta, yellow, cyan and pink) form the biological assembly and two 
flanking subunits in gray. 
 
3.2.9 Steady-State Kinetics 
Thioesterase activity was measured using the 5,5’-dithio-bis-(2-nitrobenzoic acid) 
(DTNB) coupled assay.  Reactions were carried out at 25 oC with solutions containing 50 
mM K+HEPES (pH 7.5) and 1 mM DNTB. The kinetic parameters kcat, Km, and Ki were 
measured and determined by John Latham.  
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3.3 Results and Discussion 
3.3.1 Biochemical Characterization of the Target Thioesterase PA1618 
PA1618 of P. aeruginosa is a hotdog-fold thioesterase which shares 52% sequence 
identity with the E. coli YdiI. In earlier work, we and others defined the biological function 
of YdiI as the 1,4-dihydroxynapthoyl-CoA thioesterase of the menaquinone biosynthetic 
pathway. Bioinformatic analysis (see below) was carried out to discover that the P. 
aeruginosa genome does not encode the enzymes of the menaquinone pathway and 
therefore that PA1618 must perform a different biological function than its E. coli 
counterpart YdiI. On the other hand, a side-by-side comparison of the in vitro substrate 
specificity profile measured for PA1618 in this study with that of YdiI (Wu et al. 2014), 
shows that although these profiles are not identical they share notable likeness. 
Specifically, as indicated by the steady-state kinetic constants reported in Table 3.2 it is 
evident that although both thioesterases are somewhat promiscuous, each prefers aromatic 
thioester substrates, with benzoyl-CoA being an excellent in-vitro substrate for both 
enzymes.  Mechanistic studies of  EcYdiI employed benzoyl-CoA as substrate in 18O-
solvent labeling experiments and transient kinetic analysis, and as the platform for the 
design of inert substrate analogs for X-ray structure determinations, yet no clear distinction 
between nucleophilic catalysis and general-base catalysis was forthcoming. This 
experience prompted us to invest in the development of a new effective mechanistic probe.  
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Table 3.2 Steady state kinetic parameters of PA1618-catalyzed hydrolysis of various acyl-
CoA and aryl-CoA substrates at pH 7.5 and 25 ˚C. See Materials and Methods for 
conditions.  Kinetic assays were performed by our collaborator, John Latham, Ph.D. 
 
3.3.2 The X-ray Crystal Structure of unliganded PA1618   
The unliganded selomenomethionine-substituted structure of PA1618 was refined 
to a resolution of 1.72 Å in the C2 2 21 space group.  The asymmetric unit is comprised of 
six monomers—a dimer of dimers to form a tetramer assembled in a back-to-back manner 
(Figure 3.11a) and two monomers flanking the tetramer (Figure 3.10).  The structure of 
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PA1618 represent a typical hotdog-fold in which each subunit is composed of six anti-
parallel β-strands encompassing an 5-turn α-helix with overall dimensions of ~22 Å x 22 
Å x 40 Å.  The anti-parallel β-sheets align in the order of β3- β4- β7- β8- β9- β6 as depicted 
in the secondary structure topology map (Figure 3.11b).  The active site of hotdog-fold 
enzymes are located at the interface of the homodimer, thus the dimer is the minimal 
catalytic unit.  Typical of a hotdog-fold dimer, the two subunits associate along the edge 
of the β-sheet (β6 of one subunit to β6 of the adjacent subunit) to form an elongated 12 
strand anti-parallel β-sheet.  The intersubunit interactions involve mainly the α5-helix and 
β6-sheet as well as β2 and loop between β4-α5 which are held together by 18 hydrogen-
bonds and four salt bridges.  The homotetrameric quaternary structure forms the 
biologically relevant assembly, as verified by FPLC and the back-to-back tetramer 
assembly was validated using PDBePISA (Krissinel and Henrick 2007).  The tertiary and 
quaternary structures of PA1618 are typical for members of the AB clade, based on the 
prototype of the 4-hydroxybenzoyl-CoA thioesterase from Arthrobacter sp. strain AU 
(4HBT) (Zhuang et al. 2003).  The structure of PA1618 is also conserved among the E. 
coli homologues YdiI (4K4A) and YbdB (4K4C) (Wu et al. 2014), where the biological 
unit is also a tetramer and the dimer of dimers assemble in a back-to-back manner.  
Structural overlay of the dimer of the 3 homologs show similar tertiary structure—with a 
root mean square deviation (r.m.s.d.) of 1.32 Å and 1.83 Å for the PA1618 dimer compared 
to those of YdiI and YbdB, respectively (Figure 3.12).  
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Figure 3.11 a. Ribbon representation of the tetrameric PA1618 structure with subunits A, 
B, C, D labeled on the right.  b. Secondary structure topology map of PA1618 monomer 
showing six β-strands to form the β-sheet that wraps around the α5 central helix. 
90˚ 
a. 
b. 
142 
 
   
Figure 3.12 Structural alignment of YdiI homologs generated in PyMOL.  YdiI (salmon), 
YbdB (light blue) align with PA1618 (magenta) with an r.m.s.d. of 1.32 Å and 1.83 Å, 
respectively. 
 
3.3.3 Structures of PA1618 variants 
Structures of PA1618 variants, E64A and Q49A, were determined to ensure that 
the single mutations did not vary from wt in the overall structure or active-site 
configuration.  The r.m.s.d. between the unliganded wt PA1618 and the Q49A variant is 
0.75 Å and between wt PA1618 and E64A variant is 0.86 Å.  The r.m.s.d between the two 
variants is 0.49 Å.  The major contributing factor for the deviation between the wild-type 
and variant proteins lies within the β-sheets, specifically β5 and β6 strands of each subunit.  
In the case of the wild-type selenomethionine replaced structure, the β5 and β6 strands are 
shorter by four residues and thus it contains an elongated loop connecting strands β5—β6 
 
90˚ 
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and strands β6—β7 compared to the variant structures (Figure 3.11a and Figure 3.13 top).  
The active site (Figure 3.13 bottom) residue positions did not show significant change.   
 
Figure 3.13 Structural alignment of wt PA1618 (magenta) and variants, Q49A (yellow) 
and E64A (orange).  The extended loop within the β-sheet of the wt PA1618 is boxed on 
the right.  The bottom figure shows active-site residues displayed as sticks.  The PA1618 
variants do not affect the Cα backbone structure.  
 
 
180˚ 
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3.3.4 Inert Substrate Analog Design 
In most cases, the replacement of the catalytic Glu or Asp with the isosteric Gln or 
Asn, does not remove all catalytic activity. Indeed, the only example an X-ray structure of 
a catalytically inert hotdog-fold thioesterase bound with substrate is that of the Asp17Asn 
variant of the 4-hydroxybenzoyl-CoA thioesterase from Pseudomonas sp strain CBS3 
bound with 4-hydroxybenzoyl-CoA (Benning 1998). Thus, for structure determination an 
inert substrate analog is preferable. The two thioester analogs that have been used as 
crystallization ligands possess either a methylene ketone function (O=C-CH2-SCoA) 
(Figure 3.15 left) or simply a thiomethylene group (CH2-SCoA) (Figure 3.15 middle) in 
place of the thioester moiety (O=C-SCoA). Both classes of analogs are inert to hydrolysis. 
Unfortunately, neither analog constitutes the perfect catalytic site probe. Unlike the native 
substrate, the thiomethylene adduct is unable to participate in the hydrogen bonds that takes 
place between the substrate thioester C=O and the N-terminal residue of the conserved α-
helix. This interaction has been shown to be essential to the orientation of the substrate for 
catalysis, as well as for generating binding energy (Chapter 1, section 1.3.4). Likewise, the 
use of the methylene ketone adduct introduces a CH2 group to the reaction center, and the 
accommodation of the added steric requirements in turn effects the alignment with the 
catalytic carboxylate residue, and the ability of the enzyme to bind the substrate water 
molecule.  
              The minimal structural change needed to render the hotdog-fold thioester substrate 
resistant to catalytic turnover is the substitution of the sulfur atom with an oxygen atom 
(Figure 3.15 right). The oxygen ester is intrinsically less susceptible to hydrolytic 
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cleavage, and equally important, it is expected to conserve the space requirements and 
hydrogen bonding capabilities of the thioester. As a test case, we set out to synthesize the 
oxygen ester counterpart to the PA1618 substrate benzoyl-CoA and to carry out the 
structure determination of the liganded enzyme. This structure would be evaluated in a 
side-by-side comparison with the structure PA1618 bound with the methylene ketone 
analog, phenacyl-CoA.  
 
                  
 
Figure 3.14 Design of an inert substrate analog.  Phenacyl-CoA (left) contains additional 
methylene group, thiomethylene group (middle), and benzoyl-Od-CoA (right). 
 
3.3.5 Liganded structures 
Structures of PA1618 in complex with phenacyl-CoA and benzoyl-OdCoA were 
determined to a resolution of 1.6 Å and 1.72 Å, respectively.  The crystals were 
isomorphous with the same arrangement and number of subunits in the assymetric unit and 
hence the same tetramer assembly. All four active sites of the phenacyl-CoA bound 
tetrameric structure are occupied by ligand.  As for the benzoyl-OdCoA bound structure, 
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there are two ligands present in the tetramer, with one bound at each dimer interface.  
Electron density for ligands in the remaining active sites was partially present but poor, 
thus the ligand structures were not modeled into these sites.  For the purpose of simplicity, 
subunits C and D of the coordinate file will be used for discussion for all structures.  
Superimposition of the wild-type unliganded structure with the phenacyl-CoA and 
benzoyl-OdCoA bound structure have a r.m.s.d. of 0.74 Å with no significant perturbation 
in side chain positioning and side chain B-factors within 10 Å of the ligands (Figure 3.15). 
[It should be noted that the low RMSD is slightly biased by the fact that the unliganded 
structure was used as the isomorphous phasing model for the liganded structures].  
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Figure 3.15 Superimposition of the five PA1618 structures. PA1618 in complex with 
phenacyl-CoA is shown in green, PA1618 in complex with benzoyl-O-CoA in cyan, 
unliganded PA1618 in magenta, and substrates phenacyl-CoA and benzoyl-O-CoA are 
colored yellow and grey, respectively.  
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Figure 3.16 Structures of PA1618 bound to ligands.  (a) Phenacyl-CoA (b) Benzoyl-
OdCoA.  Ligand bound structures displaying subunit A in magenta and B in yellow on left 
and binding site showing the protein molecular surface as a semitransparent surface 
covering a ribbon diagram of wt PA1618. The ligand excluded Fo-Fc electron density for 
Q49 
H55 
E64 
G56 
Q49 
H55 
E64 
G56 
a. 
b. 
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the fully occupied CoA molecule is shown as a grey mesh and is contoured at the 1.0σ 
level.   
 
In both liganded structures, the substrate analogs were positioned at the dimer 
interface of the functional dimer.  The phenacyl-CoA bound structure was obtained to 
identify active site residues as well as the interactions that contribute to the binding for 
substrate stabilization.  In a comparative analysis of PA1618 structure bound to phenacyl-
CoA and that of the E. coli homologue, YdiI bound to phenacyl-CoA (4K4A), the phenacyl 
and pantetheine moieties aligned perfectly.  The residues involved in binding of the 
pantetheine arm include His91, Leu92, Arg93, Gly56, Leu53, Val83*, and the C=O 
backbone of Gly84* (* indicate residues of the opposing subunit) (Figure 3.16).  These 
substrate binding residues are conserved in E. coli YdiI with the exception of Leu92, which 
is a Val in YdiI.  Backbone residues Arg93, Leu92, His91, Gly56, and Gly84* and side 
chains of Leu53, and Val83* form the H-bond and van der Waals interactions with the 
pantetheine moiety.  The pyrophosphate group aligned well with YdiI Phenacyl-CoA 
structure and is tightly bound to the protein as indicated by its relatively low B-factor 
(16.24-23.00 Å for the pyrophosphate compared to 12.1-25.9 Å for nearby protein side-
chains).  The pyrophosphate and nucleotide moieties lie at the surface of the protein 
between the back-to-back dimer interface of the tetramer.  Protein ligands to the 
pyrophosphate come from the opposing dimer.  The amide backbone of Arg111** and side 
chains Thr112** and His108** located at the loop between β5 and β6 form the ionic bonds 
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that stabilize the pyrophosphate. (** indicate residues of the opposing dimer.)  The ribosyl 
3’-phosphate is also positioned near the same region in both structures and is loosely bound 
by a H-bond from a conserved Arg side chain (Arg93 in PA1618, Arg91 in YdiI) (Figure 
3.18).  The adenosine nucleotide sits at the surface of the protein with no apparent binding 
interactions to the protein and in fact, only one of the four liganded sites shows electron 
density for the nucleotide.  An elongated loop (residues 41-64) between β4 and α9 serves 
as a lid over the substrate binding tunnel for solvent exclusion and is highly conversed in 
YdiI with the exception of His48 (Lys47 in YdiI).  A structure of YdiI in complex with 
undeca-2-one-CoA (4K4B) displayed a shift in the loop to accommodate the long acyl 
chain (Figure 3.19).  The flexibility observed in this loop region is likely conserved in 
PA1618, thus allowing a number of substrates to bind the active site, albeit at lower affinity 
compared to benzoyl-CoA as shown by the corresponding steady-state kinetic constants.  
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Figure 3.17  Structural alignment of PA1618 bound to phenacyl-CoA bound (green) and 
YdiI with phenacyl-CoA bound (yellow).  Different shades represent dimer subunits A 
(lighter shade) and B (darker shade). Phenacyl-CoA ligand bound to YdiI is colored 
magenta and ligand bound to PA1618 in gray.  Conserved side chains involved in binding 
of the pantetheine moiety is represented in sticks shown in green.  
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Figure 3.18 Ligand binding interactions between the dimer of dimers. Tetrameric PA1618 
bound to phenacyl-CoA (top); inset (bottom) shows the residues involved in binding and 
stabilization of the pyrophosphate moiety of the bound ligand. 
 
Arg111** 
Thr112** 
His108** 
Arg93 
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Figure 3.19 Superimposition of YdiI structures bound to phenacyl-CoA (light green) and 
undeca-2-one-CoA (orange).  The loop region between the C-terminus of β4 and N-
terminus of the elongated α9 (on right) shows a ~2.5 Å displacement to accommodate a 
larger substrate. 
 
3.3.6 Steady-State kinetics for verification of catalytic residues  
The PA1618 structure complexed with phenacyl-CoA was used to identify the 
catalytic residues responsible for the hydrolysis of the thioester.  Like the prototypical 
4HBT, PA1618 contains the active site carboxylate Glu64.  The active site variant E64A 
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was made and was shown to be catalytically inactive (Table 3.3).  To insure that the 
mutation did not alter the structure, the X-ray crystal structure for the E64A mutant was 
determined (Table 3.1) and shown to be similar to that of wild type (r.m.s.d. = 0.85 Å) 
with the exception of the removed Glu64 side chain.  In addition, in PA1618 complexed 
with phenacyl-CoA, the conserved Gln49 amide side chain is positioned 3.6 Å from the 
sulfur atom to stabilize the transition state thiolate, as was also observed in 4HBT (Song et 
al. 2012).  To examine the extent of contribution to catalysis by the glutamine, the mutant 
Q49A was generated and shown to have a decrease in efficiency of ~103  fold (kcat/KM = 
103s-1M-1) compared to wild type (Table 3.5). The residual activity of Q49A was surprising 
since the analogous mutation in 4HBT abolished all activity (Song et al. 2012).  The crystal 
structure of the Q49A was determined and showed no global change in fold (r.m.s.d. 0.75 
Å) (Table 3.1).  In PA1618 the His55, and the backbone amide nitrogen of Gly56 are 
positioned within hydrogen-bond distance (3.49 and 2.96 Å, respectively) to the carbonyl 
oxygen, a feature also characteristic of the AB clade thioesterase 4HBT.   
PA1618 kcat (s
-1) Km (μM) kcat/Km  (M-1s-1) 
Wild-type 56 ± 1 12 ± 1 4.6 x 106 
E64A <1 x 10-4 ----- ------ 
Q49A (2.2 ± 0.3) x 10-2 5.0 ± 0.3 4.4 x 103 
 
Table 3.3 Steady state kinetic parameter of PA1618 and variants catalyzing the hydrolysis 
of benzoyl-CoA at pH 7.5 and 25 oC.  See Materials and Methods for details.  These 
experiments were performed by John Latham.  
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3.3.7 Ligand bound Active Site comparison reveals general base mechanism 
Although the structure of PA1618 with the ligand phenacyl-CoA proved to be 
useful in the identification of substrate binding and catalytic residues, the geometry of the 
-CH2-S-CH2-C=O bonds (Figure 3.20) does not allow for attainment of a true active site 
configuration.  Therefore, the prediction of the catalytic mechanism is prohibited based 
solely on the distance measurement between the acyl carbon and the active site glutamate.  
To circumvent the dilemma of having a spatially distorted substrate configuration in the 
active site, the substrate mimic benzoyl-Od-CoA was synthesized and used as a ligand in 
PA1618.  Benzoyl-Od-CoA was shown to be a competitive inhibitor (Table 3.4) with a Ki 
similar to that of phenacyl-CoA (19 µM vs 35 µM respectively).  The PA1618 crystal 
structure with benzoyl-Od-CoA was determined to 1.72 Å resolution (Table 3.1).  As 
expected, the benzoyl-OdCoA configuration in the active site varied from that of phenacyl-
CoA in the corresponding complex.   
 
 
 
 
Table 3.4 Steady-state inhibition constants for competitive substrate analog and product 
inhibitors of PA1618 hydrolysis of benzoyl-CoA. See Materials and Methods for details.  
These experiments were performed by John Latham.  
 PA1618  Ki (µM) 
Phenacyl-CoA 35 ± 5 
Benzoyl-oxoCoA 19 ± 3 
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The active-site side chain residues of both ligand bound structures are positioned 
nearly identically to one another (Figure 3.20).  The phenacyl-CoA and benzoyl-OdCoA 
pantetheine group align well and are held in place by the same hydrogen-bond network and 
van der Waals interactions.  The benzene ring and carbonyl also aligns well with < 1.0 Å 
displacement.  However, in the case of phenacyl-CoA the addition of the methylene group 
of the phenacyl-CoA ligand causes a “kink” with a cis-like configuration of the -CH2-S-
CH2-C=O portion as opposed to the tetrahedral geometry of the -CH2-O-C=O- group that 
is more representative of true ligand geometry.  In this relaxed/elongated conformation of 
the benzoyl-OdCoA bound structure, we identified a water molecule (HOH171) 2.8 Å from 
Glu64 carboxyl side-chain oxygen and carbonyl of the ligand that was not present in the 
phenacyl-CoA bound structure (Figure 3.20).  
Based on the phenacyl-CoA structure, the absence of water and the shift of the 
carbonyl toward Glu64 would have led us to conclude that PA1618 catalyzed its reaction 
via a catalytic nucleophile. Glu64 is within “striking distance” of the carbonyl carbon (3.7 
Å) of the ligand and forms a 65.9˚ angle between the trigonal center of the phenacyl-CoA 
carbonyl and the Oɛ of the Glu64.  Notably, the absence of water at the active site is due 
in part to the volume of the binding pocket and the additional hydrophobicity of the 
methylene.  Although the absence of water in the active site is suggestive of nucleophilic 
catalysis, previous mechanistic work performed on the E. coli homologue YdiI suggests 
otherwise (Wu et al. 2014).  In YdiI, the multiple-turnover transient kinetic experiment did 
not demonstrate a "burst" phase (where the hydrolysis of the mixed anhydride is rate 
limiting), a signature of nucleophilic catalysis (Zhuang et al. 2012; Song et al. 2012), but 
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rather a single phase (Wu et al. 2014). In contrast, the structure of PA1618 bound to 
benzoyl-OdCoA includes an active-site water, suggesting that Glu64 serves as the general 
base, instead of as the catalytic nucleophile.  The water, HOH171 (with a B-factor of 27.5), 
is positioned in the correct geometry with respect to the carbonyl carbon of the CoASH, 
for a backside nucleophilic attack.  The geometry of attack of the deprotonated water 
nucleophile, HOH171, to the trigonal carbonyl of the ligand is at a 95.5˚ angle with a 
distance of 2.8 Å to the carbonyl C.  This model is in agreement with the detailed 
mechanistic work on the homologue YdiI, however, without a detailed mechanistic study 
on PA1618 the mechanism of either base or nucleophilic catalysis cannot be definitively 
stated.     
 
Figure 3.20 Superimposition of bound benzoyl-dOCoA and phenacyl-CoA with catalytic 
residue side chains shown in sticks (left), active site of phenacyl-CoA ligand bound 
(middle), and active site of benzoyl-OdCoA ligand bound (right).  All H-bond interaction 
distances between side chains and ligand are measured in Angstroms.   
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3.4 Conclusions 
In summary, this chapter reveals the binding interactions between the enzyme, 
PA1618, and a substrate analog, benzoyl-Od-CoA, to give a true snapshot of the Michaelis 
complex.  In a comparison between two ligand bound substrates, phenacyl-CoA and 
benzoyl-Od-CoA, we show that to discriminate between a nucleophilic and a general-base 
catalytic mechanism of a hotdog-fold thioesterase enzyme using X-ray crystallography, it 
is necessary to have an isosteric and isoelectronic inert substrate analog.  The additional 
methylene group in phenacyl-CoA revealed a kink in the ligand at the active site in order 
to maintain the correct hydrogen bond network of the pantetheine moiety and the leaving 
group.  As a result, the water molecule that acts as a general base catalyst can no longer 
occupy this space.  On overall goal of this work also attempts to determine the true 
physiological substrate and determine the function of PA1618 in P. aeruginosa. Although 
the true function of the enzyme is still under investigation, we have shown that the PA1618, 
orthologous to the E. coli thioesterase YdiI, catalyzes the hydrolysis of thioesters with 
preference for aromatic substrates in vitro. 
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Chapter 4: 
Structural analysis of Hotdog Fold thioesterases: identifying substrate specificity 
determinants 
4.1 Introduction 
4.1.1 Naturally occurring organohalogen compounds 
More than 4,500 naturally occurring organohalogen compounds, both biogenic and 
abiotic, have been documented by 2010 (Gribble 2010).  Most organohalogens contain 
chorine or bromine but some contain iodine or fluorine produced by living organisms or 
during natural abiogenic processes, including volcanoes, forest fires, and other geothermal 
processes (Gribble 2003).  In the last four decades, the number of natural organohalogen 
metabolites discovered increased significantly, with only 200 documented compounds 
(150 organchlorines and 50 organobromines) in 1973 (Siuda & DeBernardis 1973).  This 
striking increase is in part due to improved technologies and a surging interest in the 
potential of organohalogenated compounds as a source for new medicinal drugs.  By 2002, 
the breakdown of organohalogen compounds included 2200 chlorine-, 1950 bromine-, 95 
iodine-, and 100 fluorine-containing organic compounds (Gribble 2003).   
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4.1.2 Sources of organohalogens  
The majority of biogenic organohalogen compounds are found in marine-derived 
plants, animals and bacteria but many others are found in terrestrial plants, fungi, lichen, 
bacteria, insects, and some in higher organism animals including humans (Gribble 1996a; 
Gribble 1996b; Gribble 1999; Gribble 2000).  Marine seaweeds and algae are producers of 
a multitude of simple to complex organohalogen metabolites, mainly chlorinated and 
brominated compounds that are presumably synthesized as a chemical defense.  Some 
examples include secondary metabolites found in the Hawaiian seaweed “limu kohu” 
(Asparagopsis taxiformix) and red alga (Bonnemaisonia hamifera and Laurencia) (Figure 
4.1a) (McConnell & Fenical 1977; McConnell & Fenical 1980; Moore 1977).  Marine 
sponges also contain a plentiful source of halogen containing compounds essential for 
survival.  Some interesting organohalogen compounds recently discovered in sponges 
include halogenated derivatives of fatty acid (Pham et al. 1999), pyrroles (Fattorusso & 
Taglialatela-Scafati 2000), indoles (Qureshi & Faulkner 1999), phenols (Utkina et al. 
1998), tyrosines (Nicholas et al. 2001) and terpenes (Miyaoka et al. 1998) to name a few 
(Figure 4.1a).  Marine animals like the acidians (sea squirts), nudibranchs (sea slugs), soft 
corals (gorgonians), bryozoans (moss animals) (Morris & Prinsep 1999; Sheu et al. 1999; 
Ortega et al. 2000; Rudi et al. 2000; Gribble 2003), marine bacteria including 
acetinomycetales (Hardt et al. 2000) and fungi including genus Fusarium and Emericella 
(Figure 4.1a) (Renner et al. 1998; Nielsen et al. 1999) have also been found to produce an 
array of organohalogen compounds. 
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Overall, terrestrial producers of organohalogens in comparison to marine organisms 
are relatively few.  Most terrestrial plants compared to marine plants do not contain 
halogenated compounds; however, many exceptions do exist.  To name a few, several 
legumes such as peas, lentil, vetch and fava bean biosynthesize the growth hormone 4-
chloroindole-3-acetic acid.  Chloromethane have been found to be produced by potato 
tubers and bromomethane by broccoli, cabbage, mustard, bok-choi, radish, turnip, and 
rapeseed (Miles et al. 1993).  Fungi produce a variety of organohalogens and are one of the 
earlier known organohalogen producing organisms discovered (particularly chorine-
containing halogens) .  Examples of organohalogen producing bacteria include over 50 
species of Streptomyces and of particular importance, Amycolatopsis orientalis, which is 
the producer of the antibiotic vancomycin used to treat penicillin-resistant infections 
(Figure 4.1b) (Dudley H. Williams 1996; Williams, D.H., Bardsley 1999).  Insects produce 
chemicals containing halogens for communication (“pheromones”) and defense 
(“allomones”), notably 2,6-dichlorophenol, a sex pheromone in several tick species 
(Berger 1983), and two chlorinated steroids found in German cockroach as aggregation 
pheromones (Sakuma & Fukami 1993).  Organohalogens in higher animals and humans 
are rare; however, some have been identified.  For examples Ecuadorian frog Epipedobates 
tricolor and the thyroid gland of dogs contain epibatidine and iodolactone, respectively.  
And recently, myeloperoxidase in human white blood cells was identified to induce 
halogenation by generating hypochlorous acid (Hazen & Heinecke 1997; Heinecke 2000; 
Henderson et al. 2001).  Human myeloperoxidase converts chlorophenols to chlorinated 
dioxins and dibenzoflurans (Huwe et al. 2000). 
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Abiogenic sources of organohalogen compounds account for a large variety of 
diverse halogenated compounds.  These compounds result from natural combustion from 
biomass fires, volcanoes, and other geothermal processes.  In 2000, a study of volcanic 
gases collected from four different volcanos in Japan and Italy identified many novel 
organohalogens—100 organchlorines, 25 organobromines, 5 organofluorines, and 4 
organoiodines (Jordan et al. 2000). 
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Figure 4.1 Examples of the chemical diversity and complexity of naturally produced 
organohalogens from a. marine life and b. terrestrial species.  Figure modified from 
(Gribble 2003).   
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4.1.3 Natural fluorinated metabolites  
Most of the organohalogen compounds discussed above are chlorine and bromine 
containing compounds.  However, fluorine containing natural organic products, though 
very rare, are of particular interest because of fluorine’s chemical properties and 
therapeutic potential in drug discovery.  Fluorines found in nature are mostly in the form 
of inorganic minerals like fluorite (CaF2) and cryolite (Na3AlF6), with only ~30 naturally 
occurring organofluorine compounds discovered (Gribble 2002).  Fluorine-containing 
molecules are especially interesting in pharmaceutical drugs because fluorine is the most 
electronegative element and has a similar atomic radius to hydrogen but with a relatively 
short C-F bond length.  These unique properties allow for a replacement of hydrogen by 
fluorine resulting in changes in molecular properties (ie. stability, reactivity, conformation, 
hydrogen-bond formation, and lipophilicity) while having little steric change (Smart 2001; 
Müller et al. 2007; Purser et al. 2008; Biffinger et al. 2004).   
Some biogenic organofluorine structures are show in Figure 4.2.  One of the best 
known and most abundant natural organofluorine products is fluoroacetic acid 1, a highly 
toxic compound. Fluoroacetate toxicity works by disrupting the citric acid cycle (TCA 
cycle) because it structurally resembles the structure of acetate.  This mechanism is 
discussed in detail in section 4.1.5.  It was first discovered in 1943 from the Southern 
African plant Dichapetalum cymosum (Butler 1965) and later found to be synthesized in 
the bacterium Streptomyces cattlya in 1986 (Sanada et al. 1986).  Research over the decades 
has identified several plant species to biosynthesize fluoroacetate, however, Streptomyces 
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cattlya is still the only fluoroacetate (and fluorothreonine 2) producing microbe known to 
date.  The 5’-fluorodeoxyadenosine 3 metabolite has been identified in Streptomyces 
cattlya as the first fluorine incorporation step in the fluoroacetate and fluorothreonine 
biosynthesis pathway, a reaction catalyzed by 5′-fluorodeoxyadenosine synthase 
(Schaffrath et al. 2003).  Fluorocitrate 4 is often accumulated in small amounts in plants 
that produce fluoroacetate because it is the product of the condensation reaction between 
FAc-CoA with oxaloacetate by citrate synthase upon entry of the TCA cycle (Yu & Miller 
1970; Peters & Shorthouse 1972).  Other fluorinated compounds found in nature are ω-
fluorinated fatty acids 5, first discovered in seeds of a shrub, Dichapetalum toxicarium, 
with high toxicity levels that is frequently used as rodenticide (WARD et al. 1964).  And 
nucleoidin 6 is a compound first isolated in 1957 from Streptomycies calvus to have a broad 
spectrum of antibiotic activity (S. O. Thomas, V. L. Singleton, J. A. Lowery, R. W. Sharpe, 
L. M. Preuss, J. N. Porter 1957).   
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Figure 4.2  Examples of biogenic organofluorine compounds (Weeks et al. 2010). 
 
4.1.4 Fluoroacetate poisoning mechanism 
It was discovered in the late 1800’s that fluoroacetic acid, along with methyl 
fluoroacetate (MFA) and 2-fluoroethanol, were a highly toxic class of organic compounds.  
Additionally, its colorless, odorless, soluble and stable properties made it an excellent 
warfare agent, added to the water source, used during World War II (Sartori 1951) and as 
a rodenticide in the US in 1946 (Proudfoot et al. 2006).  Fluoroacetate is highly toxic in 
humans, with a toxic dose of 0.5-2.0 m/kl.  Symptoms of fluoroacetate if ingested include 
convulsions, vomiting, cardiac failure, and respiratory failure.  Research into the 
mechanism of fluoroacetate poisoning was underway shortly after the war.  Between 1948 
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and 1949, several research groups observed an increase in citric acid accumulation in 
animal tissues when treated with fluoroacetate (Peters 1950; Kalnitsky 1948; Potter & 
Busch 1950) and discovered that fluoroacetate can enter the TCA cycle and prevent 
utilization of citric acid (Potter & Busch 1950). 
Before discussing the mechanism of fluoroacetate toxicity, it is important to review 
the mechanism of the TCA cycle.  The TCA cycle is an obligatory series of ten reactions 
used in all aerobic organisms to generate energy in the form of adenosine triphosphate 
(ATP).  Energy sources derived from carbohydrates, fats and proteins undergo designated 
metabolic pathways that are ultimately broken down to acetic acid.  Acetic acid enters the 
TCA cycle in the form of acetyl-CoA.  A condensation reaction between acetyl-CoA and 
oxaloacetate by citrate synthase produces one molecule of citrate and CoASH.  The 
following step is an isomerization reaction converting citrate to cis-aconitate intermediate 
and resulting in D-isocitrate product catalyzed by aconitase (Figure 4.3).  For the purpose 
of understanding fluoroacetate toxicity, only the first two steps of the TCA cycle are 
relevant.  However, to summarize, subsequent steps of the cycle yields 1 ATP, reduction 
of 3 NAD+ to NADH and reduction of 1 FAD to FADH2.  NADH and FADH2 products 
enter the electron transport chain (ETC) to produce 3 ATP for each NADH and 2 ATP for 
each FADH2, resulting in a total of 12 ATP per cycle. 
Fluoroacetate poisoning occurs by the compound entering the TCA cycle owing to 
its structural similarity to acetate.  Fluoroacetate itself does not appear to inhibit any TCA 
cycle enzymes (Martius 1949).  Instead, enzymes involved in the first steps of the TCA 
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cycle are non-specific and cannot discriminate between acetate and fluoroacetate.  Thus, 
fluoroacetate can combine with CoASH to form fluoroacetyl-CoA (FAc-CoA) and enters 
the TCA cycle in substitution for acetyl-CoA.  Entry of FAc-CoA via citrate synthase 
produces fluorocitrate.  Fluorocitrate reacts with aconitase to form a fluoro-cis-aconitate 
intermediate, and an addition of water displaces the fluoride to form 4-hydroxy-trans-
aconitate, which is a strong non-covalent inhibitor of aconitase, thereby halting the cycle 
(Lauble et al. 1996).  This results in the observed accumulation of citrate and energy 
deprivation. 
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Figure 4.3 TCA cycle.  Top left is a structural comparison between acetyl-CoA and FAc-
CoA.  Because of the structural similarity between acetyl-CoA and FAc-CoA, TCA 
enzymes cannot distinguish between the 2 substrates and will accept FAc-CoA.  The 
pathway shows FAc-CoA entry (in red) into the TCA via citrate synthase and continues to 
the next step via aconitase before forming the inhibitory complex with aconitase. 
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4.1.5 Natural producers of fluoroacetate—Streptomyces cattleya  
Fluoroacetate is known to be naturally produced by over 40 plant species found in 
Australia, Brazil and Africa (Aganga et al. 2011; Laurie E. Twigg 1991; Peters & 
Shorthouse 1972; Harper & O’Hagan 1994).  It was first discovered in the poisonous leaves 
of Dichapetalum cymosum in 1944 (Aganga et al. 2011).  However, Streptomyces cattleya, 
a soil microbe can also produce its own fluoroacetate as a defense mechanism.  
Interestingly, it is the only microbe known to produce fluorinated compounds (including 
fluoroacetate and fluorothreonine) and our understanding of the fluorinated metabolite 
biosynthesis pathway comes almost exclusively from Streptomyces cattleya (Deng et al. 
2004; Sanada et al. 1986).  Additionally, S. cattleya can biosynthesize other antibiotics 
including thienamycin (Rodríguez et al. 2011) and cephamycin C (Bodner et al. 2011). 
 
4.1.6  Fluoro metabolite biosynthesis pathway in Streptomyces cattleya 
The pathway and gene cluster involved in the biosynthesis of fluoroacetate and 
fluorothreonine have been characterized through biochemical analysis and genome 
sequencing (Figure 4.4a).  Fluorinase enzyme (flA) mediates the incorporation and 
formation of a C-F bond by catalyzing the nucleophilic attack of a fluoride ion to S-
adenosyl-L-methionine (SAM) to form 5’-fluoro-5’-deoxyadenosine (5’-FDA) and L-
methionine (Bodner et al. 2011).  The adenosine base is removed and replaced by a 
phosphoryl group by a phosphorylase (flB) for form 5-fluoro-5-deoxy-D-ribose-1-
phosphate (5-FDRP) (Cobb et al. 2004).  The subsequent step involves a ring opening 
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isomerization reaction by 5-FDRP isomerase converting 5-FDRP to 5-fluoro-5-deoxy-
ribulose-1-phosphate (5-FDRu1P) (Onega et al. 2007).  Next, 5-FDRu1P aldolase 
catalyzes a reverse aldol reaction to generate fluoroacetaldehyde, which is the branching 
point to the products fluoroacetate and fluorothreonine.  A NADH+-dependent 
dehydrogenase oxidizes fluoroacetaldehdye to fluoroacetate (C D Murphy et al. 2001).  
And a pyridoxal phosphate (PLP)-dependent transaldolase catalyzes the condensation 
reaction between the fluoroacetaldehyde and L-threonine to produce 4-fluorothreonine and 
acetaldehyde (Cormac D. Murphy et al. 2001).  A 12 kb gene cluster reported by Huang et 
al. (Huang et al. 2006) in 2006 identified the flA and flB genes to be adjacent to one another 
(Figure 4.4b).  The cluster includes 12 open reading frames which may play a role in 
fluorometabolite biosynthesis and degradation.  However the exact roles of the surrounding 
genes flA and flB is unclear, except for flI and flK.  Gene flI was found to be an S-
adenosylhomocysteine hydrolase which acts to relieve S-adenosylhomocysteine inhibition 
of fluorinase.  The gene flK that lies downstream of flA, flB and flI, is a thioesterase 
important in the organism’s own fluoroacetate detoxification pathway (Huang et al. 2006).  
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Figure 4.4   Biosynthesis and gene cluster of fluorometabolites. a. biosynthetic pathway of 
fluoroacetate and fluorothreoine in S. cattleya.  Figure taken from (Zhao et al. 2012)  b. 
Gene cluster of S. catteya containing enzymes involved in biosynthesis.  FlK is the 
thioesterase gene.  Figure taken from (Huang et al. 2006). 
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4.1.7 flK gene and structure 
The flK gene produces a small (139 amino acids) protein with specific thioesterase 
activity for FAc-CoA.  This enzyme is particularly interesting due to its unusual specificity 
for FAc-CoA and its ability to discriminate against its structurally similar analog, acetyl-
CoA.  Catalysis of the substrate results in a CoASH molecule and fluoroacetic acid which 
protects the host from fluoroacetate poisoning (Figure 4.5a).  The enzyme insures that if 
FAc-CoA is formed, it is quickly degraded and prevented from entry to the TCA cycle 
where it is metabolized into the lethal inhibitor, 4-hydroxy-trans-aconitate.   
A BLAST search of flK gene identified many homologs with predicted thioesterase 
function, a representative number of homologous sequence alignments shown in Figure 
4.5 (Huang et al. 2006).  Sequence identity ranged from 26%-54%.  Identified homologs 
have no known functions, however several are from thermophilic bacteria and a few are 
thermo/acidophilic archaea species.  The sequence alignment identified nine conserved 
amino acid residues—Gly8, Thr42, Glu50, Leu61, Gly69, His76, Ala78, Gly83, and 
Gly116.  It is predicted from sequence analysis that flK is a unique thioesterase which 
employs a catalytic triad-like mechanism utilizing Thr42 (instead of Ser), Glu50 and His76, 
where Thr42 acts as the nucleophile (Sfakianos et al. 2002).  While the use of threonine as 
a nucleophile has been reported in some proteases, flK is the first thioesterase reported to 
use a threonine in place of a serine as the catalytic nucleophile.                                        
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Figure 4.5  Thioesterase activity and protein sequence alignment of Flk orthologs.  a. 
Activity of FlK thioesterase hydrolyzes thioester bond of FAc-CoA to produce 
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fluoroacetate and CoASH. b.  BLAST search of FlK orthologs show conserved active site 
residues that form the catalytic triad, Thr—Glu—His (Huang et al. 2006).  
 
Structures of flK have been solved by Weeks et al (Weeks et al. 2010). and Dias et 
al. (Dias et al. 2010) in 2010 revealing the structure of flK thioesterase to resemble a typical 
Hotdog fold with an elongated central α-helix and 5 antiparallel β-sheets that surround the 
α-helix (Figure 4.6a).    In addition to the minimal hotdog fold, a 3-turn α-helix composed 
of 11 amino acids extends from the C-terminus of the protein that is stabilized by loops 
connecting the β-strands of the opposing dimer.  Also unique to the structure of flK is a 
short helical segment “lid” inserted in the loop between β-stand 1 and the N-terminus of 
the central α-helix that sits over the active site.  The quaternary structure is a dimer 
assembled with the ‘hotdog’ α-helices facing one another and joining of the anti-parallel 
sheets form a 10-stranded sheet.   Dimer interactions include a cysteine, Cys73, of both 
subunits to form a disulfide bond covalently joining the two subunits, along with 
hydrophobic and hydrogen bond interactions. 
The active site, as predicted by sequence alignment and confirmed by site-directed 
mutagenesis and kinetic assays, is comprised of Thr43, His76, and an acid.  This catalytic 
scaffold is reminiscent of the catalytic triad seen in the α/β-hydrolyase superfamily of 
thioesterases (Chapter 1, section 1.3.2).  However, there is a controversy between the two 
reports of the structure as to what molecule serves as the acid in the catalytic triad.  In the 
paper by Dias et al., the authors proposed a catalytic triad comprised of Thr43, His76, and 
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a coordinated water molecule on the basis of the location of the Glu50 and the active site 
water.  They argue that water is in closer proximity to Thr42 than Glu50 and kinetic 
analysis of the E50A mutant increased kcat.  In contrast, the Weeks et al. paper reported a 
catalytic triad comprised of Thr43, His76, and Glu50.  Their data showed that Glu50 is 
important in catalysis because an E50Q mutant showed significant loss of activity in kcat.  
It is important to note here, that although it is evident that Thr is utilized as the catalytic 
residue, the position of the conserved Glu50 residue is consistent with several other Hotdog 
fold thioesterases that utilize a Glu as a catalytic residue (Cao et al. 2009; Song et al. 2012; 
Song et al. 2006) (detailed in Chapter 1, section 1.3.4-5).  A total of 15 structures of flK 
have been deposited into the Protein Data Bank (PDB)—10 from Dias et al. and 5 from 
Weeks et al.  Ten of the 15 structures are ligand bound structures containing fragments or 
analogs of FAc-CoA.  However, based on these structures, there is no consensus for ligand 
binding to the active site which is evident from the superimposed ligand structures (Figure 
4.6b).  Both papers attribute FAc-CoA specificity to a conserved arginine residue, Arg120, 
and the minimal protein interactions with the substrate carbonyl (C=O).  This is further 
discussed in the results section of this chapter. 
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Figure 4.6 Structure of FlK (3KX7) and ligands bound at the active site tunnel.  a. Overall 
structure of FlK with each subunit colored in light cyan and blue.  The active site is circled 
C-term helix 
Helical “lid” 
Active sites 
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in red, C-terminal helix in brown, and the helical “lid” in orange. b. Structure superposition 
of all 10 ligand bound FlK structures showing a lack of consensus in binding. 
 
4.1.8  Orthologs of flK with unknown function from M. acetivorans and B. Vulgatus 
Streptomyces cattleya is the only known microbe to encode a pathway for fluorine 
incorporation and biosynthesis of fluorometabolites.  However, a BLAST search of the 
gene flK identifies many orthologs of flK with sequence similarity between 42%-78% 
found in many phyla.  We have selected three flK orthologs from different species to 
characterize structurally and determine their biochemical and in vivo functions.  Selected 
orthologs include Galf1995 from Gallionella capsiferriformans, MA0038 from 
Methanosarcina acetivorans, and BVU1957 from Bacteroides vulgatus.   
Methanosarcina acetivorans is a methane producing microbe found in diverse 
environments including oil wells, trash dumps, deep-sea hydrothermal vents, and oxygen-
depleted sediments beneath kelp beds.  It is the only species of the Methanosarcina genus 
capable of using three separate pathways for methane production including the 
methylotrophic (methanol, methlamines, and methylsulfides), carboxidotrophic, and the 
acetoclastic pathways (Lieber et al. 2014). Bacteroides vulgatus  is an intestinal microbiota 
(Ramanan et al. 2014) and Gallionella capsiferriformans is an iron-oxidizing Gram-
negative bacterium (Emerson et al. 2010; Weiss et al. 2007).  In this chapter, structures of 
the M. acetivorans and B. vulgatus flK orthologs where solved to examine the molecular 
similarities and differences that may contribute to the fluoroacetate specificity seen in S. 
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cattleya.  This project was done collaboration with Lucas Zimney from the University of 
New Mexico who performed the kinetic analyses under the advisement of Dr. Debra 
Dunaway-Mariano.  
 
4.2 Materials and Methods 
4.2.1 Materials 
Purified proteins were obtained from Lucas Zimney.  High-throughput sparse 
factorial crystallization screens used to identify initial hits were purchased through 
Microlytic (MCSG Suite).  Reagents for crystallization were purchased through Hampton 
Research.  Coenzyme A ligand was purchased through Sigma-Aldrich.  Diffraction 
screening and data collection was carried out on our home source X-ray diffractometer 
(Bruker AXS), and beamlines at Stanford Synchrotron Radiation Light Source (SSRL) and 
National Synchrotron Light Source (NSLS). 
4.2.2 Protein preparation  
Proteins expression and purification were done by Lucas Zimney (UNM).  MA0038 
construct contains C-terminus His-tag in a pET-23a(+) vector and was purified via nickel 
affinity column.  Purified protein was stored in buffer containing 50 mM HEPES, 200 mM 
NaCl, pH 6.5.  BVU1957 purification was done by native purification and separated by 
DEAE anion exchange column and size exclusion chromatography.  Purified BVU1957 
proteins were stored in buffer containing 50 mM MES, 200 mM NaCl, pH 6.5.  The buffer 
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conditions were determined using the thermofluor solubility assay (detailed in Chapter 
2.2.6). 
 
4.2.3 Crystallization of MA0038 and BVU1957 
Purified protein was concentrated to 15 mg/mL for initial crystal screening using 
high-throughput sparse factorial crystallization screens by Microlytic (MCSG suite).  The 
MCSG suite contains four sets of 96-well (384 total) crystallization conditions organized 
in order of decreasing crystal productivity derived from crystallization trails of 40,000 
diverse proteins. Crystal hits were first confirmed to be protein crystals from their 
diffraction patterns.  One out of the seven hits resulted in protein diffraction (Figure 4.7).  
This condition was used for optimization.  Protein crystals of BVU1957 were obtained 
using the same protocol as MA0038.  Seven out of the seven hits yielded high resolution 
protein diffraction (Figure 4.8).  
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Hit Condition 
1 0.16 M calcium acetate, 0.08 M sodium cacodylate, 14.4% (w/v) PEG 8000, 
20% (v/v) glycerol, pH 6.5 
2 0.2 M sodium chloride, 0.1 M imidazole, 0.4 M NaH2PO4, 1.4 M K2HPO4, 
pH 8.0 
3 0.1 M sodium cacodylate, 1 M sodium citrate tribasic, pH 6.2 
4 0.05 M Bis-Tris, 45% PPG P 400, pH 6.5 
5 0.2 M calcium chloride, 0.1 M HEPES, 30% (w/v) PEG 4000, pH 7.5 
6 0.2 M sodium acetate, 0.1 M Tris, 30% (w/v) PEG 4000, pH 8.5 
7 0.2 M magnesium chloride, 0.1 M Tris, 30% (w/v) PEG 4000, pH 8.5 
 
Figure 4.7  Crystal hits from MCSG Suite screens for MA0038.  Only the crystallization 
condition from Hit #3 (highlighted in green) resulted in diffraction patterns consistant with 
protein crystals.  Top shows the images of the crystals that correspond to the conditions in 
the table. 
Hit 5 Hit 6 
Hit 2 Hit 4 
Hit 7 
Hit 1 Hit 3 
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Hit Condition 
1 0.1 M Tris, 30% (w/v) Polyethylene glycol monomethyl ether 2,000, pH 8.0 
2 0.1 M Tris, 28% (w/v) Polyethylene glycol 4,000, pH 8.0 
3 10% v/v 2-Propanol, 0.1 M BICINE, 30% (w/v) Polyethylene glycol 1,500, 
pH 8.5 
4 20% v/v 2-Propanol, 0.1 M MES monohydrate, 20% (w/v) Polyethylene 
glycol monomethyl ether 2,000, pH 6.0 
5 10% v/v Polyethylene glycol 200, 0.1 M BIS-TRIS propane, 18% (w/v) 
Polyethylene glycol 8,000, pH 9.0 
6 0.2 M sodium chloride, 0.1 Na2HPO4:KH2PO4, 10% (w/v) PEG 8000, pH 6.2 
7 0.1 M Bis-Tris, 25% (w/v) PEG 3500, pH 6.5 
 
Figure 4.8  Crystal hits from MCSG Suite screens for BVU1957.  All crystals yielded good 
diffraction and all hits, except Hit #6, were in the space group P212121.  The condition used 
for optimization is highlighted in teal. 
1 mm 
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A total of three structures are reported here- wild-type MA0038 unliganded 
structure, wild-type BVU1957 unliganded structure, and wild-type BVU1957 liganded 
structures complexed with CoASH.  MA0038 was purified and concentrated to 15 mg/mL 
in 20 mM HEPES, 200 mM NaCl, pH 6.5 and BVU1957 was concentrated to 15 mg/mL 
in 20 mM MES 200 mM NaCl, pH 6.5.  Optimization of all crystals was obtained using 
the hanging-drop vapor diffusion method using 1.0 μl protein at 10-15 mg/ml and equal 
volume of well solution.  Optimized crystallization condition for MA0038 comprised 0.1 
M sodium cacodylate, 1.1 M sodium citrate, pH 8.0 and were grown at 17 ˚ C.  Most crystals 
formed as small clusters of needles that yielded low quality and poor resolution diffraction 
data (at ~8.0 Å).  The crystal that yielded good quality diffraction was a long rectangular 
shape with dimensions of 0.3 mm x 0.04 mm x 0.04 mm.  Crystals formed within 2-3 days 
but larger crystals continued to grow for up to 4 weeks.  Crystals were then cryo-protected 
using paratone prior to cryo-cooling in liquid nitrogen.  Diffraction data was collected at 
the National Synchrotron Light Source (NSLS) in Brookhaven National Labs on beamline 
X-25. 
Crystals of BVU1957 were grown in 25% PEG3350 and 0.1 M Bis-Tris-HCl, pH 
6.5 at 17˚C.  Large three-dimensional pyramidal crystals formed within 2-3 days with 
dimensions of 1 mm x 0.6 mm x 0.6 mm.  the liganded structure of BVU1957 in complex 
with CoASH was obtained via soaking experiments.  Crystals were soaked with 2 mM 
CoASH for 4 days and 1 hour prior to cryo-cooling, the drop was again saturated with 
additional 5 mM CoASH.  Paratone was used as the cryo-protectant and cryo-cooled in 
liquid nitrogen.  It is worth noting here that crystals soaked with 2 mM CoASH did not 
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yield definitive electron density for ligand in the active site.  However, soaking with 5 mM 
CoASH caused crystals to crack and decompose over time.  Diffraction data for unliganded 
BVU1957 was collected at our home X-ray source, Bruker AXS and CoASH bound 
BVU1957 data was collected via remote access to Stanford Synchrotron Radiation 
Lightsource (SSRL) beamline 12-2. 
 
4.2.4 X-ray data: Collection, data processing, model building and Structure 
Refinement 
Diffraction data for MA0038 was collected using single wavelength (1.1 Å) on 
beamline X-25 at NSLS with a Dectris Pilatus 6M detector.  MA0038 crystals diffracted 
to a resolution of 1.83 Å with unit-cell dimensions of a=41.55 Å, b=85.89 Å, c=164.72 Å, 
α=β=γ= 90˚, in the space group C2221.  The data processing (integration, scaling and 
reduction) was done using HKL2000 (Otwinowskiz & Minor 1997).  Molecular 
replacement was used for phasing using Phenix Phaser-MR (Adams et al. 2010).  The 
Streptomyces cattleya fluoroacteyl-CoA thioesterase (flK) structure (3KX7) was used as 
the MR model (48.3% sequence identity).  Initial model resulted in R-work and R-free of 
0.4789 and 0.4849, respectively.  A resolution cutoff at 2.23 Å significantly improved R-
values due to poor high resolution data beyond 2.20 Å.  The model was refined in Phenix 
with maximum-likelihood target, individual B-factor refinement, simulated annealing and 
finally rigid body refinement. Ordered solvent molecules were added automatically in 
Phenix once R-work reached 0.30.  Iterative rounds of refinement between Phenix Refine 
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and manual refinement in the graphics program COOT lead to a final R-work and R-free 
of 0.2170 and 0.2662, respectively.  
BVU unliganded data was collected to a resolution of 1.39 Å using a Bruker 
MICROSTAR micro-focus rotating anode with Helios optics and Platinum 135 CCD 
detector fitted with a four-circle kappa goniometer, at Boston University, Department of 
Chemistry.  Data was reduced using SAINT (AXS B.S.) and scaled using AXS from the 
PROTEUM2 software suite (AXS B.P).  Unit-cell dimensions of unliganded BVU1957 
crystals were a=46.387 Å, b=64.252 Å, c=83.789 Å, α=β=γ=90˚, and in the space group 
P212121.  The S. cattleya flK structure (3KV8) was used for molecular replacement in 
Phenix Phaser-MR, having 30.9% sequence identity.  Starting refinement R-work and R-
free values were 0.5244 and 0.5295, respectively and refined in Phenix with maximum-
likelihood target and individual B-factor refinement.  Refinement was run with a resolution 
cutoff of 1.66 Å to obtain 91.9% completeness in the highest resolution shell.  Iterative 
rounds of refinement between Phenix Refine and manual refinement in the graphics 
program COOT lead to a final R-work and R-free of 0.1630 and 0.203, respectively.  
The data for BVU in complex with CoASH was collected at SSRL on beamline 11-
1 using single wavelength (0.98 Å) with a Dectris PILATUS 6M detector.  Data was 
collected to a resolution of 1.19 Å.  Unit cell dimensions were similar to unliganded 
BVU1957 crystals, a=46.506 Å, b=64.671 Å, c=83.732 Å, α=β=γ=90˚, and in the same 
space group P212121.  Data was processed using an autoXDS script developed at SSRL 
(Gonzalez and Tsai 2010).  Isomorphous replacement of the unliganded BVU structure was 
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used for phase information.  The data was refined to a resolution cutoff of 1.457 Å due to 
poor completeness in the high resolution shell (30.73%).  The CoASH and pantetheine 
ligand model was made in ChemDraw and the pdb file and constraints were generated 
using Phenix eLBOW (Adams et al. 2010). 
The final models were validated using the RCSB Validation Server. The dihedral 
angles of all residues are within the allowed region of the Ramachandran plot.  Refinement 
statistics and model geometry for all three structures are listed in Table 4.1.  
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Table 4.1 Data collection and refinement statistics.  Statistics for the highest resolution 
shell are shown in parentheses.   
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4.2.5 Steady-State Kinetics 
Activity was measured using the colorimetric thiol detection reagent, the 5,5’-dithio-bis-2-
nitrobenzoic acid (DTNB) assay.  A Shimadzu UV1800 UV Spectrometer was used to 
monitor absorbance at 412mm ( = 13.6 mM-1cm-1) at 25 C in 500 L total reactions.  
Steady-state kinetic assays were performed by Lucas Zimney.   
 
4.3 Results and Discussion 
4.3.1 Overall Structure of MA0038 
The crystal structure of MA0038 was solved in the space group C2221 with unit 
cell dimensions of a=41.55, b=85.89, c=164.72, α=β=γ= 90˚.  The asymmetric unit consists 
of a dimer which also forms the biological quaternary structure in solution, verified by 
analytical size-exclusion chromatography (Figure 4.9a).  The dimerization interface is 
joined by interactions between the two central α-helices and the β5 strand of each monomer 
to extend the β-sheet across both subunits resulting in a ten-stranded β-sheet.  A C-terminal 
lysine side chain amino group, Lys137, anchors the C-terminus α-helix to the adjacent 
subunit by hydrogen bonding to the C=O backbone of Ala81 and the carboxyl group of 
Asp110 located at the connecting loops between β5—β6, and β7—β8, respectively (Figure 
4.9c).  
The MA0038 (143 amino acids) monomer structure possesses the typical 
characteristics of a hotdog-fold with a central five-turn α-helix (α4; residues 43-61) and 
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five antiparallel β-strands (β1-β5-β8-β7-β6) that wrap around the central α-helix.  Unique 
to these minimal hotdog-fold characteristics, MA0038 also possesses an additional 10 
residue, three-turn α-helix in the C-terminus (α9) as well as an elongated 25 amino-acid 
sequence between β1 and α4 that fold into two single turn helices (α2 and α3) joined by a 
five residue loop (Figure 4.9b).  This additional loop segment resembles the helical “lid” 
seen in the structure of the MA0038 ortholog, Flk, from S. cattleya described above, thus 
it will continue to be referred to as the “helical lid” henceforth.  The high substrate 
specificity and preference for small substrates among Flk orthologs can be attributed in 
part to the helical “lid” because of its interactions with the core of the structure.  The lid is 
in a “locked” position over the active site held by six specific interactions that prevent large 
flexible motion of the loop, thus preventing expansion of the active-site pocket.  These 
interactions include four hydrogen bonds formed between side chains Tyr28 and the amide 
backbone of Leu49, backbone carbonyl of Val36 and side chain Gln68, backbones of 
Phe40 and Thr82, and side chain residues of Ser31 and Try52, and Thr43 and His78.  
Additionally, a salt-bridge interaction is formed between Lys22 and Glu30 (Figure 4.10). 
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Figure 4.9  Structure and secondary topology of MA0038.  a. Overall structure of MA0038 
shown as a dimer and colored by peptide chain.  b. topology map of monomer, blue shows 
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α-helices and yellow are β-strands.  The region labeled in red represents the helical lid.  c.  
Interactions between two subunits that form the dimer. 
 
 
 
Figure 4.10 Interactions that anchor the lid over the active site.  The segment colored in 
cyan represents the helical lid and the rest of the protein is colored magenta to show the 
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interactions between the lid residues and the core of the protein.  Residues in sticks are 
amino acids that participate in these interactions. 
 
4.3.2 Overall Structure of BVU_1957 
The overall structure of BVU_1957 closely resembles that of its homologs Flk and 
MA0038.  The crystal structure was solved in the space group P212121 with unit cell 
dimensions of a=46.387 Å, b=64.252 Å, c=83.789 Å, α=β=γ=90˚.  Similar to the MA0038 
structure, the BVU_1957 quaternary structure also forms a dimer joined at the β4-strand 
of each monomer in the asymmetric unit of the crystal and in solution (Figure 4.11).  The 
BVU_1957 (123 amino acids) monomer comprises of a central five-turn α-helix (α3; 
residues 32-50) and five antiparallel β-strands (β1- β4- β7- β6- β5) wrapped around the α-
helix.   BVU_1957 also contains the additional C-terminus helix, albeit a shorter 2-turn α-
helix and a helical “lid” inserted between β1 and α3.  The lid shows one single turn helix 
(α2; residues 19-22) and a long loop connecting α2 and α3 instead of another single turn 
helix.  The smaller lid structure appears to form a smaller substrate binding pocket.  Bond 
interactions between the lid and the rest of the structure reveal more interactions than the 
MA0038 lid contributing to an even more closed active site pocket.  Hydrogen-bond 
interactions include the backbone of Val13 with backbone of Gly73 and Asp74, Asn17 and 
Val12, Gly25 and Met44, Ser24 and Arg110, Gly23 and Asn41, Phe30 and Ser70, and 
Thr32 and His66; and a salt-bridge interaction formed between Asp26 and Lys115 (Figure 
4.12).  
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Figure 4.11  Structure and secondary topology of BVU_1957.  a.  Overall structure of 
BVU_1957 shown as a dimer and colored by peptide chain.  b. topology map of monomer, 
blue shows α-helices and yellow are β-strands.  The region labelled in red represents the 
helical lid.   
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Figure 4.12  Interactions that anchor the lid over the active site of BVU_1957.  The 
segment colored in pink represents the helical lid and the rest of the protein is colored 
yellow to show the interactions between the lid residues and the core of the protein.  
Residues in sticks are amino acids that are participating in these interactions. 
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4.3.4 Structural comparison between flk orthologs  
Four structures of Flk orthologs have been determined by X-ray crystallography.  
The MA0038 from M. acetivorans and BVU_1957 from B. vulgatus were solved and 
described above.  The structure of Flk from S. cattleya, 3KX7 and 3P2R, was solved by 
two groups Dias et al. (Dias et al. 2010) and Weeks et al. (Weeks et al. 2010), respectively.  
Another orthologous structure of TTHA0968, from T. thermophiles was solved by Pioszak 
et al. and deposited in the PDB (2CWZ) but no publication is associated with the structure.  
The pairwise sequence identity between the S. cattleya Flk and other orthologs ranges from 
30%-60% (Figure 4.13).  It should be noted that Flk shares 60.4% sequence identity with 
an ortholog, Galf_1995, from G. capsiferriformans.  Attempts to crystallize this ortholog 
have been unsuccessful as crystals do not produce high quality diffraction (detailed in the 
Appendix).  However, kinetic experiments were performed for comparison of substrate 
preference and a model was generated using Phyre2 (Kelley & Sternberg 2009) for 
structural comparison.  The Phyre2 model of TTHA0968 generated a monomeric hotdog 
domain with r.m.s.d. of 0.82 Å compared to Flk.  A second monomer was generated to 
form the dimeric unit by superimposition using the structure of Flk.  All structures are 
superimposed in Figure 4.14 showing comparable structural features.   
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Figure 4.13  Sequence alignment of Flk orthologs and statistics. a. Sequence alignment of 
5 FlK generated in Escript3.0.  Residues colored in red show 100% conservation, boxed 
and red text show represent similar residues.  Secondary structure topology is labeled above 
the sequence and is based on the Flk structure.  Residues with a star below are the active 
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site residues. b. Table shows pairwise sequence identity between each ortholog and the 
rmsd of the structures.  
 
Figure 4.14  Structural alignment of Flk and 4 orthologs.  Structures of FlK (3KV8) and 
TTHA0967 (2CWZ) are from the PDB; Galf1957 is a model generated using Phyre2; 
MA0038 and BVU_1957 structures solved by X-ray crystallography. 
 
All five structures include a six-turn central α-helix with five antiparallel β-strands 
in the monomer and form a dimer by joining of a β-strand of each subunit by a series of 
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hydrogen bonds to form an elongated sheet.  In the Flk structure, a cysteine disulfide 
(Cys73) covalently joints the two subunits; however, this bond is not conserved in any 
other orthologs discussed.  The pairwise sequence identity and r.m.s.d. of the structures are 
listed in Figure 4.13b.  The major differences between the five structures presented here 
is the varying length in the C-terminus helix and the helical “lid”.  The C-terminal helix of 
BVU_1957 consists of seven amino acid residues to form a 2-turn helix, MA0038, 
Galf_1995, and Flk forms a three-turn helix made up of 12 residues, and TTHA0967 
consists of 17 residues that form a five-turn α-helix.  The helix of each structure is stabilized 
by interactions within the connecting loops between η3 and β2 of one subunit and the 
connecting loop between η2 and α3, β2 and β3, and β4 and β5 of the adjacent subunit (refer 
to sequence alignment Figure 4.13a). 
The most striking difference is the length and secondary structure of the helical 
“lid” between the N-terminal β-strand (β1) and elongated α-helix (α2).  Firstly, the “lid” is 
atypical of the hotdog-fold domain and it is thought to be important in substrate specificity 
as it is positioned over the active site and minimizes the active-site space.  In many hotdog 
thioesterases, the “lid” is replaced by a 10-12 amino acid loop or contains a short single 
turn helix (ie. 1C8U, 1TBU, 1NJK, 3B7K, 2OWN). The helical “lid” of BVU_1957 and 
TTHA0967 has lengths of 19 and 20 amino acid residues.  The BVU_1957 loop contains 
a single-turn α-helix (residues 19-22) while the “lid” of TTHA0967 is comprised of a short 
β-hairpin.  The remaining three structures, Flk, MA0038 and Galf_1957, have a “lid” 
comprised of 25 residues which folds to a helix-hairpin-helix motif.  We use these 
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structural similarities and differences along with kinetic activity to determine the key 
structural features of substrate selectivity.  
The lid interactions of BVU1957 and MA0038 are discussed above showing a 
network of hydrogen bonds and a salt-bridge that anchors the “lid” over the active site.  
However, a similar analysis of the PA1618 structure, which was shown to be a highly 
promiscuous enzyme in chapter 3, revealed minimal interactions in the loop (Figure 4.15).  
PA1618 contains a 12 amino acid flexible loop which accommodates a wide range of 
substrates.  The three interactions formed are within the N- and C-terminus of the loop 
leaving the majority of the loop to “open” or “close” over the active site depending on the 
size and length of the substrate.  To further analyze the flexibility of the “lid”, the three 
structures (MA0038, BVU_1957, and PA1618) were colored by B-factor (Figure 4.16) 
which describes the average displacement of an atom from the mean position.  The more 
flexible an atom is, the greater the B-factor.  In the MA0038 structure, the average Cα B-
factor of the macromolecule is 15.50 Å2 and the B-factor of the “lid” (circled in red) ranges 
between 6.75 Å2 and 17.62 Å2 suggesting that the lid is relatively inflexible.  There is an 
even smaller range of movement was observed in the structure of BVU_1957, where the 
B-factors of the lid have a narrow range between 3.9 Å2 and 9.5 Å2 compared to the average 
B-factor of the protein of 12.6 Å2.  The loop of PA1618 appeared to be relatively flexible 
compared to structures containing a helical “lid”.  The Cα B-factors of the loop region was 
between 20.0 Å2 and 32.5 Å2 compared to the average macromolecule B-factor of 27.4 Å2.  
Together, this observation further suggests that flexibility (or rigidity) in the connecting 
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loop is crucial for substrate identification and the active-site pocket size which is defined 
by the interactions made between the loop and the core of the protein. 
   
Figure 4.15 Structure of PA1618 loop interactions as example of promiscuous enzyme.  
Structure is shown in as ribbon diagram in gray.  The region colored in red is the loop that 
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is positioned over the active site.  Side chains displayed as sticks are residues involved in 
hydrogen bond interactions made between the loop and the core of the protein. 
 
 
Figure 4.16 Ribbon diagrams of MA0038, BVU_1957, and PA1618 structures colored by 
B-factor.  The color spectrum range from red (hot) to blue (cold), where hot represents 
regions of high flexibility and blue represents high rigidity.  The areas circled in red are 
the helical “lid” of MA0038 and BVU_1957, and the loop of PA1618.  
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4.3.5 Kinetic comparison  
Thioester hydrolysis activity was measured to determine the kcat and Km values of 
each enzyme toward the substrate FAc-CoA and structurally similar substrates, acetyl-CoA 
and formyl-CoA (Table 4.2).   All enzymes, with the exception of BVU_1957, have 
activity within a physiologically relevant range of kcat/Km for FAc-CoA between 10
3-105 
M-1s-1.  Flk, MA0038 and TTHA0967 show high preference and specificity for FAc-CoA 
over acetyl-CoA, with a three to four order of magnitude difference. The catalytic 
efficiency of these enzymes towards FAc-CoA and acetyl-CoA is mostly affected by the 
change in Km rather than kcat, suggesting that fluorine is important for substrate binding.  
Galf_1995 show reasonable activity towards all substrates, though it showed slightly 
higher preference for formyl-CoA, followed by FAc-CoA.  BVU_1957, however, showed 
no detectable activity towards acetyl-CoA hydrolysis, some activity for FAc-CoA and, 
interestingly, very high activity for formyl-CoA.   
The active site of Flk and its orthologs are comprised of a catalytic triad including 
highly conserved Thr, Glu, and His.  Previous reports ascribed Thr42 of Flk as the catalytic 
nucleophile.  However, recent detailed mechanistic studies suggest an acyl-enzyme 
intermediate with Glu50 in which His76 is involved in the Cα deprotonation.  In this 
proposed mechanism, the role of Thr42 is to stabilize the hydrogen bonding network 
between Glu50 and His76 (Weeks et al. 2015).  Two mutants in MA0038 were generated, 
Thr43A and E51A, to test the importance of active site residues in catalysis.  However, the 
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results were ambiguous for determination of catalytic residues as both mutants appeared to 
be catalytically dead. 
 
Table 4.2 Steady-state kinetic parameters of FlK, MA0038, Galf_1995, TTHA0967, and 
BVU_1957 for comparison of substrate preference.   
 
4.3.6 Structure of BVU_1957 in complex with CoASH 
 Attempts to obtain ligand bound structures of BVU_1957 to study the substrate-
enzyme interactions at the active site proved to be a challenge.  Both methods of co-
crystallization and soaking were tried with acetyl-Od-CoA and acetyl-CoA.  The acetyl-
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Od-CoA is a substrate analog of acetyl-CoA where the thioester bond is replaced by an 
ester to prevent thioester hydrolysis.  Additionally, crystallization of wild-type BVU_1957 
with acetyl-CoA was attempted because kinetic experiments showed undetectable activity 
for acetyl-CoA (Table 4.2).  Even though no catalytic activity is seen with acetyl-CoA, 
BVU_1957 does hydrolyze the thioester bond of FAc-CoA, therefore acetyl-CoA seemed 
to be a good substrate analog for active-site binding.  Other substrate analogs including 
fluoroacetyl-Od-CoA and formyl-Od-CoA synthesis is in progress and is being carried out 
by Lucas Zimney.   
 A total of 44 X-ray crystallographic data sets of BVU_1957 crystals containing 
acetyl-Od-CoA, acetyl-CoA or CoASH ligand were collected and processed.  However, all 
but one data set, showed partial and noncontiguous density for the substrate at best.  In 
many cases, there was continuous density spanning the distance of a 3 to 4-carbon acyl 
chain where the pantetheine binds at the dimer interface “tunnel”.  Unfortunately, when the 
pantetheine moiety was modeled into this density, the structure refinement statistics 
worsened suggesting a poor fit.  
 One crystal structure of BVU_1957 in complex with CoASH was obtained showing 
continuous density for the entire pantethine moiety.  This structure was determined to a 
resolution of 1.19 Å and was solved in the space group P212121 with unit cell dimensions 
similar to those of the unliganded structure.  The r.m.s.d. between the CoASH liganded 
structure and the unliganded BVU_1957 structure is 1.09 Å with minimal change in the 
overall structure (Figure 4.17).   
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Figure 4.17 Structure of BVU_1957 with CoASH bound at the active site.  a. Unliganded 
(subunit A in light blue and subunit B in gray) and liganded (subunit A in tan and subunit 
B in magenta) structures of BVU_1957 superimposed showing little change in the overall 
structure.  b. Active sites of BVU_1957 with active-site residues and ligands shown as 
sticks.  Electron density of ligand omit map displayed at 1.0 sigma in grey mesh.  CoASH 
is modeled into the electron density in active site 1 and pantetheine is modeled into the 
density in active site 2. 
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Two ligands were modelled into this structure at the opposing ends of the active 
site.  One molecule of CoASH was modelled between the C-terminus of the central α-helix 
and connecting loop of subunit A and the middle segment of the central α-helix of subunit 
B (active site 1) (Figure 4.17a and c).  The second ligand model is a truncation of CoASH 
where only the pantetheine moiety is used as a model (active site 2).  This ligand is 
positioned at the “tunnel” of the dimer interface between the C-terminus of the central α-
helix of subunit B and middle segment of the subunit A central α-helix.  Although only 
CoASH ligand was added during crystallization, no density was present for the 
pyrophosphate and the adenosine nucleotide at either active-site positions.  In active site 2, 
however, only pantetheine was modeled into the existing density because a symmetry mate 
molecule is positioned to sterically block most possible conformations.  Since there is no 
density and no apparent order in the adenosine diphosphate moiety, it was omitted from 
the model (Figure 4.18).  The pyrophosphate moiety is often hydrogen bonded to residues 
of an adjacent dimer, often seen in tetramers with a back-to-back or front-to-front 
formation.  Since BVU1957 is a dimer and does not form any crystallographic tetramers, 
we do not expect to see density for the pyrophosphate.  
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Figure 4.18  Structure of BVU1957 dimer (subunits colored in magenta and yellow) and 
symmetry mate (in grey) shown in ribbons.  An electrostatic surface map is displayed at 
50% transparency showing one of the active sites is blocked by the adjacent symmetry 
mate and the opposing active site is open to solvent. 
 
4.3.7 Active site pocket comparison between ligands of all FlK bound 
In addition to specific side chain interactions dictating the specificity for a 
fluorinated carbon over a –CH3, this class of enzymes are also highly specific for small 
leaving groups due to the substrate binding pocket size.  The helical “lid” interactions 
formed over the active site prevented flexibility in the active-site pocket.  Thus, we looked 
at differences in the active-site binding pocket of each ortholog.  To calculate the size of 
the binding pocket and determine the area and volume, online server CASTp (Computed 
Atlas of Surface Topography of proteins) was used (Dundas et al. 2006).  The algorithm 
identifies surface and interior pockets and analytically calculates the area and volume of 
90˚ 
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each pocket or cavity using 1.4 Å radius spheres to identify regions of accessibility.  In 
each of the calculations, the areas (Å2) and volumes (Å3) determined were similar with the 
exception of BVU_1957 (Figure 4.19a).  The area and volume of BVU_1957 is about half 
that of the Flk and other orthologs, suggesting perhaps a smaller binding pocket for 
substrates.  This is in agreement with kinetic data as BVU_1957 shows high activity for 
formyl-CoA (5.7 X 107 M-1s-1) which is five orders of magnitude greater than the 
hydrolysis of FAc-CoA (6.3 X 102 M-1s-1).  The difference in catalytic efficiency is 
contributed by both the kcat and Km, but is mostly affected by the substrate binding as the 
Km of FAc-CoA (96 μM) is 1,600-fold greater than Km for formyl-CoA (~ 60 nM).  
Similarly, the van derWaals surface map showing pockets and cavities generated in PyMol 
show a similar trend (Figure 4.19b).  These surface maps are used for fitting of ligands at 
the active site to generate substrate bound models. 
209 
 
 
 
 
210 
 
 
 
Figure 4.19  Structural comparison of active site cavities in Flk and orthologs. a. Each 
structure is shown in gray ribbons with analytically measured active site area (Å2) and 
volume (Å3) (in table) based on cavity space filling using spherical probes of 1.4 Å radius.  
b. respective structures shown as ribbons with 50% transparency and pockets and cavities 
shown in electrostatic surfaces.   
 
4.3.8 Ligand bound active site 
To analyze the substrate binding pockets of Flk orthologs, model of ligands bound 
to the enzyme at the active sites were generated.  Models were made using the CoASH 
bound BVU structure as guidance for ligand fitting at the active site.   
MA0038 and Flk superimpose  with an relatively low r.m.s.d. of 1.28 and share 
similar kinetic parameters.  The active-site residues (His78, Thr43, and Glu51 of MA0038) 
align identically, except that Glu51 is shifted by 1.0 Å .  Fitting of a FAc-CoA molecule 
into the active site cavity shows a distance of 2.8 Å between Glu51 and the Cα of the ligand 
suggesting the ligand model is in reasonable conformation to form the Michaelis complex.  
Though this model is not sufficient to propose a mechanism, it can be used to assess the 
active site pocket to analyze substrate specificity.  The ligand model fit well in the tunnel 
leading to the active site, but interestingly, an unoccupied space in the pocket suggested 
that MA0038 may be active for slightly larger substrates.  Therefore, MA0038 was 
subjected to a large substrate screen (Chapter 5), where the enzyme was tested for 
thioesterase activity against a library of ~50 different CoA substrates.  Results further 
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proved the specificity of the enzyme for FAc-CoA and low activity for acetyl-CoA, but 
also identified a new substrate, acetoacetyl-CoA, with some hydrolysis activity.  Modelling 
of acetoacetyl-CoA was into the active site filled the unoccupied space (Figure 4.20a). 
Next, we examined the solvent channel of the BVU_1957 structure.  Kinetic 
experiments showed BVU_1957 was most active for formyl-CoA, and some detectable 
activity for FAc-CoA, but not acetyl-CoA.  In the active site pocket volume calculation, 
BVU_1957 also had the smallest volume in comparison to other orthologs, which is in 
agreement with the kinetic profile.  The ligand formyl-CoA was modeled into the active 
site in the same conformation of FAc-CoA used in the MA0038 model.  The formyl-CoA 
substrate fills the allowable space of the active site with minimal space for larger substrates 
(Figure 4.20b). 
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Figure 4.20  Active site with ligand bound models. a. Ribbon diagram and active site 
surface of superimposed FlK (in magenta) and MA0038 (in light orange) with the 
structures shown with 50% transparency.  Side chains of active site residues are shown as 
sticks and numbered according to position of FlK and MA0038 in parenthesis.  Ther two 
ligands modeled into the pocket are acetoacetyl-CoA (cyan) and fluoroacetyl-CoA 
(yellow).  b. Green transparent ribbon of BVU1957 with active site pocket surface shown.  
Side chains in green sticks are active-site residues.  Ligand formyl-CoA (in olive green) is 
modeled into the active site. 
 
4.3.9 Bioinformatics for functional annotation  
The gene neighborhoods of the selected Flk orthologs were analyzed for functional 
annotation.  Ten genes upstream and downstream of the Flk ortholog gene were mapped 
(Figure 4.21).  Unfortunately, no obvious functional information was extracted from this 
analysis.  Most genes in the MA0038 gene cluster are unannotated with few exceptions of 
genes related to tRNA synthesis, a peptidase (sec11), binding proteins (Erf1 and MA0037), 
and pyruvate synthesis pathway proteins.  
Surrounding genes of Galf_1995 suggests involvement in the arginine metabolism 
pathway.  Galf_1995 may function as an acetyl-CoA thioesterase housekeeping gene to 
regulate and maintain the cellular equilibrium concentration between acetyl-CoA and free 
CoASH.  This may explain the high observed Km (230 μM) in the in vitro kinetic 
experiments because high cellular concentrations of acetyl-CoA are required for many 
214 
 
 
 
pathways and CoA is the main downstream metabolite of carbon sources.  Although the 
Km for FAc-CoA and formyl-CoA is in the low micromolar range, 9.5 μM and 7.6 μM, 
respectively, cellular concentrations of these molecules are also found in much lower 
concentrations. 
A number of genes surrounding TTHA0957 from T. Termaphilus functions in the 
phenylacetic acid degradation pathway.  However, the role of TTHA0957 remains 
unknown as it did not have any activity for the hydrolysis of phenylacetyl-CoA (tested by 
Lucas Zimney; data not shown).  Because surrounding genes are predicted to be involved 
in the phenylacetic acid degradation pathway and have not been experimentally 
characterized, one possibility is that the entire putative phenylacetic acid degradation 
pathway gene cluster was copied from an ancestoral gene but the gene has evolved to 
produce enzymes with different substrate specificity. Gene neighborhood analysis of 
BVU_1957 of B. vulgatus, was also inconclusive.  However, one hypothesis based on the 
structural and kinetic studies conducted here suggests BVU_1957 is a formyl-CoA 
thioesterase that produces CoASH and formic acid which may be an alternate source of the 
one-carbon pool. 
215 
 
 
 
   
216 
 
 
 
Figure 4.21  Gene context of FlK orthologs for functional analysis.  The hotdog 
thioesterase gene is marked in red and the upstream and downstream ten genes are mapped.  
Most genes are unannotated and some have predicted functions.  The known or predicted 
functions for surround genes are from NCBI gene annotation.  a.  MA0040 (tRNA-
modifying protein); Erf1 (peptide chain release factor 1); argS (arginyl-tRNA synthetase); 
MA0037 (DNA polymerase II small subunit); Sec11 (signal sequence peptidase); porA, 
porB, porD, porG (pyruvate synthesis pathway enzymes). b. Galf_1986 (response regulator 
receiver protein); Galf_1987 (integral membrane protein MviN); Galf_1989 (30S 
ribosomal protein S20); Galf_1990 (acetylornithine and succinylornithine 
aminotransferase); Galf_1991, Galf_1992 (ornithine carbamoyltransferase); Galf_1996 
(argininosuccinate synthase); Galf_2000 (DJ-1 family protein); Galf_2002 (OsmC family 
protein); Galf_2003 (decaheme-associated outer membrane protein); Galf_2004 
(decaheme c-type cytochrome, DmsE family); Galf_2005 (cytochrome class I).  c.  
TTHA0957 (dihydrodipicolinate synthase); TTHA0958 (bifunctional 2-hydroxyhepta-2,4-
diene-1,7-dioate isomerase/5-carboxymethyl-2-oxo-hex-3-ene-1,7-dioate decarboxylase); 
TTHA0959 (5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase); 
TTHA0950 (4-hydroxyphenylacetate-3-hydroxylase); TTHA0962 (homoprotocatechuate 
2,3-dioxygenase); TTHA0965, TTHA0969, TTHA0970, TTHA0971 (phenylacetic acid 
degradation protein PaaI, PaaD, PaaC, PaaB, respectively); TTHA0966 (phenylacetyl-CoA 
ligase); TTHA0968 (bifunctional aldehyde dehydrogenase/enoyl-CoA hydratase); 
TTHA0973 (TetR family transcriptional regulator). d. BVU_1948 (transcriptional 
regulator); BVU_1949 (dihydrofolate reductase); thyA (thmidylate synthase); BVU_1952 
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(RNA polymerase ECF-type sigma factor); BVU_1954 (tRNA and rRNA cytosine-C5-
methylase); BVU_1955 (DNA topoisomerase); BVU_1958 (helicase); BVU_1959 
(aconitate hydratase); BVU_1961 (citrate synthase); BVU_1964 (3-oxo-5-alpha-steroid 4-
dehydrogenase); BVU_1965 (NADH:Flavin oxidoreductase); BVU_1966 
(oxidoreductase).  
 
 4.4 Conclusion 
The FAc-CoA thioesterase, Flk, is a remarkably specific enzyme found in S. 
cattleya.  It catalyzes the thioesterase reaction of FAc-CoA to produce CoASH and 
fluoroacetate.  In S. cattleya, Flk plays a very specialized function in preventing host 
toxicity by metabolizing FAc-CoA before entry into the TCA cycle.  Importantly, it is 
capable of recognizing and selecting against acetyl-CoA despite its cellular abundance and 
availability to accept acetyl-CoA (2mM in cells) as a substrate(Weeks et al. 2015).  
Additional evidence to suggest the biological role of Flk is that the gene is co-localized in 
the organofluorine secondary metabolite biosynthetic pathway.  Interestingly, S. cattleya 
is the only known organism to have this pathway, yet the Flk gene is conserved in many 
organisms.  The four evolutionary distinct FlK orthologs selected in this study gave insight 
to the unique structural differences in this class of hotdog enzymes that contribute to 
specificity.   
 A commonality shared between all Flk homolog structures is the addition of an 
elongated loop sequence termed the helical “lid” that is positioned over the active site to 
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create a small, enclosed acyl binding pocket.  Although mechanistic studies are required to 
determine fluorine specificity, the structures reveal an inflexible lid which sterically 
prevents acyl groups of more than three carbon atoms long to fit in the active-site pocket.  
In particular, BVU_1957 had the smallest binding pocket with high hydrolytic activity 
towards formyl-CoA.  Notably, all orthologs are active for formyl-CoA and FAc-CoA but 
select against acetyl-CoA suggesting all the orthologous enzymes evolved from a common 
formyl-CoA thioesterase ancestor. 
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Chapter 5: 
Development of high-throughput thioester substrate assay for the determination of 
substrates for unannotated Hotdog Fold Thioesterases 
5.1 Introduction 
5.1.1 Need for high throughput substrate determination method and goals 
 Advances in genome sequencing have led to rapidly growing identification of novel 
Hotdog fold thioesterase genes.  To date, ~88,000 have been predicted to be Hotdog 
thioesterases found throughout all branches of life.  In the past decade, the number of 
predicted hotdog fold thioesterase increased by sixty-fold.  In 2004, Dillon, S. et al. 
reported 1,357 hotdog thioesterases (Dillon & Bateman 2004).  The vast majority of these 
genes are completely unannotated.  In the case of most enzyme superfamilies, there is a 
lack of high throughput annotation methodology to meet the demands of the increasingly 
large genome database.  Currently, there is no high throughput method for functional 
annotation of uncharacterized hotdog thioesterases.   
            Hotdog thioesterase hydrolyze the thioester bond of an acyl-CoA (or holo-ACP) to 
produce an organic acid and a free CoASH (or holo-ACP).  For the purpose of this study, 
we focus on substrates that contain CoA instead of holo-ACP due to the stability and 
availability of CoA substrates relative to holo-ACP substrates.  It should be noted that from 
structural studies, binding is minimally affected by the adenosine nucleotide of CoA or 
ACP of holo-ACP as these components sit on the “outside” of the protein (Cao et al. 2009; 
Kotaka et al. 2009; Song et al. 2012; Nguyen et al. 2014).  Therefore, we expect that the 
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acyl-holo-ACP thioesterases will also act as acyl-CoA substrates, albeit to a lesser extent, 
as CoA retains only the pantheteine and acyl group required for binding to the enzyme.   
 Many metabolic pathways involve the ligation of a CoASH which represents the 
“activated state” of the molecule for biosynthesis, degradation, or intracellular trafficking 
(Chapter 1).  Thus, the thioesterase activity marks the termination step of the pathway.  In 
addition to uncharacterized enzymes, many metabolic pathways involving CoA activation 
remain unknown.  Many pathways are unique to microbes and plants that do not exist in 
higher organism eukaryotes.  The wide range in acyl-CoA substrates that the Hotdog fold 
can catalyze, including halogenated compounds, makes these enzymes of particular interest 
for studying how nature selects and reacts on such molecules. 
 The study presented here entails the design of a high throughput thioesterase 
activity screening method to determine substrates of uncharacterized enzymes.  Enzymes 
were selected by the generation of a sequence similarity network (SSN).  These selected 
targets are expressed and purified for assaying and results are subsequently mapped to the 
SSN.  The overall goal of this study is to annotate the superfamily for its in vitro function 
and biological range. 
 
5.1.2 Factors to consider for high throughput screening 
 Many factors must be taken into consideration when designing a high throughput 
screen (HTS).  First and foremost, the assay must be robust and sensitive.   Requirements 
for HTS development include relevant selection of enzymes and substrates to be screened, 
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protein production and purification method, a buffer condition that is suitable for most 
enzymes, characterization of any required cofactors, and choice of detection technology.   
 High throughput assay development for substrate determination of enzymes can be 
achieved by one of three methods.  The assay can be designed to either detect substrate 
depletion, product formation or direct binding of the E-S complex (Figure 5.1) (Acker & 
Auld 2014).  Detection of substrate depletion using an enzyme activity assay can be 
monitored by some method of substrate detection in which the remaining substrate at the 
end of an assay is quantifiable.  Similarly, increase in product formation requires a 
detectable readout for the product.  For example, many kinase and phosphatase HTSs have 
been development using quantifiable phosphate detection assays (Chen 2009).  
Furthermore, development of HTSs has been done by competitive displacement binding 
methods in which a radiolabeled or fluorescently labeled known substrate or inhibitor is 
used as a competitive ligand to determine binding affinities of screened compounds 
(Guarnieri et al. 2011).  Readout methods can include radiolabeling, fluorescence 
activation (Mastrobattista et al. 2005), UV-Vis absorption (He & Yeung 2003), or 
colorimetric detection (Furubayashi et al. 2014; Jimsheena & Gowda 2009).  Importantly, 
the assay should be universal to all enzymes or compounds to be screened. 
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Figure 5.1 Detectable species used to measure enzyme activity, where P is the detection 
of product, E0 is the unbound enzyme, ES is the enzyme-substrate complex and S is the 
substrate. 
 
 The form of enzyme being targeted must be well understood.  In all biochemical 
experiments, where the enzyme of interest is purified and isolated from its native 
environment, the stability and activity of the enzyme can be significantly affected.  In the 
cellular context, the enzyme is likely to be in a crowded environment in which it is 
continuously participating in transient interactions with other protein binding partners or 
metabolites that aid in the stability and regulation of the enzyme (Ellis 2001; Senske et al. 
2014).  When taken out of its native environment and subjected to purification protocols, 
stability is often compromised.  This presents one of the most challenging steps in 
biochemistry and more so for high throughput protein production.  It is also important to 
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know the enzyme class and whether cofactors are involved in enzyme activity or structural 
integrity.  Additionally, the purity of the enzyme must be assessed to ensure that 
contaminants do not contribute to the calculation of enzyme concentration or affect the 
enzyme activity.  This is often achieved by mass spectrometry which can both confirm the 
existence of contaminants and verify the expected mass of the protein of interest (Mann et 
al. 1993).  Effects of the compound vehicle need to be considered.  Many organic 
compounds for screening have poor solubility in water or aqueous buffer; therefore, they 
are often stored in polar organic solvents like dimethylsulfoxide (DMSO) or methanol 
(Acker & Auld 2014).  However, these solvents can have an effect on enzyme activity and 
should be tested.  Additionally, determining an appropriate substrate concentration is 
crucial in the design of a HTS.  The detection range or the sensitivity of the assay must be 
considered. 
 The work presented here is the development of a HTS to measure the activity of 
>50 substrates simultaneously.  Three assays that measure thiol concentration were first 
tested for a suitable assay for the measurement of acyl-CoA hydrolysis.  Ultimately, 
Ellman’s reagent was chosen for use in the HTS and the assay using that reagent was 
optimized.  We show the results of 42 previously uncharacterized Hotdog thioesterases 
subjected to the HTS and demonstrate the substrate range and promiscuity of the enzyme 
family.  
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5.2 Materials and Methods 
5.2.1 Materials 
 All compounds including DTNB and CoA substrates were purchased through 
Sigma Aldrich and Avanti Polar Lipids.  SpectraMax M5 from Molecular Devices was 
used for absorbance measurements.  All other equipment used for assays were purchased 
through Fisher Scientific.  Thiolyte, a monobromobimane reagent, was purchased through 
EMD Millipore.  Thiol and Sulfide Quantitation Kit (papain assay) was purchased through 
Invitrogen.  
 
5.2.2 Sequence similarity network generation and target selection 
 Sequence similarities networks (SSN) were generated by an all-by-all blast of the 
Hotdog domain superfamily using UIUC BioClusters.  Sequences and superfamily 
members were defined and obtained through Pfam and InterPro.  The thioesterase 
superfamily SSN was generated using InterPro ID IPR006683 at an e-value of e-30 and e-50 
with sequence length cutoff of 250 amino acids to exclude multi-domain sequences.   
 
5.2.3 Protein preparation  
A list of protein targets were sent to the protein core facility at Albert Einstein 
College of Medicine headed by the Almo Lab, where a streamlined method for protein 
production is implemented.  Genes were cloned in pSGC23 vectors containing a 6X-His 
tag and tested for expression in E. coli BL21(DE3) cell strain.  Proteins that failed the 
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expression test were considered “fail” and those that expressed were further purified via 
Ni2+ affinity column.  Purified protein product was confirmed via mass spectrometry. 
 
5.2.4. Substrate preparation 
 All substrates used in this screen were purchased through Sigma Aldrich and Avanti 
Polar Lipids (Table 5.1).  Substrates were purchased in small quantities (1-5 mg) to ensure 
a relatively fresh batch of substrate was being used at the time of screening.  All substrates 
were resuspended in a buffer containing 50 mM Hepes pH 7.6, 100 mM NaCl and 10% 
DMSO to a stock concentration of 10 mM for storage.  
 
 substrate Mol. Wt. 
 short chain fatty acids (1-6) saturated  
1 Acetyl coenzyme A sodium salt 809.57 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(C)=O)=O)=O)([O-
])=O)([O-])=O 
 
2 n-Propionyl coenzyme A lithium salt 823.6 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC)=O)=O)=O)([O-
])=O)([O-])=O 
 
3 Butyryl coenzyme A lithium salt hydrate 833.59 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(C4=CC=CC=C4)=O
)=O)=O)([O-])=O)([O-])=O 
 
4 Hexanoyl coenzyme A trilithium salt hydrate 901.49 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCC)=O)=O)=O)([O
-])=O)([O-])=O 
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 branched fatty acids  
5 Acetoacetyl coenzyme A sodium salt hydrate 851.61 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC(C)=O)=O)=O)=O)([
O-])=O)([O-])=O 
 
6 DL-3-Hydroxy-3-methylglutaryl coenzyme A sodium salt hydrate 955.62 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC(C)(O)CC(O)=O)=O
)=O)=O)([O-])=O)([O-])=O 
 
7 DL-β-Hydroxybutyryl coenzyme A lithium salt 853.62 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC(O)C)=O)=O)=O)([O
-])=O)([O-])=O 
 
8 Glutaryl coenzyme A lithium salt 881.63 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCC(O)=O)=O)=O)=
O)([O-])=O)([O-])=O 
 
9 Isobutyryl coenzyme A lithium salt 837.62 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(C(C)C)=O)=O)=O)([O-
])=O)([O-])=O 
 
10 Isovaleryl coenzyme A lithium salt hydrate 851.65 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC(C)C)=O)=O)=O)([O
-])=O)([O-])=O 
 
11 Malonyl coenzyme A lithium salt 853.58 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC(O)=O)=O)=O)=O)([
O-])=O)([O-])=O 
 
12 Methylmalonyl coenzyme A tetralithium salt hydrate 891.34 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(C(C)C(O)=O)=O)=O)=
O)([O-])=O)([O-])=O 
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13 
Succinyl coenzyme A sodium salt 867.61 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCC(O)=O)=O)=O)=O)
([O-])=O)([O-])=O 
 
14 β-Methylcrotonyl coenzyme A lithium salt 849.63 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(/C=C(C)/C)=O)=O)=O)(
[O-])=O)([O-])=O 
 
   
 short chain fatty acids (1-6) unsaturated  
15 Crotonoyl coenzyme A trilithium salt 853.41 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(/C=C/C)=O)=O)=O)([O
-])=O)([O-])=O 
 
   
 medium chain fatty acids (7-15) saturated  
16 Decanoyl coenzyme A monohydrate 939.8 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCC)=O)=O)
=O)([O-])=O)([O-])=O 
 
17 Lauroyl coenzyme A lithium salt 955.77 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCC)=O)=
O)=O)([O-])=O)([O-])=O 
 
18 Myristoyl coenzyme A lithium salt 977.89 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCC)=
O)=O)=O)([O-])=O)([O-])=O 
 
19 Octanoyl coenzyme A lithium salt hydrate 893.73 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCC)=O)=O)=O)
([O-])=O)([O-])=O 
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20 tridecanoyl Coenzyme A (ammonium salt) 1014.38 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCC)=O)
=O)=O)([O-])=O)([O-])=O 
 
21 pentadecanoyl Coenzyme A (ammonium salt) 1042.41 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCC)
=O)=O)=O)([O-])=O)([O-])=O 
 
   
 long chain fatty acids (16-26) saturated  
22 Palmitoyl coenzyme A lithium salt 1004.94 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
)=O)=O)=O)([O-])=O)([O-])=O 
 
23 n-Heptadecanoyl coenzyme A lithium salt 1019.97 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
C)=O)=O)=O)([O-])=O)([O-])=O 
 
24 Stearoyl coenzyme A lithium salt 1034 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CC)=O)=O)=O)([O-])=O)([O-])=O 
 
25 nonadecanoyl Coenzyme A (ammonium salt) 1098.47 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CCC)=O)=O)=O)([O-])=O)([O-])=O 
 
26 arachidoyl Coenzyme A (ammonium salt) 1112.49 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
27 henarachidoyl Coenzyme A (ammonium salt) 1126.5 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CCCCC)=O)=O)=O)([O-])=O)([O-])=O 
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28 docosanoyl Coenzyme A (ammonium salt) 1140.52 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CCCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
29 tricosanoyl Coenzyme A (ammonium salt) 1154.53 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CCCCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
30 Arachidonoyl coenzyme A lithium salt 1053.99 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCC/C=C/C/C=C/C/C=
C/C/C=C/CCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
31 pentacosanoyl Coenzyme A (ammonium salt) 1182.57 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CCCCCCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
32 hexacosanoyl Coenzyme A (ammonium salt) 1196.58 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
CCCCCCCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
33 diphytanoyl Coenzyme A (ammonium salt) 1112.49 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC(C)CCCC(C)CCCC(
C)CCCC(C)C)=O)=O)=O)([O-])=O)([O-])=O 
 
34 α-hydroxy octadecanoyl Coenzyme A (ammonium salt) 1100.45 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(C(O)CCCCCCCCCCC
CCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
   
 long chain fatty acids (16-26) unsaturated  
35 Palmitoleoyl coenzyme A lithium salt 1003.93 
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O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCC/C=C/CCCC
CC)=O)=O)=O)([O-])=O)([O-])=O 
 
36 (10Z-heptadecenoyl) Coenzyme A (ammonium salt) 1068.43 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCC/C=C\CCC
CCC)=O)=O)=O)([O-])=O)([O-])=O 
 
37 (6Z-octadecenoyl) Coenzyme A (ammonium salt) 1082.44 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCC/C=C\CCCCCCC
CCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
38 (9Z-octadecenoyl) Coenzyme A (ammonium salt) 1082.44 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCC/C=C/CCCC
CCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
39 (11Z-octadecenoyl) Coenzyme A (ammonium salt) 1082.44 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCC/C=C\CC
CCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
40 Linoleoyl coenzyme A lithium salt 1029.96 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCC/C=C/C/C=C
/CCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
41 (9Z, 12Z, 15Z-octadecatrienoyl) Coenzyme A (ammonium salt) 1078.41 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCC/C=C/C/C=C
/C/C=C/CC)=O)=O)=O)([O-])=O)([O-])=O 
 
42 (6Z,9Z,12Z-octadecatrienoyl) Coenzyme A (ammonium salt) 1078.41 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCC/C=C/C/C=C/C/C
=C/CCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
43 (5Z,8Z,11Z,14Z-eicosatetraenoyl) Coenzyme A (ammonium salt) 1104.43 
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O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCC/C=C\C/C=C/C/C=
C/C/C=C/CCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
44 (5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl) Coenzyme A (ammonium salt) 1103.06 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCC/C=C\C/C=C/C/C=
C/C/C=C/C/C=C/CC)=O)=O)=O)([O-])=O)([O-])=O 
 
45 docosahexaenoyl Coenzyme A (ammonium salt) 1128.43 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC/C=C\C/C=C/C/C=C
/C/C=C/C/C=C/C/C=C/CC)=O)=O)=O)([O-])=O)([O-])=O 
 
46 (15Z-tetracosenoyl) Coenzyme A (ammonium salt) 1166.53 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCC/C
=C/CCCCCCCC)=O)=O)=O)([O-])=O)([O-])=O 
 
   
 aromatic   
47 Benzoyl coenzyme A lithium salt 871.64 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(C4=CC=CC=C4)=O)=O
)=O)([O-])=O)([O-])=O 
 
48 Phenylacetyl coenzyme A lithium salt 885.67 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CC4=CC=CC=C4)=O)=
O)=O)([O-])=O)([O-])=O 
 
   
 derivatives  
49 04:0 Pyrene Coenzyme A 1088.3 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCC4=CC5=CC=CC6
=C5C7=C4C=CC=C7C=C6)=O)=O)=O)([O-])=O)([O-])=O 
 
50 12:0 Biotinyl Coenzyme A 1241.45 
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O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCNC(C
CCCC4C(NC(N5)=O)C5CS4)=O)=O)=O)=O)([O-])=O)([O-])=O 
 
51 16-NBD-16:0 Coenzyme A 1234.44 
 
O[C@@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)[C@H](OP([O-])([O-
])=O)[C@H]3COP(OP(OCC(C)(C)C(O)C(NCCC(NCCSC(CCCCCCCCCCCCCCC
NC4=CC=C([N+]([O-])=O)C5=NON=C45)=O)=O)=O)([O-])=O)([O-])=O 
 
Table 5.1 List of substrates in the HTS with molecular weight and SMiLES string.  Refer 
to appendix section 3 for structure and chemical description of substrates.  
 
5.2.5 Substrate screening assay 
 High throughput substrate screens were performed in 384-well format.  All assays 
were done in duplicate.  Each well contained a different substrate at a final concentration 
of 200 μM and 1 mM DTNB.  Prior to the addition of enzyme, an absorbance reading at 
A410 was performed for background subtraction.  Enzyme was added to a final 
concentration of 10 μM to each well.  The total volume of each reaction was 20 μl.  The 
absorbance at A410 was monitored immediately after addition of enzyme over 10 minutes 
with one measurement per minute using a SpectraMax M5 plate reader.  The enzyme 
activity curves were plotted as absorbance as a function of time. 
 
5.3 Results and Discussion 
5.3.1 Hotdog Fold network and target selection 
The goal of the HTS was to functionally annotate a selection of Hotdog enzymes 
to represent the majority of the superfamily for which we could begin to assign function to 
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other uncharacterized enzymes based on its related orthologs.  In order to select an unbiased 
representation of the superfamily, we exploited the use of sequence similarity networks 
(SSN) to easily visualize the sequence relationship in proteins.  An initial SSN was 
generated using the Enzyme Function Initiative (EFI) Biocluster at the University of 
Illinois.  This network was generated using sequences defined by the InterPro Thioesterase 
superfamily (IPR006683), a subdivision of the Hotdog domain (IPR029069), which 
includes 88,551 protein sequences.  Within the thioesterase superfamily, ~81,396 proteins 
contain a single Hotdog fold domain, ~879 proteins contain tandem hotdog domains, and 
~4,874 are fusion proteins containing a DNA binding and kinase domain.  The remaining 
proteins include fusion domains containing HAD domains, transcriptional regulator 
domains, transporters, and nucleotide binding domains to name a few.  
The dataset was created by importing the thioesterase superfamily sequences into 
the Biocluster to conduct an all-by-all BLAST of the 88,551 protein sequences.  Parameters 
used to run the all-by-all BLAST through the BioCluster included the assignment of 
blacklight processor for the post-blast steps to accommodate a large (>50K) number of 
sequences, and an e-value of 1e-5 is specified.  All other specifications used the default 
parameters.  Once the data set was complete, an appropriate e-value was determined using 
output information from the all-by-all BLAST.  The goal of this SSN is to cluster sequences 
that can be considered isofunctional.  Although the isofunctional sequence cutoff is family 
dependent and unclear for the Hotdog thioesterase family, we started with the general “rule 
of thumb” cutoff of ~35% - 40% sequences identity for the clustering of isofunctional 
protein sequences (Zhao et al. 2014).  Selecting an informative e-value is crucial for 
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understanding the sequence, structure, and function relationship of enzymes.  Thus, it is 
important to choose an e-value that is stringent enough to separate unrelated genes but not 
biologically significant matches.  To achieve this, an e-value should be chosen that 
corresponds to approximately 40% identity.  The “number of edges histogram”, a plot of 
edges vs. e-value, was first analyzed (Figure 5.2a).  This plot assists in determining an e-
value that gives isofunctional clustering.  The lower e-value range gives fewer edges, 
resulting in more independent clusters, while the higher e-values have more edges which 
represent the relationship between isofunctional clusters.  At an approximate e-value of 
>1e-20 a network containing >10M edges would be produced which is likely too lenient and 
results in non-isofunctional clustering.  Likewise, an e-value that is smaller than 1e-95 will 
produce a network that is too stringent and likely result in partitioning of truly isofunctional 
sequences. Thus, based on the edges vs. e-value output, an e-value between 1e-20 and 1e-95 
was selected.  The next output to analyze was the length histogram which plots sequence 
length vs. occurrence, to assess the heterogeneity of the data set.  This data shows the 
number of proteins that are single hotdog domains (and the range in length of the domain) 
or fusion proteins that contain either a domain duplication of a hotdog domain or another 
different domain.  In this case, the majority of sequence data were single hotdog domains 
ranging between ~110-180 amino acids in length (Figure 5.2b).  Because the vast majority 
of the family were shown to be single hotdog domain proteins, a 250 amino acid sequence 
cutoff was chosen to exclude multidomain protein sequences.  Additionally, two quartile 
plots were generated (alignment length vs. e-value and percent identity vs. e-value) to assist 
in e-value determination (Figure 5.2c and d).  These graphs showed the length in sequence 
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or the percent of the entire sequence responsible for the e-value calculation.  At a more 
stringent e-value (smaller e-value), more of the sequence is used for alignment.  In contrast, 
a larger e-value uses smaller stretches of sequences to find short portions of alignment 
which results in a less significant alignment.  The maximum e-value that should be 
considered is that which corresponds to a value that uses full length sequences, in this case 
~1e-10, since the domain size is between 110-180 residues.  At this e-value, the percent 
sequence identity corresponds to ~28%.  The general “rule-of-thumb” for isofunctional 
orthologs is >40% sequence identity.  Thus, we chose a smaller e-value of e-30, which 
corresponds to 35% sequence identity. 
The network generated was a representative network or “metanode” network using 
an e-value threshold of 1e-30 which corresponds to approximately 35% sequence identity. 
In a network, the node (circle) represents one protein sequence and an edge (line connecting 
the nodes) represents the sequence relatedness between the connected nodes.  Each cluster 
is the group of nodes joined by an edge which is defined by the e-value threshold.  The 
clusters represent the sequence diversity within the superfamily.  In the case of the 
metanode generated in this SSN, each node represents a set of sequences related by 95% 
or greater sequence identity.  Due the enormous size of the superfamily, a metanode 
network allows for a more manageable dataset to analyze. 
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Figure 5.2  Outputs from all-by-all BLAST of the Thioesterase superfamily (InterPro ID 
IPR006683) for analysis of generating a SSN.  a) Number of edges histogram, b) Length 
histogram, c) alignment length vs. e-value, and d) percent identity vs. e-value. 
 
The final SSN is shown in Figure 5.3 with the initial targets selected for HTS 
displayed.  A total of 465 proteins were selected—seven of which are considered “structure 
no function” (SNF) which have atomic structure information but no functional annotation.  
Six of the SNF proteins are hypothetical 4-hydroxybenozyl-CoA thioesterases (4-HBT) 
(PDB ID’s 1IXL, 1Z54, 3DKZ, 3E1E, 3HM0, and 3NWZ) and one is a hypothetical acyl-
CoA thioesterase (PDB ID 2EIS).  The remaining targets are completely uncharacterized.  
The first criterion for target selection was choosing those for which genomic DNA was 
available to the protein core facility.  At the time of our initial selection process, genomic 
DNA from 359 different taxonomic ID was available for cloning.  The available genes 
were mapped to the SSN showing diversity in sequence (nodes colored in yellow were 
targets).  Fortunately, these targets had good coverage of the entire superfamily, with 
several representative targets in each of the larger clusters and some scattered targets 
throughout the small clusters. 
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Figure 5.3  SSN generated with e-value cutoff of 1e-30.  Selected targets for the protein 
production pipeline are colored in yellow and SNF targets are colored magenta.  Sequences 
with known function are in blue with the known activities labeled.  ACOT13 is acyl-CoA 
thioesterase 13; 1,4-DHNA-CoA is 1,4-dihydroxy-2-naphtholyl-CoA thioesterase; 4-HB-
CoA is 4-hydroxybenzoyl-CoA thioesterase. 
 
5.3.2 Assay development – Finding a suitable assay  
 Three thiol detection assays were tested and compared in order to find a method 
that best fit the criteria of a HTS — Invitrogen’s thiol detection assay, a colorimetric DTNB 
assay, and a fluorescence reagent monobromobimane (mBrB).  Characterized enzymes, 
241 
 
based on literature and kinetic experiments, were used as controls for assay optimization.  
Five enzymes showing varying degrees of specificity (MA0038 and Galf_1995) and 
promiscuity (ACOT12, YbgC and PA1618) were used; the kinetic constants for the 
substrates are listed in Table 5.2.  These enzymes were used to test the suitability of the 
potential assays methods and the advantages and disadvantages of each assay are described.  
One of the main qualifications for suitability is the sensitivity of the assay, particularly 
because minimal substrate should be used to ensure that substrates are soluble.  Minimal 
volume is also important due to cost efficiency, difficulty in synthesizing substrates, and 
difficulty in purifying protein.  The assay must also have a minimal number of steps and 
show good reproducibility.  For all assays described below, experiments were conducted 
in a buffer containing 50 mM HEPES pH 7.2 and 50 mM NaCl at room temperature. 
 
Thioesterases Known substrates Kcat (s
1) Km (μM) kcat/Km (M-1s-1) 
MA0038 flouracetyl-CoA 37 19 2.0 x 106 
Galf1995 flouracetyl-CoA 11 3.3 3.3 x 106 
ACOT12 propanoyl-CoA 11 800 1.3 x 104 
 butyryl-CoA 0.83 89 9.3 x 103 
 Hexanoyl-CoA 2.1 900 2.3 x 103 
 Octanoyl-CoA 0.05 44 1.1 x 103 
YbgC lauroyl-CoA 0.17 14 1.2 x 104 
 Myristoyl-CoA 0.24 5.3 4.8 x 104 
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Isobutyryl-CoA 1.3 1200 1.1 x 103 
 Butyryl-CoA 1.2 700 1.7 x 103 
 Propanoyl-CoA 1.38 490 2.8 x 103 
PA1618 benzoyl-CoA 56 12 4.6 x 106 
 4HBA-CoA 9.3 3 3.1 x 106 
 1,4-DHN-CoA 0.55 2 2.8 x 105 
 Courmaroyl-CoA 2.5 2.7 9.3 x 105 
 Oleoyl-CoA 0.39 35 1.1 x 104 
 Acetyl-CoA 0.43 116.5 3.7 x 103 
 Lauroyl-CoA 0.28 60 4.7 x 103 
 Myristoyl-CoA 0.91 158 5.8 x 103 
 Hexanoyl-CoA 0.10 19.2  5.2 x 103 
 
Table 5.2 List of five characterized thioesterases used for HTS method development and 
validation.  Substrates for each enzyme are listed in order of highest to lowest measured 
kcat/Km. 
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5.3.2.1 Invitrogen’s Thiol and Sulfide Detection Kit 
 Invitrogen’s thiol and sulfide detection kit was the first tested for use in the HTS 
assay.  The assay uses a colorimetric detection method.  Invitrogen engineered a modified 
papain enzyme (papain-SSCH3) containing a disulfide-inactivated active site.  In the 
presence of thiols, the disulfide derivative is stoichiometrically reduced to produce the 
active form of papain (Figure 5.4a) (Singh et al. 1993; Singh et al. 1995).  The enzyme 
activity is then measured using the papain substrate, N-benzoyl-L-arginine, p-nitroanilide 
(L-BAPNA) (Figure 5.4b).  This stop-time assay was performed by incubating a mixture 
of 5 μl CoA substrate and 5 μl enzyme at room temperature for 45 min.  Subsequently, 100 
μl papain-SSCH3 was added to the mixture and incubated for 1 hour.  Lastly, 100 μl of 
substrate, L-BAPNA, was added and incubated for 1 hour prior to absorbance measurement 
at A410.   
 
 
Figure 5.4  Papain assay schematic.  a. modified papain with disulfide to inactivate 
enzyme.  Presence of thiols reduces the disulfide to active enzyme. b. readout of papain 
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activity using substrate L-BAPNA which produces a colorimetric output (Singh et al. 1993; 
Singh et al. 1995).  
 
 The optimal concentration for substrate and enzyme was tested using the 
functionally characterized thioesterase, PA1618.  A standard curve was first generated 
using known concentrations of CoASH to detect the optimal range of thiol detection.  The 
linear range of thiol detection was best between 0.2 nmol and 1 nmol (or 1 μM and 5 μM).  
Initial concentrations for protein and substrate were determined using PA1618 activity for 
benzoyl-CoA and lauroyl-CoA (Table 5.3a).  From this data, 200 μM substrate 
concentration and 2 μM protein concentration were determined to be optimal.  Thus, these 
concentrations were used to test HTS suitability.  A small scale enzyme vs. substrate assay 
was conducted for method validation using five characterized thioesterase enzymes and 
seven CoA substrates using a 95-well plate format.  The absorbance after normalization by 
subtraction of no protein and no substrate background resulted in the absorbance values 
shown in Table 5.3b.  Results from control enzymes reflected the expected outcomes.  
MA0038 and Galf1995 are expected to be specific for fluoroacetyl-CoA and thus to have 
no activity for any of the substrates tested (Zimey, unpublished). Acot12 is known to have 
a small range of substrates, particular butyryl-CoA (Latham, unpublished).  Though 
butyryl-CoA was not included in the test screen, Acot12 was most active for the isobutyryl-
CoA isomer.  YbgC and PA1618 are considered promiscuous enzymes with many known 
substrates (Chen et al. 2013; Latham 2012).  The small screen showed YbgC activity for 
isobutyryl-CoA, myristoyl-CoA, and lauroyl-CoA, all of which are expected to be 
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substrates.  PA1618 has been shown to catalyze fatty acid acyl-CoA and aromatic CoA 
substrates, with preference for aromatic CoA substrates (Latham 2012).  The results reflect 
the promiscuity of the enzyme as it showed activity for all six substrates.  However, we 
expected benzoyl-CoA to have the highest absorbance because of its high activity, but this 
was not case (discussed below). 
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Table 5.3  Small scale screen for assay optimization of papain assay.  a. Activity of 
thioester hydrolysis at varying concentrations of enzyme (PA1618) and substrates 
(benzoyl- and lauroyl-CoA) to determine a starting concentration for HTS assay.  Values 
represent normalized absorbance at A410.  b. A small protein vs. substrate screen of known 
enzyme activity was used to validate that the method may be applied other thioesterases.  
Results shown were converted to nmol of CoA hydrolyzed.  
 
5.3.2.2 Monobromobimane (Thiolate) 
 Monobromobimaine (mBrB) is a heterocyclic compound often used for thiol 
quantification by fluorescent labelling.  The compound itself is not fluorescent but the 
alkylation of thiol groups with displacement of bromide produces fluorescence (Figure 
5.5).   Several trials of varying enzyme, substrate, and mBrB concentrations were 
performed using PA1618 to determine optimal concentrations for enzyme activity and 
account for fluorescent quenching.  From a standard curve of known CoASH 
concentrations, it was determined that >1 mM mBrB produced significant fluorescent 
quenching, thus 0.5 mM mBrB was used for the screen, and the lower detection limit was 
determined to be ~10 uM CoASH.  The reaction was carried out by mixing 10 μM (and 0.1 
μM) PA1618 and 100 μM substrates and incubated for 15 min, followed by addition of 0.5 
mM final concentration of mBrB.  The fluorescent probe was incubated at room 
temperature for 30 min prior to fluorescence measurements at absorption/emission maxima 
of ~394/490 nm.   
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Figure 5.5  Reaction of mBrB for thiol detection. 
 
 Results from this assay were unexpected and showed discrepancies between two 
enzyme concentrations (Figure 5.6).  At the lower concentration of PA1618, results were 
as predicted, showing best activity for benzoyl-CoA which was completely hydrolyzed in 
the reaction.  Next, low activity was seen for myristoyl-CoA, octanoyl-CoA, and 
tridecanoyl-CoA.  At 0.1 μM enzyme concentrations, results reflected the expected 
substrate range of PA1618 for aromatic and medium chain fatty acid CoA substrates.  At a 
higher protein concentration (10 μM) benzoyl-CoA again showed complete substrate 
hydrolysis.  However, all other substrates (except for octanoyl-CoA) resulted in greater 
calculated CoASH concentration than what was possible from the amount of input 
substrate.  A similar trend was seen in the papain assay and is discussed in section 5.3.3. 
 
+   CoASH +  H+ + Br
-
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Figure 5.6 mBrB assay testing hydrolysis of select CoA substrates against PA1618.  
Substrate concentration 100 μM.  The chain length of the acyl-CoA substrates are 14:0 
(myristoyl-CoA), 8:0 (octanoyl-CoA), 13:0 (tridecanoyl-CoA), 21:0 (henarachidoyl-CoA), 
and 23:0 (tricosanoyl-CoA).  
 
 
 
 
0
50
100
150
200
250
300
350
400
[C
o
A
SH
] 
μ
M
CoA substrates
0.1uM PA1618
10uM PA1618
249 
 
5.3.2.3 DTNB assay 
 Ellman’s reagent (5,5'-dithiobis-(2-nitrobenzoic acid) or DTNB) is a widely used 
compound for the quantification of thiols.  The optimization of the DTNB assay followed 
a similar protocol as that for the papain assay.  A standard curve was first generated to 
determine the concentration limits.  The optimal concentration range is between 2 nmol 
and 50 nmol (or 20 μM and 500 μM).  The initial concentration optimizing experiment 
included a range of substrate concentration (10 μM to 500 μM), protein concentration (0.2 
μM and 200 μM) and 1 mM DTNB in a 100 μl final volume.  The absorbance at A410 was 
measured after 45 min (Table 5.4a).  Due to lower sensitivity of the DTNB assay, a small 
screen was carried out with 500 μM substrate and 2 μM enzyme.  The five enzymes listed 
in Table 5.2 were used to test the activity against seven substrates.  The resulting trend in 
substrate range and preference for the selected enzymes were comparable to the results 
from the papain assay (Table 5.4b).   
 
 
 
Figure 5.7  Reaction of colorimetric DTNB reaction assay. 
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Table 5.4 Results from DTNB assay optimization. a. Test of PA1618 activity against 
benzoyl-CoA substrate to determine starting concentration. b. small scale enzyme vs. 
substrate screen for method validation. 
 
 In another test that mimics the experiments conducted in the mBrB assay, PA1618 
appeared to show a similar discrepancy between the results from two enzyme 
concentrations.  At a low enzyme concentration, PA1618 is highly active and specific for 
benzoyl-CoA.  However at 10 μM, PA1618 not only hydrolyzes other acyl-CoA substrates, 
but also reports a higher CoASH concentration than the total substrate (100 μM) added 
(Figure 5.8). 
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Figure 5.8  DTNB assay testing hydrolysis of select CoA substrates against PA1618.  
Substrate concentration used is 100 μM.  Results show similar discrepancy between 
different enzyme concentrations as mBrB assay. 
 
5.3.3 Advantages and Disadvantages of the Assays 
 The Ellman’s reagent-based assay was ultimately chosen as our method of thiol 
detection for the thioesterase HTS.  The thiol detection by papain assay was highly 
sensitive for low CoASH concentration which was ideal for small volume assays.  
However, though the assay can potentially be used in high-throughput mode, the major 
disadvantage is the long overall assay time (~2 hours) and the limited shelf-life of the 
modified papain-SSCH3 enzyme.  Because we expect the enzyme screening process to be 
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an ongoing project, the detection reagent should ideally be stable over a long period of 
time.  Furthermore, the mBrB detection method by fluorescence labeling of CoASH was 
suitable for high throughput and required far less experimental preparation and assay time 
compared to the papain assay.  However, the discrepancies seen between two enzyme 
concentrations was a major issue that needed to be addressed.  Since this effect was seen 
in all three assay types (papain, mBrB and DTNB assays), we can rule out the possibility 
of experimental error or an inherent problem with the assay.   
 To investigate this further, the substrate library was expanded to include the 
entire library of 51 substrates.  Both the mBrB and DTNB assays were performed to 
compare results.  Assays were done in parallel using 2 μM PA1618 and 200 μM substrate 
in a total final volume of 100 μL.  The reaction was incubated for 45 min at room 
temperature prior to measurement.  Because PA1618 is biochemically well characterized, 
we used the hydrolysis of benzoyl-CoA as a benchmark for the best substrate.  In both 
assays, ~100% of the benzoyl-CoA was hydrolyzed with ~200 μM CoA detected after 45 
min.  However, in many of the medium and long chain fatty acid CoA substrates, detection 
by fluorescence and absorbance exceeds the maximum substrate concentration (Figure 
5.9a and b).  Our explanation for this result is the lack of product solubility.  The critical 
micelle concentration (CMC) for many of the long chain fatty acids (LCFA) is in the 
micromolar to nanomolar range.  When micelles form, the fatty acid aggregates interfered 
with the assay resulting in an apparent high fluorescence signal or absorbance.  Therefore, 
the final product CoASH formation could not be used as an accurate measurement of 
substrate hydrolysis.  This is a common problem that arises in working with enzymes that 
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catalyze LCFA.  From our observations and reported solubility limits, all substrates appear 
to be soluble at 200 μM when the acyl chain is conjugated to a CoA molecule.  However, 
upon hydrolysis, free fatty acids aggregated into micelles.  In efforts to increase solubility, 
DMSO was added but showed little to no change in the results.  Additionally, bovine serum 
albumin (BSA) was used to attempt to sequester the fatty acids but little change was 
observed.  In order to circumvent this problem, we used the DTNB assay to measure the 
rate of CoASH production over time.  The greatest advantage of the DTNB assay, albeit 
sacrificing sensitivity, is that DTNB is a continuous assay in which activity can be 
monitored over time.  In addition to overcoming the problem of skewed results due to 
micelle formation, it also provides an easy way to check for potential experimental errors 
such as the presence of air bubbles giving false positive results or false negative results due 
to product inhibition.  To point out some of the disadvantages of this assay, it is less 
sensitive compared to the papain and mBrB assays.  Also, DTNB has a small range of pH 
in which it is active, between pH 7.0-8.0.  Although this not a concern for the current HTS 
because all experiments are conducted at pH 7.6, it could limit the general applicability of 
the assay for determining kinetic parameters of enzymes that are functional at pH extremes.  
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Figure 5.9  Full substrate activity assay of PA1618 using a. mBrB fluorescence assay and 
b. DTNB assay.  Each assay was done in duplicate (n1 and n2) and the orange dotted line 
marks the readout that corresponds to 200 μM CoASH determined by a CoASH standard 
curve.  
 
5.3.4 Determining substrate and enzyme concentrations 
 Selecting a substrate concentration for HTS is not trivial and requires careful 
consideration.  Although choosing a substrate concentration was discussed in the assay 
optimization section above, it is important to summarize some of the main points of 
consideration when selecting a concentration.  A range of concentrations were tested during 
assay optimization to determine an appropriate concentration where the signal from 
product release of at least 10 μM (lower limit of thiol detection for DNTB under the 
conditions used) difference over the background was considered a true substrate hit.  Since 
substrate screening will monitor the change in absorbance as a function of time 
(Δabs412/min), the minimum rate corresponded to ~1 μM/min (or 0.5% of total substrate 
hydrolysis per minute) when measured over 10 min.  To ensure a significant and 
measureable rate, the kcat and Km of enzymes should be considered.  Fortunately, many 
Hotdog fold thioesterases have been kinetically characterized providing values for catalytic 
efficiency for comparison to the high throughput results.  Based on the literature, the range 
in Km values of characterized hotdog thioesterases are in the low to high micromolar range 
(examples shown in Table 5.5).  Thus, we chose a 200 μM substrate concentration which 
is > Km of most hotdog thioesterases.  Likewise, the concentration of enzyme is 
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proportional to the rate (Vmax=kcat[E]t) and should also be given sufficient consideration.  
A concentration of 10 μM was chosen based on the kcat range of known thioesterases.  From 
the prototypical kcat values listed in Table 5.2, the slowest catalytic rate is ~0.05 s
-1.  Thus, 
assuming this represents the lower range of kcat values for the superfamily and the substrate 
concentration is sufficient to reach ½ Vmax, we can calculate a minimum Vmax of ~0.25 
μM/s (or 15 μM/min) when 10 μM enzyme is used, which is a significant rate compared to 
background changes in absorbance.   
 
Enzyme  Km Substrates 
YbgC 40-600 μM Medium acyl-CoA (4, 8, 12, 14, 16, 18C) 
hTHEM2 5-300 μM Medium-long acyl-CoA 
Flk 30 μM Fluoroacetyl-CoA 
4 HB-CoA 1.5 μM 4-Hydroxybenzoyl-CoA 
PaaI 10-200 μM Phenylacetyl-, Hydroxy-phenylacetyl-CoA 
YciA 6.6-13 μM Lauroyl-, isobutyryl-CoA 
ACOT9 16 μM Isobutyryl-CoA 
Table 5.5  Examples of biochemically characterized Hotdog thioesterases with Km for 
different substrates.  In paranthesis for YbgC substrates are the acyl chain length. 
 
 
 
258 
 
5.3.5 Assaying Characterized Enzymes  
 Assays were all performed in duplicate in 384-well plates, in which each well 
contained a different substrate to be screened.  A background absorbance reading was taken 
prior to addition of enzyme, and was considered time point tmin = 0.  Subsequently, protein 
was added to a final concentration of 10 μM to each well simultaneously and the 
absorbance was measured at every 1 min for 10 min using the SpectraMax M5 plate reader.  
Figure 5.10a is an example of the raw data collected for PA1618.  A plot of rate (Δabs412/ 
min) for each substrate was made to clearly visualize the linear period of the reaction 
(Figure 5.10b).  The final output was presented as a ratio of the substrate hydrolyzed per 
min to the total substrate concentration.   
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Figure 5.10  Example of raw data from HTS of the complete library of substrates against 
PA1618.   a. A plot of absorbance vs. time where each curve respresents a different 
substrate. b. A plot of the ΔAbs/min for each substrate used to acquire the rate of 
hydroylsis.  
 
 Seven characterized hotdog thioesterases were used in method validation.  
Although the screen does not give information about the kinetic parameters (kcat or Km), it 
yields the relative catalytic efficiency compared with other substrates.  Therefore, we can 
begin to rank the best to worst substrates catalyzed by a particular thioesterase.  The seven 
control enzymes include PA1618, YdiI (Latham et al. 2014), 3HBT (unpublished), 
hTHEM2 (Wei et al. 2009), PaaI (Song et al. 2006), YdbD (Chen et al. 2009), and MA0038 
(chapter 4) (Figure 5.11).  Overall, the control experiments gave the expected results.  For 
each enzyme, the results were compared to the reported kinetic data.  The boxed cells in 
the figure represent published substrate hits that have a kcat/Km of ≥102 M-1s-1.  In the case 
of PA1618, YdiI and hTHEM, many new substrates were identified which was not 
surprising since these enzymes are known to be highly promiscuous.  PaaI is specific for 
phenylacetyl-CoA, YbdB for benzoyl-CoA, and MA0038 is specific for fluoroacetyl-CoA.  
In most cases, the results matched the known kinetic profiles.  While many new substrates 
emerged as “hits”, the predicted physiological substrates still displayed the highest 
catalytic efficiency.  With this, we established what was considered a good substrate and a 
poor substrate.  The highly active, “good” substrates were those which resulted in >10% 
(or 0.10) hydrolysis per minute and “poor” substrates were those which resulted in 3-9% 
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(or 0.03 to 0.09) hydrolysis per minute.  We used these parameters to analyze unannotated 
targets. 
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Figure 5.11  Method validation of complete HTS substrates against seven characterized 
Hotdog thioesterase enzymes.  Values represent the ratio of total substrate hydrolysis per 
minute.  
 
5.3.6 Overall analysis of uncharacterized thioesterase targets 
 To date, 42 uncharacterized hotdog thioesterase targets were successfully expressed 
and purified.  These enzymes were subjected to the full screen of 51 substrates.  The 
screened targets were mapped onto the hotdog full SSN (Figure 5.12), with nodes colored 
in green representing enzymes that have been screened and in yellow representing targets 
currently in the pipeline for expression testing.  Figure 5.13 displays the results on a heat 
map where each column is an enzyme and each row is a substrate.  The figure is organized 
from enzymes that are most substrate promiscuous to those that are most specific.  
Although the current data is a relatively small subset from our ultimate screening goal, it 
provides a glance at the substrate landscape that Hotdog thioesterase enzymes can cover.  
Additionally, the screened enzymes were well scattered across the network suggesting that 
they are functionally unrelated. 
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Figure 5.12  SSN of Hotdog thioesterases defined by InterPro family IPR006683.  Selected 
targets (465 genes) chosen for protein production are colored in yellow.  Targets that have 
been successfully purified and screened by the HTS are colored in green to show the 
distribution of enzymes currently screened.  Nodes in blue are proteins with known 
function. 
 
 From the heat map, it is immediately apparent that approximately a quarter of the 
enzymes were active towards the majority of the substrates screened.  According to the 
definition of “good” and “poor” substrate, two enzymes exhibited some hydrolysis activity 
for every substrate (having an activity score of >0.03).  It is also apparent that 
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approximately half the enzymes are highly promiscuous.  In order to classify enzymes by 
their level of promiscuity, two plots of the number of enzymes as a function of the number 
of substrate hits for an enzyme were generated—the first was a plot of substrates 
considered “good” hits (≥0.10) (Figure 5.13a) and another of all hits (≥0.03) (Figure 5. 
13b).  The curve of “good” hits resembled a positively skewed distribution with a mode of 
1 substrate, median of 6.5 substrates, and average of 11 substrates.  The plot of all substrate 
hit resulted in a more even distribution with a mode of 13, median of 17 and average of 22 
substrates.  In order to account for both “good” and all hits, the sum of the two plots was 
generated and used to define the limits of substrate specificity and promiscuity (Figure 
5.13c).  The top 25% of enzymes with the fewest substrate hits were assigned as specific 
enzymes (≤5 substrates), between 25%-75% were assigned as promiscuous (6 ≤ substrates 
≤ 30) and those 25% with the most substrate hits were assigned as very promiscuous (≥ 31 
substrates). 
 By these criteria, 14 targets were specific, 16 were promiscuous, 6 were very 
promiscuous, and 3 had no identified substrates.  Thus, ~33% of the sampled superfamily 
members were specific and 67% were promiscuous.  Enzymes with no identified substrates 
were excluded from further analysis.  A simple explanation is that the enzyme is highly 
specific for a substrate that is not currently in the screen, or alternatively due to the 
freeze/thawing of protein, it is no longer active.  Other possibilities may include pH or 
temperature sensitivity.  For example, Q73TX1 is a predicted thioesterase from 
Mycobacterium avium subspecies paratuberculosis, which is an obligate pathogenic 
bacterium affecting the gut.  The bacterium is known to be heat resistant and is viable up 
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to 71˚C (Sung & Collins 1998).  Thus, it would be worthwhile to screen the enzyme at 
higher temperatures.  This analysis, however, was based on results considered “good” hits.  
When similar rules were applied for “good” hits to account for low active substrates 
(≥0.03), 11 were specific, 19 were promiscuous, and 9 were very promiscuous.  Thus, 23% 
of enzymes were shown to be specific and 77% were promiscuous.  In either case, the 
current data suggests that the superfamily is high promiscuous.  
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Figure 5.13.  HTS results from the 42 functionally unknown targets.  The heat map is 
shown on a scale from 0 to 1 where 0 is no activity and 1 represents complete substrate 
hydrolysis within 1 min of assay.  The green heat map at the bottom denotes the number 
of substrates catalyzed by an enzyme.  The top row (≥0.1) signifies the number of substrates 
considered “good” hits and the bottom row (≥0.03) are considered “all” hits. 
 
268 
 
 
269 
 
Figure 5.14  Defining enzymes that are specific, promiscuous and very promiscuous. a. A 
plot of number of enzymes as a function of number of hits for “good” hits and b. all hits. 
c. A plot of the sum of the number of substrate hits from graphs a and b to define specificity 
and promiscuity.  The first 25% with the least number of hits is considered specific (5 hits 
or more), 25%-75% is promiscuous (6-30 hits) and the 25% with the most hits is very 
promiscuous.   
 
 Next, the results table was transformed and organized from the most to least 
commonly used substrates to show the frequency of substrate usage catalyzed by the 
screened enzymes (Figure 5.15).  Surprisingly, acetyl-CoA (the smallest substrate among 
the screen) was not ranked among the most commonly used substrates.  In fact, the highest 
ranked substrates were primarily long acyl-CoA chains.  The general trend for the most 
popular substrates was 18 to 24 carbon acyl-CoA and the least used substrates were 
branched fatty acid acyl-CoA substrates.  Out of the 39 enzymes that showed activity, 22 
enzymes were active against tridecanoyl-CoA (15:0) and hexacosanoyl-CoA (26:0) (most 
frequent), and 2 enzymes were active for β-methylcrotonyl-CoA and malonyl-CoA (least 
frequent).  Another trend that emerged from this analysis is that even for promiscuous 
enzymes, there was some level of specificity for the type of substrates preferred.  For 
example, aside from the very promiscuous enzymes that accepted almost all substrates, 
most enzymes fell into one of 3 categories—1) preference for short and branched 
substrates, 2) long and very long acyl chains, and 3) aromatic substrates.  Enzymes were 
binned according to the three categories and revealed that 20% of enzymes preferred short 
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and branched substrates, 40% preferred long and very long acyl chains, and 40% preferred 
aromatic substrates.  
 While most of the screened enzymes do not currently have structural information, 
Q5LMG0 was among the SNF (structure no function) targets.  Q5LMG0 is a thioesterase 
with unknown function from Silibacter pomeroyi, a Gram-negative marine bacterium. The 
HTS identified three substrate hits showing preference for very long fatty acid acyl-CoA.  
Q5LMG0 exhibited high activity towards pentacosanoyl-CoA (25:0) and hexacosanoyl-
CoA (26:0), and low activity towards palmitoleoyl-CoA (18:1).  The overall structure of 
Q5LMG0 (3E1E) resembled a typical hotdog fold thioesterase containing six antiparallel 
β-sheets wrapped around a six-turn α-helix, and an additional helix at the N-terminus 
(Seetharaman 2008).  This structure was used to generate a ligand fitted model to 
understand preference for long fatty acid acyl-CoA.  The ligand, pentacosanoyl-CoA 
(25:0), was positioned in the active-site tunnel where the thioester bond of the substrate 
was placed within hydrogen bond distance from a conserved carboxylate residue, Asp63, 
located in the middle region of the central α-helix of one subunit and a conserved aromatic 
residue, His54, at the N-terminus of the central α-helix of the opposing subunit.  It should 
be noted, however, that a conserved carboxylate residue often found at the N-terminal loop 
of the central α-helix was not present in this structure.  From the model, about 15 carbons 
of the substrate acyl chain were bound within the active site “tunnel”.  The remaining 
substrate acyl group extends through the length of the tunnel and does not make specific 
interactions with the protein.  This demonstrates a possible reason for the lack of specificity 
for very long chain fatty acids.   
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Figure 5.15 HTS results organized to show frequency of substrates catalyzed by an 
enzyme.  Heat map is shown on a scale from 0 to 1 where 0 is no activity and 1 represents 
complete substrate hydrolysis within 1 min of assay.  The green heat map at the bottom 
denotes the number of enzymes that can hydrolyze a particular substrate.  The top row 
(≥0.1) signifies the number of enzymes that had “good” activity and the bottom row (≥0.03) 
are “all” enzymes that hydrolyzed the substrate. 
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Figure 5.16  Example of structure to function relationship.  Protein shown in purple ribbon 
is of uncharacterized SNF target (Q5LMG0 with PDB ID 3E1E).  Transparent surface in 
white shows the active site tunnel that guides the substrate thioester to the active site and 
acyl group is strung throw the tunnel space to the outside of the protein.  The substrate, 
pentacosanoyl-CoA (25:0), is modeled into the active site using COOT and is shown in 
sticks. 
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5.4 Conclusions 
 This project describes a method for the characterization of functionally unknown 
enzymes belonging to the Hotdog thioesterase superfamily by a combination of 
bioinformatics, enzyme activity HTS and X-ray crystal structure analysis.  A SSN of 
Hotdog thioesterase protein sequences defined by InterPro family ID (IPR006683) was 
generated for a selection of functionally distinct members to represent the superfamily.  An 
activity screening method was optimized for high throughput to identify substrates 
catalyzed by the selected protein targets using a simple colorimetric thiol detection reagent, 
DTNB.  Presently, 465 thioesterases were selected to represent the ~88K sequences in the 
superfamily.  Of these selections, 42 have been successfully purified and subjected to the 
HTS which accounts for 9% of the total selected thioesterase targets.  Although, our current 
screen is limited to what is commercially available, it provides a good representation of the 
diversity of natural CoA thioester substrates.  The majority of the screen includes varying 
lengths of fatty acid acyl-CoA and varying degrees of unsaturation, with some aroy-CoA 
and other derivatives.   
 Our current results suggest that the superfamily is highly promiscuous and the 
majority of the enzymes are active for more than one substrate.  We have also demonstrated 
in this chapter and in chapters 3 and 4, the structural features that determine the substrate 
specificity/promiscuity as well as the preference for the overall substrate structure (ie. 
LCFA acyl-CoA, aroyl-CoA, branched acyl-CoA, etc.).  The initial findings from the HTS 
raise many questions about the superfamily.  For example, can we apply the structure to 
function relationship to the superfamily?  In other words, if a SSN with mapped known 
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functions was compared with a SSN with mapped known structures, would they look 
similar to one another? And functionally, how does a promiscuous enzyme defined by its 
in vitro activity assays translate to its in vivo function?  Are some enzymes designed to 
catalyze the hydrolysis of many substrates or are there other factors that regulate its activity 
in the cell? 
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Chapter 6: 
Conclusions and Directions for the Future 
 The central dogma of structural biology is that enzyme function is dictated by 
structure.  A reoccurring theme in this dissertation is exploring the impact of overall 
structural characteristics as well as subtle atomic detail differences that define substrate 
selectivity and enzyme specificity and promiscuity.  The atomic structures of three 
functionally unrelated enzymes from two evolutionarily distinct superfamilies—human 
phosphomannomutases, PA1618 thioesterase, and FlK thioesterase orthologs—were 
studied in detail using X-ray crystallography to assess the specific features that define 
substrate preference and mechanism.  Lastly, chapter 5 sought to investigate substrate 
specificity and promiscuity of the Hotdog fold superfamily of thioesterases on a global 
scale.  
 
6.1 Phosphomannomutase 1  
 In chapter 2, the mechanism of human PMM1 conversion from a mutase activity to 
a phosphatase activity in the presence of IMP was examined.  Specifically, the binding site 
and side chains involved in direct interactions with and long-range effects on IMP binding 
were determined by X-ray crystallography and verified by site-directed mutagenesis.  
Based on the crystal structure of IMP bound PMM1 and the radius of gyration observed by 
solution scattering in the presence of ligand, we hypothesized a mechanism in which the 
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transient binding of IMP causes transfer of the phosphoryl group of the activated 
phosphoasp to a water molecule instead of transfer to a phosphorylated sugar.   Notably, 
our results from steady-state kinetics of mutant PMM1 constructs showed that two 
positively charged arginine residues ~10-15 Å away from bound IMP were most important 
for IMP recognition.  When Arg180 and Arg183 were changed via site-directed 
mutagenesis to the uncharged amino acids, Thr and Ile, respectively, PMM1 phosphatase 
activity was severely reduced.   
 Although crystal structures of PMM1 and PMM2 have been determined, all 
structures were solved in the cap open (not catalytically competent) conformation.  
Solution scattering data of PMM1 and evidence from other HAD enzymes have confirmed 
the existence of an open (not catalytically competent) and a closed (catalytically 
competent) conformational state.  However, no atomic resolution structures of human 
PMM1 or PMM2 have been solved in the closed state.  Efforts toward solving a closed 
conformation structure are necessary to obtain a snapshot of the enzyme transition state, 
and to reveal the binding determinants of the substrate in the active site pocket.  SAXS 
results revealed cap closure in the presence of a phosphate mimic, VO4
3- plus Glc-1-P (Glc-
6-P), which together presumably form the structure analogous to the Glc 1,6-P2 
intermediate.  However, PMM1 in the presence of VO4
3- and IMP also appear to cause cap 
closure.  Thus, crystal structures of PMM1 bound to VO4
3- with a phospho-sugar substrate 
and/or IMP would give insight to specific interacting residues in the core and cap domains.  
Importantly, if both structures can be obtained, the existence of a bound, ordered water 
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molecule in the active site of the IMP bound structure would give direct evidence of 
phosphoryl hydrolysis by water as proposed in Chapter 2. 
 
6.2 Hotdog Fold Thioesterases 
 Chapters 3 and 4 discuss structural aspects of a highly substrate promiscuous 
enzyme PA1618, and an extraordinarily specific class of enzymes FlK orthologs.  Both 
enzymes belong to the Hotdog superfamily of thioesterases which is defined by a minimal 
secondary structure consisting of an elongated central α-helix and 5-7 antiparallel β-sheets 
that fold to resemble a hotdog in bun.  From the structure of PA1618 bound to two different 
substrate analogs, we showed the importance of the use of an isosteric analog to accurately 
determine the mechanism of action.  Since two types of catalytic mechanisms have been 
known to be employed by Hotdog thioesterases, nucleophilic catalysis and general base 
catalysis, it is necessary to obtain a ligand-bound structure accompanied by single-turnover 
kinetic assays to decipher the type of mechanism used.  However, as we have shown in the 
structure of PA1618 bound to phenacyl-CoA, the addition of a methyl group in the 
substrate caused displacement of a coordinated water molecule at the active site (observed 
in the benzoyl-Od-CoA bound structure) which lead to ambiguous and conflicting results 
between the structure and kinetics.  Thus, we propose that it is imperative to use an isosteric 
substrate analog in structure determination to analyze mechanisms for Hotdog 
thioesterases.  In addition to the capture of a true snapshot of the Michaelis complex, our 
collaborators also showed that PA1618 was highly promiscuous for catalyzing the 
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hydrolysis of thioester bonds of CoA substrates ranging from small aromatic to short and 
long acyl fatty acid leaving groups.  Because PA1618 was most catalytically efficient 
toward the hydrolysis of benzoyl-CoA, we determined the structure of PA1618 bound to 
benzoyl-CoA analogs.  However, to further explore the structural components that allow 
for such substrate diversity, it would, in the future, be worthwhile to determine PA1618 
structures bound to structurally disparate ligands.  Furthermore, the physiological purpose 
of PA1618 remains unclear.  Our current data suggests that perhaps it is advantageous for 
the enzyme to be promiscuous because in vivo PA1618 functions as a CoASH scavenger 
to provide the cell with CoASH for a number of other processes.  Thus, experiments to 
probe the biological function should be undertaken in the future. 
In contrast to PA1618, we explored the exceptional degree of substrate specificity 
in FlK and its orthologs.  The function of FlK in S. cattleya is well characterized 
biochemically and the enzyme is highly specific for fluoroacetyl-CoA and against 
structurally similar substrate, acetyl-CoA (Dias et al., 2010; Weeks, Coyle, Jinek, Doudna, 
& Chang, 2010).  Functionally, this selectivity is pertinent to the biological role of FlK as 
a mechanism to clear the organism of fluoroacetyl-CoA before entry into the TCA cycle. 
S. cattleya produces fluorometabolites including fluoroacetate for defense against other 
obligate aerobic organisms and it may be that the evolution of the FlK gene prevented host 
toxicity ( Gribble, 1973; Sanada et al., 1986; Dias et al., 2010).  However, the gene is 
conserved in many other organisms without a fluorometabolite biosynthesis pathway.  We 
have shown that although the fluorometabolite biosynthesis pathways are not present in the 
organisms studied, the FlK orthologs retained specificity for fluoroacetyl-CoA.  Structure 
280 
 
determination of FlK orthologs MA0038, BVU_1957, and the model of Galf_1995 showed 
a conserved “lid” sequence that is held tightly over the active-site pocket.  The “lid” was 
shown to be responsible for limiting the active-site pocket size to accommodate only small 
substrates.  However, due to the lack of an isosteric fluoroacetyl-CoA analog bound 
structure, it is still unclear as to which specific residues are involved in the recognition of 
a fluorine atom as opposed to a hydrogen atom of acetyl-CoA.  Thus, the future direction 
for this project could be to probe the specific structural features involved in the interactions 
with fluorine.  Additionally, the bioinformatics analysis of neighboring genes yielded 
inconclusive results, thus the biological functions of the orthologs remain unknown.  Future 
studies could include biological assays on the organism to tests its resistance and viability 
in the presence of fluoroacetate or other stress inducing compounds.  If the organisms do 
in fact show some level of resistance to fluoroacetate (or fluoroacetyl-CoA), deletions of 
the respective Flk ortholog gene could be made to probe the gene product’s specific 
function. 
 
6.3 High-throughput Substrate Screen 
 This dissertation included the study of two functionally unrelated enzymes in the 
Hotdog fold family.  In these two examples, we have shown the extensive range of substrate 
specificity and promiscuity among Hotdog thioesterases.  This led to the question of what 
the entire superfamily looks like with respect to the substrate range.  Was PA1618 more 
promiscuous than most other Hotdog thioesterases or is the FlK class of enzymes 
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anomalously highly specific?  In order to obtain a glimpse of the substrate range of the 
superfamily as a whole, we designed a high-throughput activity screen to assess both the 
scope of substrate diversity catalyzed by an enzyme and relatively rank the order of 
catalytic efficiency.  Presently, 42 enzymes were screened against 51 different CoA 
substrates.  While ongoing efforts toward expansion of both the enzyme library and 
substrate library are underway to increase the sampling size, we have already begun to 
draw interesting conclusions.  To summarize, our results showed that the majority of 
Hotdog thioesterases were highly promiscuous (~67-77%) suggesting that the superfamily 
is highly fluid and adaptable. 
The outcomes of this project may open up the possibility of many new projects. 
However, we are still at the nascent stages of the screening process.  The initial protein 
target lists included 465 genes to be cloned and expressed.  Currently, approximately 120 
genes have been put through the protein expression and purification pipeline with a success 
rate of 35%.  At this rate, we expect to have 165 successfully purified enzymes to be 
subjected to the HTS from the initial selection of targets.  Additionally, the substrate library 
was heavily biased towards saturated and unsaturated fatty acid acyl-CoAs simply because 
they were commercially available.  Expansion of the substrate library to include a more 
diverse selection of aromatic compounds is crucial to more accurately gauge enzyme 
specificity.  For example, one caveat of the current assessment of enzyme specificity and 
promiscuity is that there were only two aromatic compounds in the screen.  Thus, we could 
not definitively ascribe those that were aroyl-CoA specific to be truly specific because of 
the limited number of aromatically diverse substrates available.  To this end, the synthesis 
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of hydroxylated benzoyl-CoA and phenylacetyl-CoA will be underway in the near future. 
Substrates that have been synthesized previously but require scaling up in order to allow 
their addition to the library include 3-hydroxybenzoyl-CoA, 2-hydroxybenzoyl-CoA, 2,4-
dihydroxybenzoyl-CoA, 4-chlorobenzoyl-CoA, dihydroxynaphthoyl-CoA, gentisyl-CoA, 
coumaroyl-CoA, fluoroacetyl-CoA, and formyl-CoA. 
The ultimate goal of the project is to gain enough data points from the HTS to 
reliably predict the function and substrate preference of most thioesterases.  The SSN 
presented in chapter 5 of the Hotdog thioesterase superfamily was generated using an e-
value cutoff that corresponds to 35% sequence identity.  This cutoff was selected based on 
a general rule of thumb that defines orthologs as having 40% or greater sequence identity. 
By mapping the assayed enzymes to the SSN, we hope to generate a new network that 
relates sequence to function by creating a more stringent e-value cutoff in which clusters 
will represent truly isofunctional orthologs. 
Furthermore, to create a more complete functional annotation of the Hotdog 
thioesterase superfamily, bioinformatic analysis of neighboring genes will be used to 
analyze the biological role and metabolic steps of the enzyme.  This can be achieved using 
genome context networks (GCNs)- an example of which follows.  The network was 
constructed by taking the ten upstream and downstream genes of all thioesterase in the 
InterPro IPR006683 sequences and creating a new network based on the protein family to 
which it belongs (Figure 6.1b).  Each cluster represents a protein superfamily that is 
located within ±10 genes from the thioesterase gene.  The nodes are colored according to 
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the isofunctional clusters generated by the thioesterase SSN (Figure 6.1a) and the size of 
the nodes represents the relative number of genes in each node.  For example, the largest 
cluster in the GCN comprised of enzymes comprises the acyl-CoA dehydrogenase 
superfamily (Figure 6.1c) meaning that a gene encoding acyl-CoA dehydrogenase was the 
most frequently found enzyme ±10 genes from the thioesterase gene.  Each of the nodes 
represents a different cluster from the Hotdog thioesterase SSN.  In Figure 1c, the largest 
node is labeled “1” and colored light blue.  The number and color corresponds to the first 
and largest cluster from the SSN (Figure 6.1a).  This large data set is difficult to analyze 
with our current results, however, it can offer important information in the future. 
Assuming a more isofunctional clustering of the thioesterase superfamily can be achieve 
by mapping HTS results to the SSN, we can create new sets of GCNs pertaining to specific 
SSN clusters for a more meaningful analysis of possible metabolic pathways involved in 
thioesterase homologs. 
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Figure 6.1  Sequence similarity network (SSN) and genome context network (GCN).  a.  
A metanode network with e-vale of 1e-43 was generated for GCN where each cluster is 
assigned a unique number and color.  b.  GCN of the Hotdog fold thioesterase SSN extracts 
the ±10 genes with respect to the thioesterase gene location and clustered by protein family. 
c. Example of a cluster, acyl-CoA dehydrogenase.  Node color and number corresponds to
SSN cluster number and the node size represents the relative number of genes in each node. 
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6.4 Overall Conclusions 
Enzymes belonging to the HADSF and HDFSF were selected to address the 
underlying question that seeks to define specific structural features (ie. charge or size of 
side chains) and overall structural characteristics (ie. secondary structures or multi-domain 
proteins) that effect substrate selectivity.  One major finding from our studies was the 
relationship between substrate promiscuity and enzyme flexibility.  We propose, based on 
our results from PMM and Hotdog thioesterases, a general rule for substrate selectivity in 
which promiscuity is correlated with proteins containing regions of high flexibility near 
the active site. 
In the human HADSF enzyme, PMM1, flexibility of the distal phosphate binding 
loop of the cap domain was observed between the unliganded PMM1 structure and 
structures of PMM1 bound to M1P and IMP (Figure 2.13 and Figure 6.2).  The allowable 
motion in this region provides local structural changes necessary to accommodate the 
binding of a slightly larger molecule (MW of M1P is 260 g/mol vs MW of IMP is 348 
g/mol).  Although IMP is not a substrate of PMM1, it appears to mimic substrate behavior 
by binding at the same binding site as the substrate, M1P, and induces a cap-core closure 
to form the catalytically active conformation.  Thus, IMP can be included in the repertoire 
of metabolites that interact with PMM1 in a substrate-like manner.  Disruption of the β-
strand in the M1P bound structure extended the loop structure by two residues (S182 and 
G183) to increase the cap surface binding pocket for the mannose sugar moiety.  Likewise, 
the β-strand was further disrupted in the IMP-bound structure to extend the substrate 
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binding loop by another residue, starting with F181.  As the loop structure is extended, the 
size of the binding pocket of the cap domain is increased to adjust to the structure of IMP, 
namely the hypoxanthine moiety.  Therefore, the flexibility in the expandable loop region 
allowed for the versatility of binding to monophosphorylated sugar substrates as well as 
IMP with high affinity. 
Figure 6.2 Distal phosphate binding loop of three structures of PMM1—unliganded 
PMM1 (purple), M1P bound (cyan), and IMP bound (salmon).  The binding site including 
residues Gly176-Ser188 are superimposed to show disruption in the β-strand due to ligand 
binding and formation of loop secondary structure.  The terminating β-strand residues are 
labeled—Gly184 for PMM1 unliganded structure, Ser182 for M1P bound structure, and 
Phe181 for IMP bound structure. 
In addition to the flexibility of the substrate binding loop, the dynamic motion 
observed in the hinge region connecting the cap and core domains may play a role in 
substrate promiscuity.  Both human PMM1 and PMM2 are considered to be specific 
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enzymes, but in relation to one another, PMM1 is more promiscuous than PMM2. 
Therefore, we can analyze the differences in flexibility between PMM1 and PMM2 to 
understand promiscuity.  From solution scattering experiments, unliganded PMM1 resulted 
in the largest radius of gyration, Rg, compared to unliganded PMM2 and the more “PMM2-
like” PMM1 variant R180T/R183I, suggesting that wild-type PMM1 had the greatest range 
of motion between the cap and core domains.  The range of motion, as demonstrated in the 
Rg, is in part due to the charges from cap residues Arg180 and Arg183 which creates 
repulsive interactions with positively charged core domain residues Arg199 and Arg28 at 
the cap-core interface.  This is especially evident when comparing the Rg of PMM1 and 
the R180T/R183I variant.  In the inactive conformation, wild-type PMM1 resulted in an 
Rg of 33.5 ± 0.21 Å and R180T/R183I variant of 31.3 ± 0.19 Å (Table 2.8).  Because 
experimental conditions were unchanged for both enzymes, the ~2 Å difference observed 
between the wild-type and variant PMM1 can be ascribed to the repulsive charge effect by 
Arg180 and Arg183.  A greater range of motion, or flexibility in the hinge region, between 
the open and closed conformation may be correlated to promiscuity as exemplified in the 
more flexible PMM1 isoform. 
In agreement with our model, a high throughput substrate screen of HADSF 
enzymes reported the correlation between HADSF cap type and substrate range (Farelli, 
unpublished results).  This finding revealed that type C0 HADSF enzymes (most minimal 
cap insertion) had the most specific enzymes while large cap sizes of the C2a and C2b 
subfamily showed more overall promiscuity.  Although flexibility and promiscuity in the 
HADSF have not yet been examined, we can speculate that C2a and C2b have a greater 
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allowable range of motion between the domains and a greater number of interface residues 
that can provide potential interactions.  Additionally, with greater conformational change 
between the open and closed states, greater substrate promiscuity may be achieved by 
allowing the necessary space for multiple substrates to induce specific side chain 
rearrangements for proper binding of substrates. 
Similarly, enzymes belonging to the HDFSF followed the same rule of flexibility 
and promiscuity.  The examples presented in this work included a promiscuous enzyme, 
PA1618, and fluoroacetyl-CoA specific thioesterases, MA0038 and BVU_1957. 
Structural determination of the thioesterases gave insight to features responsible for the 
promiscuity and specificity in substrate selection.  Notably, in all structures, substrate 
selectivity was attributed to a loop located at the N-terminus of the elongated α-helix (the 
“hotdog”) which lies over the active site pocket.  In a comparative analysis of the three 
structures (Figure 4.16), we concluded that the mobility (measured by B-factor) of the loop 
attributed to the substrate promiscuity of the enzyme.  Likewise, the rigidity of the loop, 
termed the “lid”, of fluoroacetyl-CoA specific thioesterases lead to enzymes having very 
specific substrates.  Thus, we again observed a trend in which regions of high flexibility in 
the active site increases the substrate variability, and alternatively, regions of lesser 
mobility results in more stringent substrate selectivity. 
The proposed model which relates enzyme promiscuity to regions of flexibility is 
not entirely unprecedented.  The concept of enzyme rigidity and flexibility in catalytic 
specificity and promiscuity has been subject of investigation for decades.  This idea 
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emerged from the well-known lock and key model proposed by E. Fischer (1894) and the 
induced fit model by Koshland (1958) (Daniel E Koshland, 1994).  However, many studies 
did not involve substrate promiscuity but instead focused on catalytic promiscuity, which 
is the adaptability of new reaction mechanisms in a catalytic reaction (Demetrius, 1998; 
Gatti-Lafranconi & Hollfelder, 2013; Kazlauskas & Bornscheuer, 2012; D. E. Koshland, 
1963).  Here, we described the observation of substrate promiscuity, the ability to accept a 
range of distinct chemical groups as substrates, in relation to both local flexibility (ie. 
connecting loop near an active site) as well as large overall protein conformational changes. 
To further test this model, annotated enzymes belonging to the HADSF and HDFSF 
can be used.  Enzymes from these superfamilies would serve as ideal examples because of 
the range in flexibility—large range in flexibility between different cap types of the 
HADSF that would result in large global conformational changes and subtle local changes 
to an overall rigid Hotdog Fold.  With a wealth of information on substrate range acquired 
from the HADSF HTS (Farelli, unpublished results) and HDFSF HTS (chapter 5), we can 
begin to assign substrate promiscuity and specificity to the degree of flexibility as structural 
data becomes available. 
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Appendix 
A.1  Crystallization attempt of PMM2 
Structure of unliganded wild-type PMM2 have been deposited in the PDB by the 
Center for Eukaryotic Structural Genomics (2AMY).  Reported crystallization condition 
contained 24% PEG 2,000, 0.12 M glycine, 0.1 M triethanolamine, pH 8.5 using vapor 
diffusion hanging drop method and protein concentration of 10 mg/ml.  However, similar 
conditions did not yield crystals in our lab.  In an attempt to reproduce PMM2 crystals, 
purified protein was first subjected to a thermofluor buffer screen to determine an optimal 
buffer.  The thermofluor buffer screen is a homemade screen containing 96 different 
buffer conditions that samples a range of pH (between pH 4- 10), salts and glycerol.  The 
protein of interest is added to each conditi on with the addition of SYPRO® Orange to 
monitor protein unfolding as a function of increasing temperature.  The optimal buffer 
from the screen, as having the highest Tm, is assumed to be the most protein stabilizing 
buffer condition. 
Purified PMM2 was dialyzed into the optimal buffer and concentrated to 15 
mg/mL for crystallization.  High-throughput sparse factorial crystallization screens by 
Hampton Research (ie. crystal, PEGRx, PEG/ion, Salt, Index) have been used in attempt 
to acquire crystallization conditions of PMM2.  The most promising hit from these results 
was one containing 4% Tacsimate pH 5.0, 12 % PEG3350, 8 mM β-mercaptoethanol 
(Figure A.1). This condition was further optimized using Hampton additive screen, 
detergent screen and silver bullet screen.  Eight conditions yielded crystals (Figure A.2).  
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Figure A.1  Image of  PMM2 microcrystals prior to optimization by additive screens. 
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Figure A.2  Crystallization conditions of PMM2 in  4% Tacsimate pH 5.0, 12 % 
PEG3350, 8 mM β-mercaptoethanol and additions from Hampton additive screen, 
detergent screen, and silver bullet screen.  Images were taken after 7 days. 
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A.1.2 Media recipe for SUMO protease expression 
Recipes 
294
Table A.1  Recipe for media used to express SUMO protease. Recipe is modified from 
Weeks et al. 2006. 
A.2 Other Hotdog Thioesterases 
A.2.1 YbgC 
YbgC is an E. coli Hotdog thioesterase encoded in the Tol-Pal operon.  The 
Tol-Pal gene cluster is found across most bacteria belonging to the α, β, γ subdivision of 
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proteobacteria and involved in cell division by forming the septation ring of a dividing 
cell (Angelini et al. 2008, Gerding el al. 2007).  The exact role of YbgC in cell division is 
unclear.  Although the unliganded structuce of E. coli YbgC is known (PDB ID 1S5U), 
our goal was to solve structures of ligand bound protein to assist in the functional 
annotation of YbgC in the cell.  Based on a library of substrates tested by John Latham, it 
appeared that YbgC has modest thioesterase activity with short chain acyl-CoA substrates 
and higher preference for long chain acyl-CoA substrates.  YbgC also did not appear to 
discriminate between CoA and ACP substrates.  Therefore, crystallization of YbgC in 
complex with ACP substrates and CoA substrates were attempted. 
Purification of YbgC was performed by John Latham and stored in buffer 
containing 50 mM Hepes, 500 mM NaCl, 500 mM imidazole, and 1 mM DTT.  Upon 
receiving the protein, a thermofluor solubility screen was performed.  The buffer solution 
resulting in the highest Tm was 50 mM Bis-Tris Propaine, 100 mM NaCl at pH 6.5 
(Tm=72.9).  The remainder of purified protein was dialyzed in the buffer prior to crystal 
screening.  High-throughput sparse factorial crystallization screens by Hampton Research 
(ie. crystal, PEGRx, PEG/ion, Salt, Index) were used for identification of initial crystal 
hits of YbgC along and in complex with the 8 kDa ACP.  The condition with the most 
promising crystal hit for YbgC co-crystallized with acetone-holo-ACP was identified 
from the crystal screen containing 0.15 M Hepes 7.5 and 0.8 M potassium sodium tartrate 
tetrahydrate.  Further optimization using Hampton additive screen identified several hits 
that improved the crystal form (Figure A.3).  From these, 3 hits were chosen for 
optimization including strontium chloride, 2-propanol and methanol.  Optimization 
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procedures included varying concentration of protein, precipitant, pH of buffer, and 
microseeding.  We were able to obtain crystals of reasonable size in a needle-like shape; 
however, crystals did no produce good diffraction. 
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Figure A.3  Images of YbgC crystals in complex with acetone-holo-ACP. Complex were 
formed at a 1:1 molar ratio. 
A.2.2 Galf1995 
Galf1995 is an ortholog of the S. cattleya fluoroacetyl-CoA specific 
thioesterase (FlK).  It was selected for structural and functional studies in relation to its 
substrate specificity and structural comparison with FlK and other selected orthologs.  
The gene was cloned and purified by Lucas Zimney (UNM).  Proteins were concentrated 
to 10 mg/ml and 15 mg/ml for high-throughput sparse factorial crystallization screening 
using Microlytics MCSG screen.  The initial screen yielded no visible crystal formation.  
Next, crystallization screens were repeated with 1:10K dilution of a MA0038 crystal for 
microseeding.  A condition yielding protein crystals contained a solution of 15% 
PEG8000, 0.1M Tris pH 8.5, and 0.1M-0.25 MgCl2.  These crystals produced poor 
resolution diffraction between 5-8 Å resolution (Figure A.4).  Optimization of this 
condition may result in better diffraction.  
299
Figure A.4  Diffraction image of a Galf1995 crystal. 
A.2.3 ACOT12 
Acyl-CoA thioesterase 12 (ACOT12) from human is a multi-domain 
cytosolic/peroxisomal acetyl-CoA thioesterase (Prass et al. 1980, Suematsu el al. 2001).  
Its physiological function is still unclear.  It is a 556 amino acid long protein with two 
functional domains, the CACH domain and StarD15 domain (Figure A.5a).  The CACH 
domain is comprised of two tandem Hotdog domains that form the catalytically active 
conformation.  This thioesterase domain prefers short chain CoA, namely butyryl-CoA 
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and propanoyl-CoA (kinetics experiments performed by John Latham).  The structure of 
the CACH domain has been deposited with no functional annotation (PDB ID 3B7K, 
Figure A.5b) and the full length ACOT12 structure have yet to be determined.  The 
StarD15 domain of ACOT12 is a START (steroidogenic acute regulatory  
Figure A.5  Structure of ACOT12.  a.  schematic of ACOT12 domains.  ACOT12 is 
comprised of two tandem Hotdog domains termed the CACH domain and a C-terminal 
StarD15 domain.  b. structure of CACH domain showing two Hotdog folds (3B7K). 
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In this project, I attempted to obtain crystal structures of full length ACOT12, 
StarD15 domain, and CACH domain bound to substrate analogs.  These projects were 
done in collaboration with John Latham, Jie Zhang and Yajun Wu from the Dunaway-
Mariano Lab at UNM.  Purified proteins were obtained by our collaborators and high-
throughput sparse factorial crystallization screens were performed immediately upon 
arrival.  For all three proteins (full length ACOT12, StarD15), crystals were obtained.  
Many conditions resulted in salt crystals, confirmed by X-ray diffraction and some 
produced no diffraction.  Those that did not produce diffraction were promising as it 
suggested that crystals were likely formed from the protein (Figure 6).  However, our 
optimization efforts to date did not yield diffraction. 
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Figure A.6  Images of crystals of ACOT12, StarD15 domain and CACH domain.  
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A.3  Structures of substrates used in the thioesterase high throughput screen 
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Figure A.7  Substrate structures used in the Hotdog thioesterase HTS.  Structures, 
chemical name describes the carboxylic acid leaving group. 
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